N-CSR 1 e1264.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES

       
Investment Company Act file number                    811-06526    
     The Boston Trust & Walden Funds  
   (Exact name of registrant as specified in charter)  
One Beacon Street, Boston, MA      
    02108  
(Address of principal executive offices)
(Zip code)  
3435 Stelzer Rd. Columbus, OH      
    43219  
           (Name and address of agent for service)  
   
Registrant’s telephone number, including area code: 1-800-282-8782  
   
Date of fiscal year end: March 31  
Date of reporting period: March 31, 2013  



Item 1.  Reports to Stockholders.




  Annual Report
March 31, 2013
 

Table of Contents
       
Economic and Market Summary   3    
         
Boston Trust Asset Management Fund        

Manager Commentary

  4    

Investment Performance

  5    

Schedule of Portfolio Investments

  12    

Financial Statements

  14    

Financial Highlights

  16    
         
Boston Trust Equity Fund        

Manager Commentary

  4    

Investment Performance

  5    

Schedule of Portfolio Investments

  17    

Financial Statements

  18    

Financial Highlights

  20    
         
Boston Trust Midcap Fund        

Manager Commentary

  6    

Investment Performance

  7    

Schedule of Portfolio Investments

  21    

Financial Statements

  22    

Financial Highlights

  24    
         
Boston Trust SMID Cap Fund        

Manager Commentary

  8    

Investment Performance

  9    

Schedule of Portfolio Investments

  25    

Financial Statements

  26    

Financial Highlights

  28    
         
Boston Trust Small Cap Fund        

Manager Commentary

  10    

Investment Performance

  11    

Schedule of Portfolio Investments

  29    

Financial Statements

  30    

Financial Highlights

  32    

Environmental, Social and Governance Research and Action Update   34    
         
Walden Asset Management Fund        

Manager Commentary

  36    

Investment Performance

  37    

Schedule of Portfolio Investments

  44    

Financial Statements

  46    

Financial Highlights

  48    
         
Walden Equity Fund        

Manager Commentary

  36    

Investment Performance

  37    

Schedule of Portfolio Investments

  49    

Financial Statements

  50    

Financial Highlights

  52    
         
Walden Midcap Fund        

Manager Commentary

  38    

Investment Performance

  39    

Schedule of Portfolio Investments

  53    

Financial Statements

  54    

Financial Highlights

  56    
         
Walden SMID Cap Innovations Fund        

Manager Commentary

  40    

Investment Performance

  41    

Schedule of Portfolio Investments

  57    

Financial Statements

  58    

Financial Highlights

  60    
         
Walden Small Cap Innovations Fund        

Manager Commentary

  42    

Investment Performance

  43    

Schedule of Portfolio Investments

  61    

Financial Statements

  62    

Financial Highlights

  64    
         
Notes to Financial Statements   65    
Report of Independent Public Accounting Firm   72    
Supplementary Information   73    
Investment Adviser Contract Approval   77    
Information About Trustees and Officers   79    

Boston Trust Investment Management, Inc. (BTIM), a subsidiary of Boston Trust & Investment Management Company and an affiliate of Walden Asset Management (Walden), serves as investment adviser (the Adviser) to the Boston Trust & Walden Funds and receives a fee for its services. Walden, a division of BTIM, performs shareholder advocacy, proxy voting, screening services, and other environmental, social and governance initiatives for the Adviser and is paid a fee for these services by the Adviser.

Shares of the Funds are not deposits of, obligations of, or guaranteed by BTIM or its affiliates, nor are they federally insured by the FDIC. Investments in the Funds involve investment risks, including the possible loss of principal. Funds are distributed by BHIL Distributors, Inc. Member FINRA.

The foregoing information and opinions are for general information only. Boston Trust & Walden Funds and BTIM do not assume liability for any loss, which may result from the reliance by any person upon any such information or opinions. Such information and opinions are subject to change without notice, are for general information only, and are not intended as an offer or solicitation with respect to the purchase or sale of any security or offering individual or personalized investment advice.

The Boston Trust & Walden Funds may invest in foreign securities, which may involve risk not typically associated with U.S. investments.

The recent appreciation in the stock market has helped to produce short-term returns that are not typical and may not continue in the future. Because of ongoing market volatility, fund performance may be subject to substantial short-term changes.

Photography credits:
Cover: Bruce Field
Pages 1, 7, 39 and 43: Jim Gallagher
Pages 5, 9 and 41: Rebecca Monette
Pages 11 and 37: Janet C. Dygert

1



This page intentionally left blank.

2



  The Boston Trust & Walden Funds
A Registered Investment Company
 


Boston Trust and Walden Funds
Economic and Market Summary

(Unaudited)
  Domenic Colasacco, CFA
Portfolio Manager and President
Boston Trust Investment Management, Inc.


Stock prices advanced sharply during the 12 months ended March 31, 2013, with the S&P 500 Index closing the fiscal period just above record levels reached in October 2007. Higher equity prices were supported by what are now familiar factors. These include greater investor confidence about the domestic economic outlook, continuation of the Federal Reserve’s aggressive monetary policy and, with the primary exception of the euro zone, evidence that global business trends remain positive. We suspect investors were also pleased about the comparative lack of political drama in Washington in recent months. Congress and the President remain far apart on core fiscal policy issues; however both parties now appear more willing to compromise sufficiently to avoid a repeat of the tax, budget, and debt ceiling battles of recent years that fostered widespread concern about the economy.

Our Economic Outlook
Our economic views today are similar to those outlined in our 2012 mid-year report. At that time, we expected the domestic economy to expand through 2013, albeit modestly. Our confidence reflected positive trends in the key automotive and housing sectors, as well as the economic boost provided by the rapid development of domestic oil and gas shale deposits. We also assumed that the Federal Reserve would maintain an expansionary monetary policy, with near zero interest rates and high financial system liquidity, for the next several years. Globally, we did not expect much improvement within the euro zone or Japan; however, the economies of many emerging market countries had begun to strengthen. Taken together, we concluded that 2013 global economic growth would be close to 3%, a level that is sufficient to support continued gains in corporate profits and cash flows.

Recent economic reports have supported these general expectations. We are particularly pleased with domestic employment, which has continued to rebound at a rate of about 200,000 net new jobs per month. Job growth has helped to sustain a positive trend in consumer spending and lifted overall consumer confidence. Inflation has remained modest, in large part due to still high levels of unused labor and capital resources. Stock values usually trend higher within an environment of rising profits, low inflation and even modest economic growth, a combination we believe is likely to remain in place over at least the next year or two.

At the end of March 2013, the S&P 500 closed just above levels first reached in March 2000 and more recently in October 2007. The S&P 500 may be at a similar level, but there are few other similarities among the three peak value periods. In 2000, driven by the price bubble in the technology sector, valuations of corporate sales, profits and cash flows were roughly twice the historic average and close to the highest valuations on record. We were also about to enter an economic recession led by a drop in technology capital spending after the required Y2K expenditures ended. In 2007 equity valuations were not extreme, but a different economic bubble of far greater importance — housing — was about to burst. The value of an enormous amount of mortgage debt related to inflated house prices held on bank balance sheets dropped suddenly in 2008 and led to the worst financial debacle since the 1930’s. We suspect memories of the recent crisis are still vivid and will not list the varied consequences.

The future is as uncertain and as difficult to predict today as ever. Fundamental investment circumstances, however, are not near the respective valuation and economic extremes of 2000 or 2007. Starting with valuation, stock prices have risen sharply in recent years, but so have corporate financial results. Taken together, stocks currently sell at only average, not inflated multiples of corporate sales, profits, and free cash flows. Prevailing economic risks range from structural currency/sovereign debt problems in the euro zone to stagnation in Japan, while here in the United States we face the prospect of an entitlement-spending imbalance caused by the aging baby boomer generation. These and other difficult challenges will not go away anytime soon.

3



Manager Commentary (Unaudited)

     
     
 
Boston Trust Asset Management Fund
 
     
 
Boston Trust Equity Fund
 
 
March 31, 2013
 
     
 
Domenic Colasacco, CFA
 
     
 
Portfolio Manager and President Boston Trust Investment Management, Inc.
 
     
 
Asset Management Fund Objective
 
 
The Fund seeks long-term capital growth and income through an actively managed portfolio of stocks, bonds and money market instruments.
 
     
 
Equity Fund Objective
 
 
The Fund seeks long-term capital growth through an actively managed portfolio of stocks.
 
     
 
Investment Concerns
 
 
Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.
 
     
 
Bonds offer a relatively stable level of income, although bond prices will fluctuate, providing the potential for principal gain or loss. Intermediate-term, higher quality bonds generally offer less risk than longer-term bonds and a lower rate of return.
 
     
 
Cash equivalents offer low risk and low return potential.
 
     
     

Management Discussion of Fund Performance

 

Portfolio Review

For the 12-month period ended March 31, 2013, Boston Trust Equity Fund posted a total return of 9.76%, an underperformance compared to the 13.96% return for the S&P 500 Index. The shortfall in the Fund’s return relative to the S&P 500 benchmark was primarily due to the results of our equity selections, described in more detail below. As has often been the case in past periods of sharply rising markets, our “high quality” discipline, which seeks to identify companies with long histories of financial success, limited results as equity markets approached new highs.
 
The Boston Trust Asset Management Fund was well positioned to participate in the broad stock market uptrend. Most importantly, the Fund’s equity allocation began the period near 75% of total assets, or at the upper end of the traditional 45% to 75% range. We did not reduce the equity allocation as stock prices increased, taking full advantage of the upward price trend. In hindsight, as was the case with the Boston Trust Equity Fund, we should have been more aggressive in our individual stock selections. The aggregate investment stance, however, still enabled the Fund to post an attractive gain of 8.77% for the 12-month period. The gain was particularly attractive compared to the near zero rates available in money market investments and nominal overall bond returns. We were especially pleased that the Boston Trust Asset Management Fund’s return compared well with those of balanced mutual funds tracked by the leading firms that rank mutual fund performance.*
 
In recent weeks, Fund shareholders have begun to ask us if the time has come to assume a more conservative investment position. After all, most stock indices have increased by close to 40% in just the past 18 months and more than doubled since the lows reached at the height of the financial crisis in March 2009. We would not be surprised if the pace of stock price gains moderates in the months ahead. Neither would an actual, temporary price drop surprise us, especially if economic reports suggest that global business trends have begun to soften, as has occurred at some point during each of the past three calendar years. Yet stocks continue to provide far better longer-term intrinsic value than either bonds or money market instruments and we believe are likely to rise further in the years ahead, provided we are correct that the economy, both here and globally, will continue to improve.

* Portfolio composition is subject to change.

4



Investment Performance (Unaudited)   Boston Trust Asset Management Fund
Boston Trust Equity Fund

March 31, 2013

    Annualized
   
    1 Year Ended   5 Years Ended   10 Years Ended   Since Inception
    3/31/13   3/31/13   3/31/13   10/1/03
  Boston Trust Asset Management Fund1     8.77 %     6.00 %     7.39 %      
  Boston Trust Equity Fund1     9.76 %     6.07 %           7.00 %
  S&P 500 Index     13.96 %     5.81 %     8.53 %     6.83 %

  Barclays Capital U.S. Government/Credit Bond Index     4.56 %     5.50 %     5.06 %      

  Citigroup 90-Day U.S. Treasury Bill Index     0.08 %     0.31 %     1.66 %      

  Morningstar U.S. Open-End Moderate Allocation Funds Avg.     9.35 %     4.53 %     6.82 %      

                                 
Hypothetical Growth of a $10,000 Investment
 

The above charts represent an historical hypothetical $10,000 investment in the Boston Trust Asset Management Fund and the Boston Trust Equity Fund. The top chart signifies a 10-year performance period for the Boston Trust Asset Management Fund. The bottom chart represents an investment from October 1, 2003 (Fund inception) to March 31, 2013. Both charts represent the reinvestment of dividends and capital gains in the Funds. The returns shown on the table and graphs do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.
 
The Boston Trust Asset Management Fund is measured against a combination of equity and fixed income indices. The Boston Trust Equity Fund is measured against the Standard & Poor’s 500 Index (“S&P 500”), which is widely regarded as a gauge of the U.S. equities market. This index includes 500 leading companies in leading industries of the U.S. economy. Although the S&P 500 focuses on the large cap segment of the market, with approximately 75% coverage of U.S. equities, it is also widely viewed as a proxy for the total market. The Barclays Capital U.S. Government/Credit Bond Index is a component of the Barclays U.S. Aggregate Index. The Barclays Capital U.S. Government/ Credit Bond Index includes Treasuries (i.e., public obligations of the U.S. Treasury that have remaining maturities of more than one year), Government-Related issues (e.g., agency, sovereign, supranational, and local authority debt), and USD Corporates. The Citigroup 90-Day U.S. Treasury Bill Index reflects monthly return equivalents of yield averages that are not marked to the market. The Index is an average of the last three-month Treasury bill issues. The three-month Treasury bills are the short-term debt obligations of the U.S. Government. The Morningstar U.S. Open-End Moderate Allocation Funds Average represents performance of portfolios that seek to provide both capital appreciation and income by investing in three major areas: stocks, bonds, and cash. These portfolios tend to hold larger positions in stocks than conservative-allocation portfolios. These portfolios typically have 50% to 70% of assets in equities, and the remainder in fixed income and cash. The indices are unmanaged and their performance does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Funds’ performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.


Boston Trust Asset Management Fund
Fund Net Asset Value: $36.08
Gross Expense Ratio1: 1.00%

Boston Trust Equity Fund
Fund Net Asset Value: $16.85
Gross Expense Ratio1: 1.00%

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.
   
1
The Gross Expense Ratio is from the Fund’s most recent prospectus, dated August 1, 2012. The Gross Expense Ratio includes the impact of repayment of fees and expenses which were previously reimbursed under the terms of each Fund’s contractual expense limitation agreement, which continues through August 1, 2013 and may be terminated thereafter. The contractual fee limit under the agreement is 1.00% of each Fund’s average annual net assets. Please see each Fund’s most recent prospectus for details. Additional information pertaining to each Fund’s expense ratio as of March 31, 2013 can be found in the financial highlights. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower.

5



Manager Commentary (Unaudited)

     
     
 
Boston Trust Midcap Fund
 
 
March 31, 2013
 
     
 
Stephen J. Amyouny, CFA
 
     
 
Portfolio Manager
 
 
Boston Trust Investment
 
 
Management, Inc.
 
     
 
Fund Objective
 
 
The Fund seeks long-term capital growth through an actively managed portfolio of stocks of middle capitalization (“midcap”) companies.
 
     
 
Investment Concerns
 
 
Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.
 
     
 
Mid-capitalization funds typically carry additional risks since smaller companies generally have a higher risk of failure.
 
     
     

Management Discussion of Fund Performance

 

Portfolio Review

The Boston Trust Midcap Fund posted a total return of 9.20% for the 12-month period ended March 31, 2013 – a disappointing result in comparison to the benchmark Russell Midcap® Index, which returned 17.30%. Two primary factors contributed to the Fund’s weak performance relative to the benchmark: 1) the strong performance of lower-quality stocks versus high-quality stocks, and 2) security selection. Over the last 12 months, investors reacted positively to the aggressive monetary policies of the Fed and other central banks across the globe. As a result, investors increased their exposures to riskier assets, including stocks in lower quality companies that stand to benefit the most from a reacceleration in global economic activity. This trend presented a headwind to our investment approach, which focuses on higher-quality companies with more stable businesses, greater financial strength, and high levels of profitability. The Fund also experienced disappointing results relative to the benchmark index in two specific sectors, information technology and consumer discretionary. Within information technology, the Fund’s exposure to companies in the enterprise corporate IT markets detracted from results. This technology segment has recently experienced a softening in demand, which adversely affected the performance of several of the Fund’s holdings; however, we continue to believe that it is an attractive segment within the technology sector with solid growth prospects. In the consumer discretionary sector, many highly cyclical stocks with exposure to residential housing performed exceptionally well. This group included homebuilders, producers of household durables, and home retailers as well as companies in the materials sector that supply building and construction materials and paints.*
 
One sector of the market that performed very well and bucked the aforementioned trend of lower-quality companies was consumer staples. The Fund’s holdings in that sector performed exceptionally well, thanks in part to investors’ gravitation toward companies with relatively stable businesses and high dividend yields that offer an alternative to low yielding fixed income instruments.*
 

Portfolio Strategy

In recent years, corporations have generally grown earnings per share1 (“EPS”) from a combination of revenue growth, margin expansion, and share repurchases. We believe that revenue growth in aggregate among our portfolio companies is likely to approximate global Gross Domestic Product2 growth with perhaps a 1% to 2% additional benefit from expected acquisition activity. Based on strong free cash flow generation and very healthy balance sheets, share repurchases are also likely to contribute to future EPS growth. The wildcard in this formula remains the ability of our companies to continue to expand margins. Over the last few years, companies have benefited from operating leverage, rising productivity, low wage cost inflation, improving supply chain logistics, global sourcing, and lower interest expenses. We anticipate that future margin expansion should be modest, in comparison to current levels, and thus will contribute less to EPS growth over the next few years; although, based on present valuations that are quite reasonable, we believe that EPS growth will be sufficient to drive stock prices higher.
 
As always, the Fund will continue to hold a diversified portfolio of high-quality companies with strong balance sheets, sustainable business models, and attractive growth prospects that sell at reasonable valuations. The last point – reasonable valuations – is worth emphasizing. Thanks in large part to the sharp price appreciation of equities over the last few years many stocks now sell at valuations that imply unreasonably high future growth expectations. We continue to monitor the valuations of our Fund holdings and remain disciplined in all facets of our investment approach. In fact, despite the superior financial characteristics of our companies, the Fund presently sells at a Price-to-Earnings Ratio3 on trailing GAAP EPS that is approximately 15% below that of the Russell Midcap Index. We remain confident that our long-term investment approach and discipline will produce attractive future returns.

1
The Earnings per Share ("EPS") Growth indicates the portion of a company's profit allocated to each outstanding share of common stock. Earnings per share serves as an indicator of a company's profitability.
 
 
2
The Gross Domestic Product (“GDP”) is the measure of the market value of the goods and services produced by labor and property in the United States.
 
 
3
The Price-to-Earnings Ratio (“P/E Ratio”) is a valuation ratio of a company’s current share price to its per-share earnings. A high P/E means high projected earnings in the future.
 
 
*
Portfolio composition is subject to change.

6



Investment Performance (Unaudited)   Boston Trust Midcap Fund
March 31, 2013

    Annualized
   
    1 Year Ended   5 Year Ended   Since Inception
    3/31/13   3/31/13   9/24/07
  Boston Trust Midcap Fund1     9.20 %     9.56 %     7.20 %
  Russell Midcap® Index     17.30 %     8.37 %     5.03 %

                         
Hypothetical Growth of a $10,000 Investment
 

The chart represents the historical performance of a hypothetical $10,000 investment in the Boston Trust Midcap Fund from September 24, 2007 to March 31, 2013, and represents the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.
 
The Boston Trust Midcap Fund is measured against the Russell Midcap® Index, which is an unmanaged index that measures the performance of the mid-cap segment of the U.S. equity universe. The Russell Midcap® Index is a subset of the Russell 1000® Index. It includes approximately 800 of the smallest securities based on a combination of their market capitalization and current index membership. The Russell Midcap® Index represents approximately 31% of the total market capitalization of the Russell 1000 companies. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

Fund Net Asset Value: $13.08
Gross Expense Ratio1: 1.13%

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.
   
1
The Gross Expense Ratio is from the Fund’s most recent prospectus, dated August 1, 2012. The Gross Expense Ratio excludes the impact of any contractual fee waivers. After giving effect to such fee waivers, the Fund’s Net Expense Ratio would be 1.00%, including the indirect expenses of investing in acquired funds. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of March 31, 2013 can be found in the financial highlights. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through August 1, 2013 and may be terminated thereafter.

7



Manager Commentary (Unaudited)

     
     
 
Boston Trust SMID Cap Fund
 
 
March 31, 2013
 
     
 
Kenneth P. Scott, CFA
 
 
Stephen C. Franco, CFA
 
 
Heidi H. Vanni, CFA
 
     
 
Portfolio Managers
 
 
Boston Trust Investment
 
 
Management, Inc.
 
     
 
Fund Objective
 
 
The Fund seeks long-term capital growth through an actively managed portfolio of stocks of small to middle capitalization companies.
 
     
 
Investment Concerns
 
 
Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.
 
     
 
Small- to mid-capitalization companies typically have a higher risk of failure and historically have experienced a greater degree of volatility.
 
     
     

Management Discussion of Fund Performance

 

Portfolio Review

U.S. equity markets rose sharply for the 12-month period, with the value of the Fund’s benchmark, the Russell 2500® Index increasing 17.73%. The U.S. market welcomed continued improvement in economic fundamentals, and appeared unaffected by the ongoing fiscal challenges of the U.S. and Europe. The Boston Trust SMID Cap portfolios, which focus on higher quality, more innovative companies, posted strong gains of 10.00%, although, disappointingly, underperformed the benchmark returns by over 7.7 percentage points for the year ended March 31, 2013.
 
Generally, stocks of higher-quality companies underperform when share prices rise sharply and when expectations for volatility are low and falling. This is consistent with the view that stock values, and those of riskier companies in particular, appreciate as investors demonstrate increased appetite for risk.
 
On a key measure of quality–financial leverage–stocks with lower-quality profiles outperformed in the year ended March 31, 2013. We believe this is due not only to the typical performance patterns associated with lower-quality stocks in a strong bull market, but also to historically low interest rates. The most indebted firms currently face fewer burdens than they would in a normal interest rate environment. On other measures of quality, such as profitability, the performance impact is less clear.
 

Portfolio Strategy

The top individual stock contributors to performance this year were mortgage-servicing firm Ocwen Financial (OCN), short haul railroad firm Genesee & Wyoming (GWR), commercial kitchen equipment maker Middleby (MIDD), railroad equipment supplier Wabtec (WAB) and network storage vendor CommVault Systems (CVLT). Laggards this year were premium mattress manufacturers Tempur-Pedic (TPX) and Select Comfort (SCSS), health care software firm Quality Systems (QSII), prepaid debit card firm Green Dot (GDOT) and videoconferencing vendor Polycom (PLCM). Tempur-Pedic and Green Dot were sold due to concerns about the long-term sustainability of their business models.*
 
Boston Trust aims to maintain SMID-cap portfolio sector weights comparable to those of the overall SMID-cap market. Slight differences in sector weights had no significant impact on relative performance. However, at the subsector level there were differences that affected performance. For example, our focus on higher-quality companies resulted in underweights in certain lower-quality industries, (e.g. airlines, biotechnology, building products, and media) which performed quite well over the previous 12 months.*
 
U.S. economic activity continued to improve in early 2013, with ongoing contributions from consumers, a housing recovery, business investment, and healthy exports, complemented by low inflation and the Federal Reserve maintaining its efforts to hold interest rates at historically low levels. Thus, in spite of several, global economic challenges, the opportunity for continued, positive equity performance, including SMIDcap equity performance, remains in place.
 
That said, with a Price-to-Earnings Ratio1 of 26 times trailing earnings at March 31, 2013, the valuation of the Russell 2500® implies continued strong growth in overall SMID-cap company earnings. Wall Street analysts expect the Russell 2500® companies, in aggregate, to post approximately 20% growth in earnings in 2013. Such earnings growth can be achieved either through strong sales growth, which may be challenging for this large group of companies if the economic recovery remains modest, or through expansion of profit margins, which are already above their historical average. A shortfall in SMID-cap firms’ earnings may prove disappointing at current valuations. However, we continue to believe that investing in reasonably priced shares of a distinct subset of more innovative, higher-quality companies, whose businesses are leveraged to more sustainable elements of growth, will continue to provide substantial value to client portfolios over time.

1
The Price-to-Earnings Ratio (“P/E Ratio”) is a valuation ratio of a company’s current share price to its per-share earnings. A high P/E means high projected earnings in the future.
 
 
*
Portfolio composition is subject to change.

8



Investment Performance (Unaudited)   Boston Trust SMID Cap Fund
March 31, 2013

    Annualized
   
    1 Year Ended   Since Inception
    3/31/13   11/30/11
  Boston Trust SMID Cap Fund1     10.00 %     16.11 %
  Russell 2500TM Index     17.73 %     24.07 %

                 
Hypothetical Growth of a $10,000 Investment                
 

The chart represents the historical performance of a hypothetical $10,000 investment in the Boston Trust SMID Cap Fund from November 30, 2011 to March 31, 2013, and represents the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.
 
The Boston Trust SMID Cap Fund is measured against the Russell 2500TM Index, which is an unmanaged index that measures the performance of the small- to mid-cap segment of the U.S. equity universe, commonly referred to as “smid” cap. The Russell 2500 is a subset of the Russell 3000® Index. It includes approximately 2500 of the smallest securities based on a combination of their market cap and current index membership. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

Fund Net Asset Value: $12.05
Gross Expense Ratio1: 2.18%

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. Returns less than one year are not annualized. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.
   
1
The Gross Expense Ratio is from the Fund’s most recent prospectus, dated August 1, 2012. The Gross Expense Ratio excludes the impact of any contractual fee waivers. After giving effect to such fee waivers, the Fund’s Net Expense Ratio would be 1.00%, including the indirect expenses of investing in acquired funds. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of March 31, 2013 can be found in the financial highlights. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through August 1, 2013 and may be terminated thereafter.

9



Manager Commentary (Unaudited)

     
     
 
Boston Trust Small Cap Fund
 
 
March 31, 2013
 
     
 
Kenneth P. Scott, CFA
 
     
 
Portfolio Manager
 
 
Boston Trust Investment
 
 
Management, Inc.
 
     
 
Fund Objective
 
 
The Fund is to seeks long-term capital growth through an actively managed portfolio of stocks of small capitalization companies.
 
     
 
Investment Concerns
 
 
Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.
 
     
 
Small-capitalization funds typically carry additional risks since smaller companies generally have a higher risk of failure, and historically, their stocks have experienced a greater degree of market volatility than stocks on average.
 
     
     

Management Discussion of Fund Performance

 

Portfolio Review

U.S. equity markets rose sharply for the 12-month period ended March 31, 2013, with the value of the Russell 2000® Index increasing 16.30%. The U.S. market welcomed continued improvement in economic fundamentals, and appeared unaffected by the ongoing fiscal challenges of the U.S. and Europe. The Boston Trust Small Cap Fund, which focuses on higher quality, more innovative companies, posted a strong gain of 11.61% for the 12-month period, although, disappointingly, underperforming the benchmark return for the fiscal period. For the 5-year, 10-year, and 15-year periods ended March 31, 2013, the Boston Trust Small Cap Fund outperformed the Russell 2000® while demonstrating lower volatility.
 
Generally, stocks of higher-quality companies underperform when share prices rise sharply and when expectations for volatility are low and falling. This is consistent with the view that stock values, and those of riskier companies in particular, appreciate as investors demonstrate increased appetite for risk.
 
On a key measure of quality–financial leverage–stocks with lower-quality profiles outperformed in the year ended March 31, 2013. We believe this is due not only to the typical performance patterns associated with lower-quality stocks in a strong bull market, but also to historically low interest rates. The most indebted firms currently face fewer burdens than they would in a normal interest rate environment. On other measures of quality, such as profitability, the performance impact is less clear.
 

Portfolio Strategy

The top individual stock contributors to performance this year were mortgage servicing company Ocwen Financial (OCN), short haul railroad firm Genesee & Wyoming (GWR), pharmaceutical packaging company West Pharmaceutical (WST), architectural glass manufacturer Apogee Enterprises (APOG), and commercial kitchen equipment maker Middleby (MIDD). Laggards this year were premium mattress manufacturer Select Comfort (SCSS), health care software firm Quality Systems (QSII), prepaid debit card firm Green Dot (GDOT), alternative fuel vehicle equipment maker Fuel Systems Solutions (FSYS), and business-to-business auction firm Liquidity Services (LQDT. We sold Ocwen Financial and Genesee & Wyoming from the Fund due to market capitalization considerations, and sold Green Dot and Fuel Systems due to concerns about the long-term sustainability of their business models.*
 
Boston Trust aims to maintain small cap portfolio sector weights comparable to those of the overall small cap market. Slight differences in sector weights had no significant impact on relative performance. However, at the subsector level there were differences that affected performance. For example, our focus on higher-quality companies resulted in under weights in certain lower-quality industries (e.g. airlines, biotechnology, building products, and construction materials) that fared particularly well during the 12-month period.
 
U.S. economic activity continued to improve in early 2013, with ongoing contributions from consumers, a housing recovery, business investment, and healthy exports, complemented by low inflation and the U.S. Federal Reserve maintaining its efforts to hold interest rates at historically low levels. Thus, in spite of several, global economic challenges, the opportunity for continued, positive equity performance, including small-cap equity performance, remains in place.
 
That said, with a Price-to-Earnings Ratio1 of 34 times trailing earnings at March 31, 2013, the valuation of the Russell 2000® implies continued strong growth in overall small-cap company earnings. Wall Street analysts expect the Russell 2000® companies, in aggregate, to post approximately 20% growth in earnings in 2013. Such earnings growth can be achieved either through strong sales growth, which may be challenging for this large group of companies if the economic recovery remains modest, or through expansion of profit margins, which are already above their historical average. A shortfall in small-cap firms’ earnings may prove disappointing at current valuations. However, we continue to believe that investing in reasonably priced shares of a distinct subset of more innovative, higher-quality companies, whose businesses are leveraged to more sustainable elements of growth, will continue to provide substantial value to Fund holders’ overall portfolios over time.*

1
The Price-to-Earnings Ratio (“P/E Ratio”) is a valuation ratio of a company’s current share price to its per-share earnings. A high P/E means high current earnings.
 
 
*
Portfolio composition is subject to change.

10



Investment Performance (Unaudited)   Boston Trust Small Cap Fund
March 31, 2013

    Annualized
   
    1 Year Ended   5 Years Ended   10 Years Ended
    3/31/13   3/31/13   3/31/13
  Boston Trust Small Cap Fund1,*     11.61 %     8.95 %     12.48 %
  Russell 2000® Index     16.30 %     8.24 %     11.52 %

                         
Hypothetical Growth of a $10,000 Investment
 

The chart represents a 10-year hypothetical $10,000 investment in the Boston Trust Small Cap Fund and represents the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.
   
*
The quoted performance for the Fund reflects the performance of a collective investment fund that was previously managed with full investment authority by the parent company of the Fund’s Adviser prior to the establishment of the Fund on December 16, 2005. The performance of the collective investment fund has been restated to reflect the net expenses of the Fund after all expenses at an annual rate of 1.25%, the Adviser’s expense limitation for its initial year of investment operations. The collective investment fund was not registered with the Securities and Exchange Commission and, therefore, was not subject to the investment restrictions imposed by law on registered mutual funds. If the collective investment fund had been registered, the collective investment fund’s performance may have been adversely affected.
   
The Boston Trust Small Cap Fund is measured against the Russell 2000® Index, which is an unmanaged index that measures the performance of the small-cap segment of the U.S. equity universe. The Russell 2000® Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2000 of the smallest securities based on a combination of their market cap and current index membership. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

Fund Net Asset Value: $14.25
Gross Expense Ratio1: 1.06%

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.
   
1
The Gross Expense Ratio is from the Fund’s most recent prospectus, dated August 1, 2012. The Gross Expense Ratio excludes the impact of any contractual fee waivers. After giving effect to such fee waivers, the Fund’s Net Expense Ratio would be 1.00%, including the indirect expenses of investing in acquired funds. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of March 31, 2013 can be found in the financial highlights. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through August 1, 2013 and may be terminated thereafter.

11




Schedule of Portfolio Investments
  Boston Trust Asset Management Fund
    March 31, 2013
     

COMMON STOCKS (74.4%)                
Security Description   Shares     Fair Value ($)  
             
Consumer Discretionary (8.2%)                
Advance Auto Parts, Inc.     7,500       619,875  
Autoliv, Inc.     25,000       1,728,500  
Comcast Corp., Class A     100,000       4,201,000  
Johnson Controls, Inc.     40,000       1,402,800  
McDonald’s Corp.     32,500       3,239,925  
NIKE, Inc., Class B     80,000       4,720,800  
Omnicom Group, Inc.     60,000       3,534,000  
Ross Stores, Inc.     60,000       3,637,200  
Target Corp.     10,000       684,500  
               
              23,768,600  
               
Consumer Staples (8.8%)                
Church & Dwight Co., Inc.     25,000       1,615,750  
Colgate-Palmolive Co.     12,500       1,475,375  
Costco Wholesale Corp.     35,000       3,713,850  
Diageo PLC, Sponsored ADR     30,000       3,775,200  
McCormick & Co., Inc.     32,500       2,390,375  
Nestle SA, Sponsored ADR     40,000       2,898,800  
PepsiCo, Inc.     40,000       3,164,400  
Procter & Gamble Co.     35,000       2,697,100  
SYSCO Corp.     100,000       3,517,000  
               
              25,247,850  
               
Energy (9.3%)                
Apache Corp.     25,000       1,929,000  
Chevron Corp.     50,000       5,941,000  
ConocoPhillips     50,000       3,005,000  
Devon Energy Corp.     15,000       846,300  
Exxon Mobil Corp.     105,000       9,461,550  
Phillips 66     25,000       1,749,250  
Schlumberger Ltd.     50,000       3,744,500  
               
              26,676,600  
               
Financials (11.0%)                
BB&T Corp.     20,000       627,800  
Chubb Corp.     70,000       6,127,100  
Cincinnati Financial Corp.     125,000       5,898,750  
Comerica, Inc.     60,000       2,157,000  
Commerce Bancshares, Inc.     25,000       1,020,750  
JPMorgan Chase & Co.     100,000       4,746,000  
M&T Bank Corp.     12,500       1,289,500  
Northern Trust Corp.     22,500       1,227,600  
PNC Financial Services Group, Inc.     35,000       2,327,500  
State Street Corp.     25,000       1,477,250  
T. Rowe Price Group, Inc.     65,000       4,866,550  
               
              31,765,800  
               
Health Care (6.8%)                
Becton, Dickinson & Co.     50,000       4,780,500  
C.R. Bard, Inc.     32,500       3,275,350  
DENTSPLY International, Inc.     55,000       2,333,100  
Johnson & Johnson, Inc.     20,000       1,630,600  
Medtronic, Inc.     20,000       939,200  
Mettler-Toledo International, Inc.(a)     5,000       1,066,100  
Roche Holding AG, Sponsored ADR     30,000       1,758,000  
Saint Jude Medical, Inc.     20,000       808,800  
Stryker Corp.     20,000       1,304,800  
Varian Medical Systems, Inc.(a)     25,000       1,800,000  
               
              19,696,450  
               
Industrials (14.3%)                
3M Co.     35,000       3,720,850  
Donaldson Co., Inc.     150,000       5,428,500  
Emerson Electric Co.     75,000       4,190,250  
Expeditors International of Washington, Inc.     25,000       892,750  
Hubbell, Inc., Class B     42,500       4,127,175  
Illinois Tool Works, Inc.     75,000       4,570,500  
    Shares or        
    Principal        
Security Description     Amount ($)   Fair Value ($)
             
Industrials, continued                
Precision Castparts Corp.     30,000       5,688,600  
Rockwell Collins, Inc.     45,000       2,840,400  
United Parcel Service, Inc., Class B     50,000       4,295,000  
W.W. Grainger, Inc.     25,000       5,624,500  
               
              41,378,525  
               
Information Technology (12.9%)                
Accenture PLC, Class A     70,000       5,317,900  
Apple, Inc.     10,000       4,426,300  
Automatic Data Processing, Inc.     70,000       4,551,400  
EMC Corp.(a)     150,000       3,583,500  
Intel Corp.     10,000       218,500  
International Business Machines Corp.     30,000       6,399,000  
Microsoft Corp.     120,000       3,433,200  
Oracle Corp.     125,000       4,042,500  
QUALCOMM, Inc.     40,000       2,678,000  
Wal-Mart Stores, Inc.     35,000       2,619,050  
               
              37,269,350  
               
Materials (3.1%)                
Air Products & Chemicals, Inc.     20,000       1,742,400  
AptarGroup, Inc.     30,000       1,720,500  
Ecolab, Inc.     25,000       2,004,500  
Sigma-Aldrich Corp.     45,000       3,495,600  
               
              8,963,000  
               
TOTAL COMMON STOCKS (Cost $122,811,901)             214,766,175  
               
CORPORATE BONDS (4.1%)                
Consumer Staples (0.2%)                
Diageo Capital PLC, 5.50%, 9/30/16     500,000       574,619  
               
Financials (3.3%)                
American Express Bank FSB, BKNT, 6.00%, 9/13/17     200,000       239,030  
American Express Co., 2.65%, 12/2/22     1,926,000       1,891,380  
American Express Co., 7.00%, 3/19/18     1,500,000       1,875,064  
John Deere Capital Corp., Series D, 5.35%, 4/3/18     1,000,000       1,189,572  
JPMorgan Chase & Co., 3.15%, 7/5/16     1,500,000       1,591,663  
National Rural Utilities Cooperative Finance Corp., 10.38%, 11/1/18     500,000       730,543  
Wells Fargo & Co., 2.63%, 12/15/16     1,500,000       1,577,730  
Weyerhaeuser Co., 7.25%, 7/1/13     300,000       304,384  
               
              9,399,366  
               
Industrials (0.1%)                
Emerson Electric Co., 5.13%, 12/1/16     300,000       344,970  
               
Information Technology (0.3%)                
Oracle Corp., 5.75%, 4/15/18     750,000       905,994  
               
Telecommunication Services (0.2%)                
AT&T, Inc., 5.63%, 6/15/16     500,000       571,297  
               
TOTAL CORPORATE BONDS (Cost $10,292,870)             11,796,246  
               
MUNICIPAL BONDS (2.4%)                
Florida (0.4%)                
Florida State Board of Education, Series D, GO, 5.00%, 6/1/21, Callable 6/1/17 @ 101     1,000,000       1,165,510  
               
Illinois (0.5%)                
Illinois State, GO, 5.00%, 4/1/24, Callable 4/1/17 @ 100     500,000       551,610  
Illinois State, Series A, GO, 5.00%, 3/1/22, Callable 3/1/14 @ 100     600,000       620,706  

12   See Notes to Financial Statements




Schedule of Portfolio Investments
  Boston Trust Asset Management Fund
    March 31, 2013
     

MUNICIPAL BONDS, CONTINUED                
    Shares or        
    Principal        
Security Description     Amount ($)   Fair Value ($)  
             
Illinois, continued                
Illinois State, Series A, GO, 5.00%, 3/1/22, Prerefunded 3/1/14 @ 100     150,000       156,423  
Illinois State, Series A, GO, 5.00%, 6/1/29, Callable 12/1/16 @ 100     250,000       266,487  
               
              1,595,226  
               
Massachusetts (0.8%)                
Massachusetts State Development Finance Agency Revenue, Series R-2, 5.00%, 7/1/28, Callable 7/1/20 @ 100     460,000       531,139  
Massachusetts State Health & Educational Facilities Authority Revenue, Series A, 5.00%, 12/15/26, GO of Institution, Callable 12/15/19 @ 100     1,500,000       1,786,005  
               
              2,317,144  
               
Ohio (0.2%)                
Ohio State, Series D, GO, 4.50%, 9/15/22, NATL-RE, Callable 3/15/16 @ 100     500,000       547,525  
               
Washington (0.1%)                
Washington State, Series C, GO, 5.00%, 2/1/26, Callable 2/1/19 @ 100     250,000       294,218  
               
Wisconsin (0.4%)                
Wisconsin State, Series C, GO, 5.00%, 5/1/25, Callable 5/1/18 @ 100     200,000       235,492  
Wisconsin State, Series D, GO, 5.50%, 5/1/26, Callable 5/1/18 @ 100     750,000       904,702  
               
              1,140,194  
               
TOTAL MUNICIPAL BONDS (Cost $6,524,587)             7,059,817  
               
U.S. GOVERNMENT & U.S. GOVERNMENT AGENCY OBLIGATIONS (13.8%)
Federal Farm Credit Bank                

2.63%, 8/12/19

    11,500,000       12,423,335  

3.39%, 2/1/28

    2,000,000       2,118,096  
               
              14,541,431  
               
Federal Home Loan Bank                

4.13%, 12/13/19

    2,000,000       2,354,082  

5.25%, 9/13/13

    5,000,000       5,116,300  

5.25%, 12/9/22

    1,000,000       1,278,391  
               
              8,748,773  
               
Government National Mortgage Association                

4.00%, 9/15/40

    821,131       900,582  
U.S. Treasury Bond                

5.25%, 2/15/29

    750,000       1,017,539  
U.S. Treasury Inflation Protected Bond                

1.25%, 7/15/20

    6,334,920       7,573,424  
U.S. Treasury Note                

2.38%, 6/30/18

    6,500,000       7,018,986  
               
TOTAL U.S. GOVERNMENT & U.S. GOVERNMENT
AGENCY OBLIGATIONS (Cost $36,880,665)
            39,800,735  
               
INVESTMENT COMPANIES (5.4%)                
State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(b)     15,654,911       15,654,911  
               
TOTAL INVESTMENT COMPANIES (Cost $15,654,911)             15,654,911  
               
Total Investments (Cost $192,164,934)(c) — 100.1%             289,077,884  
Liabilities in excess of other assets (0.1)%             (404,749 )
               
NET ASSETS — 100.0%           $ 288,673,135  
               

 
(a)   Non-income producing security.
(b)   Rate disclosed is the seven day yield as of March 31, 2013.
(c)   See Federal Tax Information listed in the Notes to the Financial Statements.
ADR   American Depositary Receipt
BKNT   Bank Note
FSB   Federal Savings Bank
GO   General Obligation
NATL-RE   Reinsured by National Public Finance Guarantee Corporation
PLC   Public Limited Company

See Notes to Financial Statements   13




Financial Statements
  Boston Trust Asset Management Fund
     

STATEMENT OF ASSETS AND LIABILITIES        
March 31, 2013        
         
Assets:        
Investments, at fair value (cost $192,164,934)   $ 289,077,884  
Cash     82,950  
Interest and dividends receivable     750,927  
Receivable for investments sold     322,847  
Receivable for capital shares issued     22,834  
Prepaid expenses and other assets     14,398  
       

Total Assets

    290,271,840  
       
Liabilities:        
Payable for investments purchased     1,241,450  
Payable for capital shares redeemed     102,900  
Accrued expenses and other liabilities:        

Investment adviser

    180,769  

Chief compliance officer

    2,025  

Administration and accounting

    9,902  

Custodian

    6,968  

Transfer agent

    9,972  

Trustee

    795  

Other

    43,924  
       

Total Liabilities

    1,598,705  
       
Net Assets   $ 288,673,135  
       
Composition of Net Assets:        
Capital   $ 189,960,328  
Accumulated net investment income     810,566  
Accumulated net realized gains from investment transactions     989,291  
Net unrealized appreciation from investments     96,912,950  
       
Net Assets   $ 288,673,135  
       
Shares outstanding (par value $0.01, unlimited number of shares authorized)     8,000,174  
       
Net Asset Value, Offering Price and Redemption Price per share   $ 36.08  
       

STATEMENT OF OPERATIONS        
For the year ended March 31, 2013        
         
Investment Income:        
Interest   $ 2,018,541  
Dividends     4,459,146  
       

Total Investment Income

    6,477,687  
       
Expenses:        

Investment adviser

    1,962,274  

Administration and accounting

    318,327  

Shareholder servicing

    473  

Trustee

    11,524  

Custodian

    42,520  

Transfer agency

    35,738  

Chief compliance officer

    10,284  

Recoupment of prior expenses reimbursed by the investment adviser

    4,171  

Other

    126,977  
       

Total expenses before fee reductions

    2,512,288  

Fees voluntarily reduced by transfer agent

    (7,500 )
       
Net Expenses     2,504,788  
       
Net Investment Income     3,972,899  
       
Net Realized/Unrealized Gains from Investments:        

Net realized gains from investment transactions

    2,435,392  

Change in unrealized appreciation from investments

    16,395,428  
       
Net realized/unrealized gains from investments     18,830,820  
       
Change in Net Assets Resulting from Operations   $ 22,803,719  
       

14   See Notes to Financial Statements




Financial Statements
  Boston Trust Asset Management Fund
     

STATEMENTS OF CHANGES IN NET ASSETS                
    For the year ended   For the year ended
    March 31,   March 31,
    2013   2012
         
                 
Investment Activities:                
Operations:                

Net investment income

  $ 3,972,899     $ 3,300,658  

Net realized gains from investment transactions

    2,435,392       1,166,056  

Change in unrealized appreciation/depreciation from investments

    16,395,428       15,325,800  
             
Change in Net Assets Resulting from Operations     22,803,719       19,792,514  
             
Dividends:                

Net investment income

    (3,899,407 )     (3,373,655 )

Net realized gains from investment transactions

    (305,946 )      
             
Change in Net Assets Resulting from Shareholder Dividends     (4,205,353 )     (3,373,655 )
             
Capital Share Transactions:                

Proceeds from shares issued

    32,322,210       12,966,581  

Proceeds from shares issued in subscription in-kind(a)

          6,858,946  

Dividends reinvested

    3,883,401       3,093,298  

Cost of shares redeemed

    (23,162,238 )     (15,534,449 )
             
Change in Net Assets Resulting from Capital Share Transactions     13,043,373       7,384,376  
             
Change in Net Assets     31,641,739       23,803,235  
Net Assets:                

Beginning of period

    257,031,396       233,228,161  
             

End of period

  $ 288,673,135     $ 257,031,396  
             
Share Transactions:                

Issued

    946,104       410,393  

Issued in subscriptions in-kind(a)

          223,273  

Reinvested

    114,593       100,172  

Redeemed

    (685,885 )     (499,341 )
             
Change in Shares     374,812       234,497  
             
Accumulated net investment income   $ 810,566     $ 724,083  
             

 
Amounts designated as “—” are $0 or have been rounded to $0.
(a)   See Note 3 in Notes to Financial Statements.

See Notes to Financial Statements   15




Financial Statements
  Boston Trust Asset Management Fund
     

FINANCIAL HIGHLIGHTS                                        
Selected data for a share outstanding throughout the years indicated.
                                         
    For the year   For the year   For the year   For the year   For the year
    ended   ended   ended   ended   ended
    March 31,   March 31,   March 31,   March 31,   March 31,
    2013   2012   2011   2010   2009
                     
                                         
Net Asset Value, Beginning of Period   $ 33.71     $ 31.56     $ 28.69     $ 23.33     $ 30.31  
                               
Investment Activities:                                        

Net investment income

    0.51       0.43       0.44       0.47       0.49 (a)

Net realized and unrealized gains (losses) from investment transactions

    2.41       2.17       2.88       5.36       (6.11 )
                               
Total from investment activities     2.92       2.60       3.32       5.83       (5.62 )
                               
Dividends:                                        

Net investment income

    (0.51 )     (0.45 )     (0.45 )     (0.47 )     (0.52 )

Net realized gains from investments

    (0.04 )                       (0.84 )
                               
Total dividends     (0.55 )     (0.45 )     (0.45 )     (0.47 )     (1.36 )
                               
Net Asset Value, End of Period   $ 36.08     $ 33.71     $ 31.56     $ 28.69     $ 23.33  
                               
Total Return     8.77%       8.36%       11.65%       25.08%       (18.68)%  
                               
Ratios/Supplemental Data:                                        
Net Assets at end of period (000’s)   $ 288,673     $ 257,031     $ 233,228     $ 200,312     $ 148,401  
Ratio of net expenses to average net assets     0.96%       1.00%       1.00%       1.00%       1.00%  
Ratio of net investment income to average net assets     1.51%       1.40%       1.50%       1.84%       1.80%  

Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment advisor) to average net assets(b)

    0.96%       1.07%       1.07%       1.08%       1.08%  
Portfolio turnover rate     7.43%       18.70%       15.76%       12.90%       21.30%  

 
Amounts designated as “—” are $0 or have been rounded to $0.
(a)   Calculated using the average shares method.
(b)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated.

16   See Notes to Financial Statements




Schedule of Portfolio Investments
  Boston Trust Equity Fund
    March 31, 2013
     

COMMON STOCKS (98.8%)                
Security Description     Shares   Fair Value ($)
             
Consumer Discretionary (11.2%)                
Advance Auto Parts, Inc.     5,000       413,250  
Autoliv, Inc.     15,000       1,037,100  
Comcast Corp., Class A     50,000       2,100,500  
Johnson Controls, Inc.     10,000       350,700  
McDonald’s Corp.     17,500       1,744,575  
NIKE, Inc., Class B     16,000       944,160  
Omnicom Group, Inc.     30,000       1,767,000  
Ross Stores, Inc.     12,500       757,750  
               
              9,115,035  
               
Consumer Staples (12.0%)                
Church & Dwight Co., Inc.     10,000       646,300  
Colgate-Palmolive Co.     6,000       708,180  
Costco Wholesale Corp.     15,000       1,591,650  
Diageo PLC, Sponsored ADR     14,000       1,761,760  
McCormick & Co., Inc.     7,000       514,850  
Nestle SA, Sponsored ADR     15,000       1,087,050  
PepsiCo, Inc.     12,500       988,875  
Procter & Gamble Co.     10,000       770,600  
Reckitt Benckiser Group PLC, Sponsored ADR     20,000       288,600  
SYSCO Corp.     40,000       1,406,800  
               
              9,764,665  
               
Energy (11.4%)                
Apache Corp.     7,000       540,120  
Chevron Corp.     16,000       1,901,120  
ConocoPhillips     15,000       901,500  
Devon Energy Corp.     5,000       282,100  
Exxon Mobil Corp.     40,000       3,604,400  
Phillips 66     7,500       524,775  
Schlumberger Ltd.     20,000       1,497,800  
               
              9,251,815  
               
Financials (15.3%)                
BB&T Corp.     20,000       627,800  
Chubb Corp.     25,000       2,188,250  
Cincinnati Financial Corp.     50,000       2,359,500  
Comerica, Inc.     15,000       539,250  
Commerce Bancshares, Inc.     5,000       204,150  
JPMorgan Chase & Co.     35,000       1,661,100  
M&T Bank Corp.     5,000       515,800  
Northern Trust Corp.     7,500       409,200  
PNC Financial Services Group, Inc.     15,000       997,500  
State Street Corp.     12,000       709,080  
T. Rowe Price Group, Inc.     30,000       2,246,100  
               
              12,457,730  
               
Health Care (9.1%)                
Becton, Dickinson & Co.     17,000       1,625,370  
C.R. Bard, Inc.     12,500       1,259,750  
DENTSPLY International, Inc.     25,000       1,060,500  
Johnson & Johnson, Inc.     2,000       163,060  
Medtronic, Inc.     10,000       469,600  
Mettler-Toledo International, Inc.(a)     1,500       319,830  
Roche Holdings Ltd., Sponsored ADR     15,000       879,000  
Saint Jude Medical, Inc.     5,000       202,200  
Stryker Corp.     10,000       652,400  
Varian Medical Systems, Inc.(a)     10,000       720,000  
               
              7,351,710  
               
Industrials (18.6%)                
3M Co.     7,500       797,325  
Donaldson Co., Inc.     50,000       1,809,500  
Emerson Electric Co.     35,000       1,955,450  
Expeditors International of Washington, Inc.     5,000       178,550  
Hubbell, Inc., Class B     10,000       971,100  
Illinois Tool Works, Inc.     30,000       1,828,200  
Precision Castparts Corp.     15,000       2,844,300  
Rockwell Collins, Inc.     15,000       946,800  
United Parcel Service, Inc., Class B     14,000       1,202,600  
W.W. Grainger, Inc.     11,500       2,587,270  
               
              15,121,095  
               
Information Technology (16.8%)                
Accenture PLC, Class A     25,000       1,899,250  
Apple, Inc.     4,000       1,770,520  
Automatic Data Processing, Inc.     20,000       1,300,400  
EMC Corp.(a)     65,000       1,552,850  
Intel Corp.     5,000       109,250  
International Business Machines Corp.     10,000       2,133,000  
Microsoft Corp.     50,000       1,430,500  
Oracle Corp.     45,000       1,455,300  
QUALCOMM, Inc.     12,500       836,875  
Wal-Mart Stores, Inc.     15,000       1,122,450  
               
              13,610,395  
               
Materials (4.4%)                
Air Products & Chemicals, Inc.     5,000       435,600  
AptarGroup, Inc.     7,500       430,125  
Ecolab, Inc.     14,000       1,122,520  
Sigma-Aldrich Corp.     20,000       1,553,600  
               
              3,541,845  
               
TOTAL COMMON STOCKS (Cost $44,916,924)             80,214,290  
               
INVESTMENT COMPANIES (1.8%)                
State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(b)     1,437,072       1,437,072  
               
TOTAL INVESTMENT COMPANIES (Cost $1,437,072)             1,437,072  
               
Total Investments (Cost $46,353,996)(c) — 100.6%             81,651,362  
Liabilities in excess of other assets (0.6)%             (497,802 )
               
NET ASSETS — 100.0%           $ 81,153,560  
               

 
(a)   Non-income producing security.
(b)   Rate disclosed is the seven day yield as of March 31, 2013.
(c)   See Federal Tax Information listed in the Notes to the Financial Statements.
ADR   American Depositary Receipt
PLC   Public Limited Company

See Notes to Financial Statements   17




Financial Statements
  Boston Trust Equity Fund
     

STATEMENT OF ASSETS AND LIABILITIES        
March 31, 2013        
         
Assets:        
Investments, at fair value (cost $46,353,996)   $ 81,651,362  
Cash     21,759  
Dividends receivable     142,137  
Prepaid expenses and other assets     2,730  
       

Total Assets

    81,817,988  
       
Liabilities:        
Payable for investments purchased     582,738  
Payable for capital shares redeemed     3,800  
Accrued expenses and other liabilities:        

Investment adviser

    50,731  

Chief compliance officer

    539  

Administration and accounting

    2,889  

Custodian

    1,938  

Transfer agent

    9,316  

Trustee

    212  

Other

    12,265  
       

Total Liabilities

    664,428  
       
Net Assets   $ 81,153,560  
       
Composition of Net Assets:        
Capital   $ 47,320,846  
Accumulated net investment income     195,579  
Accumulated net realized losses from investment transactions     (1,660,231 )
Net unrealized appreciation from investments     35,297,366  
       
Net Assets   $ 81,153,560  
       
Shares outstanding (par value $0.01, unlimited number of shares authorized)     4,816,179  
       
Net Asset Value, Offering Price and Redemption Price per share   $ 16.85  
       

STATEMENT OF OPERATIONS        
For the year ended March 31, 2013        
         
Investment Income:        
Dividends   $ 1,624,034  
       

Total Investment Income

    1,624,034  
       
Expenses:        

Investment adviser

    532,984  

Administration and accounting

    87,832  

Trustee

    3,058  

Custodian

    11,984  

Transfer agency

    32,852  

Chief compliance officer

    2,733  

Recoupment of prior expenses reimbursed by the investment adviser

    8,013  

Other

    39,917  
       

Total expenses before fee reductions

    719,373  

Fees voluntarily reduced by transfer agent

    (7,500 )
       
Net Expenses     711,873  
       
Net Investment Income     912,161  
       
Net Realized/Unrealized Gains from Investments:        

Net realized gains from investment transactions

    1,142,942  

Change in unrealized appreciation from investments

    5,023,429  
       
Net realized/unrealized gains from investments     6,166,371  
       
Change in Net Assets Resulting from Operations   $ 7,078,532  
       

18   See Notes to Financial Statements




Financial Statements
  Boston Trust Equity Fund
     

STATEMENTS OF CHANGES IN NET ASSETS                
    For the year ended   For the year ended
    March 31,   March 31,
    2013   2012
         
                 
Investment Activities:                
Operations:                

Net investment income

  $ 912,161     $ 602,627  

Net realized gains from investment transactions

    1,142,942       245,312  

Change in unrealized appreciation from investments

    5,023,429       4,546,914  
             
Change in Net Assets Resulting from Operations     7,078,532       5,394,853  
             
Dividends:                

Net investment income

    (861,329 )     (589,650 )
             
Change in Net Assets Resulting from Shareholder Dividends     (861,329 )     (589,650 )
             
Capital Share Transactions:                

Proceeds from shares issued

    11,499,576       4,647,257  

Dividends reinvested

    779,539       507,274  

Cost of shares redeemed

    (6,916,458 )     (3,849,474 )
             
Change in Net Assets Resulting from Capital Share Transactions     5,362,657       1,305,057  
             
Change in Net Assets     11,579,860       6,110,260  
Net Assets:                

Beginning of period

    69,573,700       63,463,440  
             

End of period

  $ 81,153,560     $ 69,573,700  
             
Share Transactions:                

Issued

    738,195       327,501  

Reinvested

    50,238       36,786  

Redeemed

    (449,589 )     (275,060 )
             
Change in Shares     338,844       89,227  
             
Accumulated net investment income   $ 195,579     $ 144,747  
             

See Notes to Financial Statements   19




Financial Statements
  Boston Trust Equity Fund
     

FINANCIAL HIGHLIGHTS                                        
Selected data for a share outstanding throughout the years indicated.
    For the year   For the year   For the year   For the year   For the year
    ended   ended   ended   ended   ended
    March 31,   March 31,   March 31,   March 31,   March 31,
    2013   2012   2011   2010   2009
                     
                                         
Net Asset Value, Beginning of Period   $ 15.54     $ 14.46     $ 12.62     $ 8.77     $ 13.17  
                               
Investment Activities:                                        

Net investment income

    0.20       0.13       0.11       0.10       0.10 (a)

Net realized and unrealized gains (losses) from investment transactions

    1.30       1.08       1.84       3.85       (4.40 )
                               
Total from investment activities     1.50       1.21       1.95       3.95       (4.30 )
                               
Dividends:                                        

Net investment income

    (0.19 )     (0.13 )     (0.11 )     (0.10 )     (0.10 )
                               
Total dividends     (0.19 )     (0.13 )     (0.11 )     (0.10 )     (0.10 )
                               
Net Asset Value, End of Period   $ 16.85     $ 15.54     $ 14.46     $ 12.62     $ 8.77  
                               
Total Return     9.76%       8.50%       15.48%       45.13%       (32.73)%  
                               
Ratios/Supplemental Data:                                        
                                         
Net Assets at end of period (000’s)   $ 81,154     $ 69,574     $ 63,463     $ 53,583     $ 38,699  
Ratio of net expenses to average net assets     1.00%       1.00%       1.00%       1.00%       1.00%  
Ratio of net investment income to average net assets     1.28%       0.96%       0.85%       0.92%       0.86%  

Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment advisor) to average net assets(b)

    1.01%       1.07%       1.09%       1.11%       1.10%  
Portfolio turnover rate     5.69%       10.80%       14.31%       19.90%       28.85%  

 
(a)   Calculated using the average shares method.
(b)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated.

20   See Notes to Financial Statements




Schedule of Portfolio Investments
  Boston Trust Midcap Fund
    March 31, 2013
     

COMMON STOCKS (98.1%)                
Security Description     Shares   Fair Value ($)
             
Consumer Discretionary (14.1%)                
Advance Auto Parts, Inc.     6,500       537,225  
Autoliv, Inc.     9,280       641,619  
Family Dollar Stores, Inc.     9,500       560,975  
Hasbro, Inc.     15,000       659,100  
LKQ Corp.(a)     14,750       320,960  
O’Reilly Automotive, Inc.(a)     5,700       584,535  
Omnicom Group, Inc.     11,000       647,900  
Ross Stores, Inc.     11,500       697,130  
Tractor Supply Co.     2,725       283,755  
               
              4,933,199  
               
Consumer Staples (6.9%)                
Brown-Forman Corp., Class B     7,000       499,800  
Campbell Soup Co.     12,000       544,320  
Church & Dwight Co., Inc.     12,400       801,412  
McCormick & Co., Inc.     7,525       553,464  
               
              2,398,996  
               
Energy (8.8%)                
Cabot Oil & Gas Corp.     6,000       405,660  
Core Laboratories NV     5,750       793,040  
Denbury Resources, Inc.(a)     26,425       492,826  
Energen Corp.     5,000       260,050  
FMC Technologies, Inc.(a)     7,800       424,242  
Murphy Oil Corp.     5,500       350,515  
Oceaneering International, Inc.     5,000       332,050  
               
              3,058,383  
               
Financials (17.5%)                
Bank of Hawaii Corp.     6,950       353,129  
BioMed Realty Trust, Inc.     11,325       244,620  
BOK Financial Corp.     3,975       247,643  
Cincinnati Financial Corp.     15,005       708,086  
Comerica, Inc.     11,025       396,349  
Commerce Bancshares, Inc.     7,598       310,226  
Cullen/Frost Bankers, Inc.     6,500       406,445  
Digital Realty Trust, Inc.     3,800       254,258  
East West Bancorp, Inc.     12,500       320,875  
Eaton Vance Corp.     8,700       363,921  
IntercontinentalExchange, Inc.(a)     2,025       330,217  
Jones Lang LaSalle, Inc.     3,675       365,332  
M&T Bank Corp.     2,850       294,006  
Northern Trust Corp.     10,000       545,600  
SEI Investments Co.     12,400       357,740  
T. Rowe Price Group, Inc.     7,900       591,473  
               
              6,089,920  
               
Health Care (11.4%)                
C.R. Bard, Inc.     5,850       589,563  
DENTSPLY International, Inc.     11,750       498,435  
Laboratory Corp. of America Holdings(a)     4,000       360,800  
MEDNAX, Inc.(a)     2,775       248,723  
Mettler-Toledo International, Inc.(a)     3,500       746,270  
ResMed, Inc.     5,400       250,344  
Techne Corp.     3,700       251,045  
Varian Medical Systems, Inc.(a)     6,700       482,400  
Waters Corp.(a)     6,000       563,460  
               
              3,991,040  
               
Industrials (15.8%)                
AMETEK, Inc.     11,675       506,228  
C.H. Robinson Worldwide, Inc.     4,150       246,759  
CLARCOR, Inc.     6,950       364,041  
Donaldson Co., Inc.     21,000       759,990  
Expeditors International of Washington, Inc.     6,700       239,257  
Hubbell, Inc., Class B     5,300       514,683  
IDEX Corp.     6,000       320,520  
Lincoln Electric Holdings, Inc.     10,475       567,535  
Nordson Corp.     4,950       326,453  
Rockwell Collins, Inc.     5,250       331,380  
W.W. Grainger, Inc.     3,250       731,185  
Wabtec Corp.     5,800       592,238  
               
              5,500,269  
               
Information Technology (14.9%)                
BMC Software, Inc.(a)     14,500       671,785  
Check Point Software Technologies Ltd.(a)     11,000       516,890  
Citrix Systems, Inc.(a)     9,000       649,440  
F5 Networks, Inc.(a)     3,000       267,240  
Factset Research Systems, Inc.     4,000       370,400  
Fiserv, Inc.(a)     3,500       307,405  
NetApp, Inc.(a)     16,775       573,034  
Paychex, Inc.     9,500       333,165  
Riverbed Technology, Inc.(a)     13,400       199,794  
Syntel, Inc.     5,025       339,288  
Teradata Corp.(a)     11,125       650,924  
TIBCO Software, Inc.(a)     15,000       303,300  
               
              5,182,665  
               
Materials (4.9%)                
AptarGroup, Inc.     12,500       716,875  
International Flavors & Fragrances, Inc.     3,675       281,762  
Sigma-Aldrich Corp.     9,400       730,192  
               
              1,728,829  
               
Utilities (3.8%)                
AGL Resources, Inc.     7,150       299,943  
Northeast Utilities     8,466       367,932  
Questar Corp.     26,725       650,219  
               
              1,318,094  
               
TOTAL COMMON STOCKS (Cost $23,038,621)             34,201,395  
               
INVESTMENT COMPANIES (2.0%)                
State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(b)     703,557       703,557  
               
TOTAL INVESTMENT COMPANIES (Cost $703,557)             703,557  
               
Total Investments (Cost $23,742,178)(c) — 100.1%             34,904,952  
Liabilities in excess of other assets (0.1)%             (29,795 )
               
NET ASSETS — 100.0%           $ 34,875,157  
               

 
(a)   Non-income producing security.
(b)   Rate disclosed is the seven day yield as of March 31, 2013.
(c)   See Federal Tax Information listed in the Notes to the Financial Statements.

See Notes to Financial Statements   21




Financial Statements
  Boston Trust Midcap Fund
     

STATEMENT OF ASSETS AND LIABILITIES        
March 31, 2013        
 
Assets:        
Investments, at fair value (cost $23,742,178)   $ 34,904,952  
Cash     8,367  
Dividends receivable     26,434  
Receivable for capital shares issued     109,640  
Prepaid expenses and other assets     2,197  
       

Total Assets

    35,051,590  
       
Liabilities:        
Payable for investments purchased     142,499  
Accrued expenses and other liabilities:        

Investment adviser

    17,299  

Chief compliance officer

    224  

Administration and accounting

    1,373  

Custodian

    875  

Transfer agent

    8,980  

Trustee

    88  

Other

    5,095  
       

Total Liabilities

    176,433  
       
Net Assets   $ 34,875,157  
       
Composition of Net Assets:        
Capital   $ 23,456,958  
Accumulated net investment income     3,675  
Accumulated net realized gains from investment transactions     251,750  
Net unrealized appreciation from investments     11,162,774  
       
Net Assets   $ 34,875,157  
       
Shares outstanding (par value $0.01, unlimited number of shares authorized)     2,666,883  
       
Net Asset Value, Offering Price and Redemption Price per share   $ 13.08  
       

STATEMENT OF OPERATIONS        
For the year ended March 31, 2013        
 
Investment Income:        
Dividends   $ 495,141  
Less: Foreign tax withholding     (780 )
       

Total Investment Income

    494,361  
       
Expenses:        

Investment adviser

    220,142  

Administration and accounting

    38,059  

Shareholder servicing

    81  

Trustee

    1,231  

Custodian

    5,375  

Transfer agency

    31,873  

Chief compliance officer

    1,108  

Other

    18,817  
       

Total expenses before fee reductions

    316,686  
       

Fees voluntarily reduced by transfer agent

    (5,437 )

Fees contractually reduced by the investment adviser

    (16,993 )
       
Net Expenses     294,256  
       
Net Investment Income     200,105  
       
Net Realized/Unrealized Gains from Investments:        

Net realized gains from investment transactions

    747,973  

Change in unrealized appreciation from investments

    2,036,667  
       
Net realized/unrealized gains from investments     2,784,640  
       
Change in Net Assets Resulting from Operations   $ 2,984,745  
       

22   See Notes to Financial Statements




Financial Statements
  Boston Trust Midcap Fund
     

STATEMENTS OF CHANGES IN NET ASSETS                
    For the year ended   For the year ended
    March 31,   March 31,
    2013   2012
         
                 
Investment Activities:                
Operations:                

Net investment income

  $ 200,105     $ 78,677  

Net realized gains from investment transactions

    747,973       569,650  

Change in unrealized appreciation from investments

    2,036,667       1,268,521  
             
Change in Net Assets Resulting from Operations     2,984,745       1,916,848  
             
Dividends:                

Net investment income

    (207,695 )     (77,741 )

Net realized gains from investment transactions

    (662,925 )     (889,781 )
             
Change in Net Assets Resulting from Shareholder Dividends     (870,620 )     (967,522 )
             
Capital Share Transactions:                

Proceeds from shares issued

    5,383,464       2,852,941  

Dividends reinvested

    755,140       828,947  

Cost of shares redeemed

    (2,601,641 )     (2,682,664 )
             
Change in Net Assets Resulting from Capital Share Transactions     3,536,963       999,224  
             
Change in Net Assets     5,651,088       1,948,550  
Net Assets:                

Beginning of period

    29,224,069       27,275,519  
             

End of period

  $ 34,875,157     $ 29,224,069  
             
Share Transactions:                

Issued

    452,973       250,003  

Reinvested

    64,331       76,613  

Redeemed

    (219,490 )     (237,172 )
             
Change in Shares     297,814       89,444  
             
Accumulated net investment income   $ 3,675     $ 11,266  
             

See Notes to Financial Statements   23




Financial Statements
  Boston Trust Midcap Fund
     

FINANCIAL HIGHLIGHTS                                        
Selected data for a share outstanding throughout the periods indicated.
                                         
    For the year   For the year   For the year   For the year   For the year
    ended   ended   ended   ended   ended
    March 31,   March 31,   March 31,   March 31,   March 31,
    2013   2012   2011   2010   2009
                     
                                         
Net Asset Value, Beginning of Period   $ 12.34     $ 11.96     $ 9.44     $ 6.08     $ 9.23  
                               
Investment Activities:                                        

Net investment income

    0.08       0.03       0.02       0.02       0.02 (a)

Net realized and unrealized gains (losses) from investment transactions

    1.01       0.78       2.73       3.36       (3.07 )
                               
Total from investment activities     1.09       0.81       2.75       3.38       (3.05 )
                               
Dividends:                                        

Net investment income

    (0.08 )     (0.03 )     (0.02 )     (0.02 )     (0.02 )

Net realized gains from investments

    (0.27 )     (0.40 )     (0.21 )           (0.08 )
                               
Total dividends     (0.35 )     (0.43 )     (0.23 )     (0.02 )     (0.10 )
                               
Net Asset Value, End of Period   $ 13.08     $ 12.34     $ 11.96     $ 9.44     $ 6.08  
                               
Total Return     9.20%       7.24%       29.32%       55.68%       (33.03)%  
                               
Ratios/Supplemental Data:                                        
Net Assets at end of period (000’s)   $ 34,875     $ 29,224     $ 27,276     $ 16,309     $ 8,019  
Ratio of net expenses to average net assets     1.00%       1.00%       1.00%       1.00%       1.00%  
Ratio of net investment income to average net assets     0.68%       0.30%       0.25%       0.26%       0.24%  
Ratio of expenses (before fee reductions) to average net assets(b)     1.08%       1.19%       1.20%       1.32%       1.48%  
Portfolio turnover rate     16.44%       19.01%       18.58%       26.44%       22.93%  

 
Amounts designated as “—” are $0 or have been rounded to $0.
(a)   Calculated using the average shares method.
(b)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated.

24   See Notes to Financial Statements




Schedule of Portfolio Investments
  Boston Trust SMID Cap Fund
    March 31, 2013
     

COMMON STOCKS (98.9%)                
Security Description     Shares   Fair Value ($)
             
Consumer Discretionary (13.8%)                
Autoliv, Inc.     825       57,040  
Columbia Sportswear Co.     550       31,834  
Dorman Products, Inc.     950       35,350  
DSW, Inc., Class A     700       44,660  
Hibbett Sports, Inc.(a)     674       37,926  
iRobot Corp.(a)     1,450       37,207  
Life Time Fitness, Inc.(a)     725       31,016  
LKQ Corp.(a)     2,950       64,192  
Select Comfort Corp.(a)     2,325       45,965  
SodaStream International Ltd.(a)     1,302       64,631  
The Men’s Wearhouse, Inc.     900       30,078  
Tractor Supply Co.     375       39,049  
Vitamin Shoppe, Inc.(a)     775       37,859  
Weight Watchers International, Inc.     800       33,688  
Wolverine World Wide, Inc.     1,350       59,899  
               
              650,394  
               
Consumer Staples (2.4%)                
Darling International, Inc.(a)     1,300       23,348  
Hain Celestial Group, Inc.(a)     350       21,378  
The Fresh Market, Inc.(a)     600       25,662  
United Natural Foods, Inc.(a)     900       44,280  
               
              114,668  
               
Energy (6.4%)                
CARBO Ceramics, Inc.     725       66,026  
Core Laboratories NV     175       24,136  
Denbury Resources, Inc.(a)     3,100       57,815  
Geospace Technologies Corp.(a)     300       32,376  
Lufkin Industries, Inc.     750       49,792  
Oceaneering International, Inc.     750       49,807  
RPC, Inc.     1,550       23,514  
               
              303,466  
               
Financials (22.9%)                
Bank of Hawaii Corp.     1,456       73,979  
BioMed Realty Trust, Inc.     1,125       24,300  
BOK Financial Corp.     425       26,478  
Cohen & Steers, Inc.     1,425       51,400  
Commerce Bancshares, Inc.     1,365       55,733  
Coresite Realty Corp.     800       27,984  
Cullen/Frost Bankers, Inc.     550       34,392  
DuPont Fabros Technology, Inc.     2,176       52,812  
East West Bancorp, Inc.     3,075       78,935  
Eaton Vance Corp.     1,425       59,608  
Financial Engines, Inc.     1,425       51,613  
Jones Lang LaSalle, Inc.     950       94,439  
MarketAxess Holdings, Inc.     1,400       52,220  
Ocwen Financial Corp.(a)     2,225       84,372  
SEI Investments Co.     1,900       54,815  
Signature Bank(a)     1,000       78,760  
SVB Financial Group(a)     1,225       86,901  
Texas Capital Bancshares, Inc.(a)     672       27,182  
UMB Financial Corp.     725       35,576  
Umpqua Holdings Corp.     2,125       28,178  
               
              1,079,677  
               
Health Care (11.2%)                
Bruker Corp.(a)     2,775       53,002  
Covance, Inc.(a)     350       26,012  
DENTSPLY International, Inc.     525       22,271  
Haemonetics Corp.(a)     575       23,954  
ICU Medical, Inc.(a)     750       44,212  
MEDNAX, Inc.(a)     425       38,093  
Meridian Bioscience, Inc.     1,050       23,961  
Mettler-Toledo International, Inc.(a)     182       38,806  
Myriad Genetics, Inc.(a)     1,525       38,735  
Neogen Corp.(a)     452       22,406  
Quality Systems, Inc.     2,200       40,216  
ResMed, Inc.     975       45,201  
Techne Corp.     341       23,137  
Thoratec Corp.(a)     1,300       48,750  
West Pharmaceutical Services, Inc.     600       38,964  
               
              527,720  
               
Industrials (16.4%)                
Chart Industries, Inc.(a)     500       40,005  
CLARCOR, Inc.     1,125       58,928  
Donaldson Co., Inc.     2,200       79,618  
ESCO Technologies, Inc.     550       22,473  
Franklin Electric Co., Inc.     1,000       33,570  
Genesee & Wyoming, Inc., Class A(a)     652       60,708  
Hub Group, Inc., Class A(a)     975       37,499  
Hubbell, Inc., Class B     493       47,875  
IDEX Corp.     595       31,785  
II-VI, Inc.(a)     1,150       19,596  
Lincoln Electric Holdings, Inc.     850       46,053  
Lindsay Manufacturing Co.     552       48,675  
Middleby Corp.(a)     422       64,207  
Nordson Corp.     615       40,559  
Wabtec Corp.     850       86,793  
Watts Water Technologies, Inc., Class A     1,149       55,141  
               
              773,485  
               
Information Technology (14.2%)                
Blackbaud, Inc.     800       23,704  
Bottomline Technologies, Inc.(a)     800       22,808  
Coherent, Inc.     375       21,278  
CommVault Systems, Inc.(a)     450       36,891  
Factset Research Systems, Inc.     375       34,725  
InterDigital, Inc.     875       41,851  
IPG Photonics Corp.     925       61,429  
Liquidity Services, Inc.(a)     800       23,848  
Mellanox Technologies Ltd.(a)     425       23,592  
MicroStrategy, Inc., Class A(a)     222       22,440  
NIC, Inc.     1,600       30,656  
Plantronics, Inc.     1,175       51,923  
Polycom, Inc.(a)     2,800       31,024  
Power Integrations, Inc.     950       41,240  
Riverbed Technology, Inc.(a)     2,375       35,411  
Sapient Corp.(a)     3,700       45,103  
Syntel, Inc.     350       23,632  
TIBCO Software, Inc.(a)     2,000       40,440  
WEX, Inc.(a)     750       58,875  
               
              670,870  
               
Materials (6.6%)                
AptarGroup, Inc.     1,300       74,555  
Calgon Carbon Corp.(a)     3,325       60,182  
Commercial Metals Co.     3,100       49,135  
International Flavors & Fragrances, Inc.     450       34,502  
Kraton Performance Polymers, Inc.(a)     1,650       38,610  
Minerals Technologies, Inc.     1,400       58,114  
               
              315,098  
               
Utilities (5.0%)                
AGL Resources, Inc.     1,050       44,048  
American States Water Co.     1,106       63,672  
New Jersey Resources Corp.     750       33,638  
Questar Corp.     3,850       93,670  
               
              235,028  
               
TOTAL COMMON STOCKS (Cost $3,949,808)             4,670,406  
               
INVESTMENT COMPANIES (1.2%)                
State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(b)     55,076       55,076  
               
TOTAL INVESTMENT COMPANIES (Cost $55,076)(c)             55,076  
               
Total Investments (Cost $4,004,884) — 100.1%             4,725,482  
Liabilities in excess of other assets (0.1)%             (6,467 )
               
NET ASSETS — 100.0%           $ 4,719,015  
               

 
(a)   Non-income producing security.
(b)   Rate disclosed is the seven day yield as of March 31, 2013.
(c)   See Federal Tax Information listed in the Notes to the Financial Statements.

See Notes to Financial Statements   25




Financial Statements
  Boston Trust SMID Cap Fund
     

STATEMENT OF ASSETS AND LIABILITIES        
March 31, 2013        
 
Assets:        
Investments, at fair value (cost $4,004,884)   $ 4,725,482  
Cash     238  
Dividends receivable     2,548  
Receivable from adviser     1,208  
Prepaid expenses and other assets     125  
       

Total Assets

    4,729,601  
       
Liabilities:        
Accrued expenses and other liabilities:        

Chief compliance officer

    31  

Administration and accounting

    408  

Custodian

    247  

Transfer agent

    8,965  

Trustee

    12  

Other

    923  
       

Total Liabilities

    10,586  
       
Net Assets   $ 4,719,015  
       
Composition of Net Assets:        
Capital   $ 4,017,992  
Accumulated net investment income/(loss)     847  
Accumulated net realized losses from investment transactions     (20,422 )
Net unrealized appreciation from investments     720,598  
       
Net Assets   $ 4,719,015  
       
Shares outstanding (par value $0.01, unlimited number of shares authorized)     391,582  
       
Net Asset Value, Offering Price and Redemption Price per share   $ 12.05  
       

STATEMENT OF OPERATIONS        
For the year ended March 31, 2013        
 
Investment Income:        
Dividends   $ 52,804  
Less: Foreign tax withholding     (72 )
       

Total Investment Income

    52,732  
       
Expenses:        

Investment adviser

    28,883  

Administration and accounting

    7,980  

Trustee

    168  

Custodian

    1,602  

Transfer agency

    32,844  

Chief compliance officer

    152  

Other

    6,371  
       

Total expenses before fee reductions

    78,000  

Fees voluntarily reduced by transfer agent

    (5,437 )

Fees contractually reduced by the investment adviser

    (33,947 )
       
Net Expenses     38,616  
       
Net Investment Income     14,116  
       
Net Realized/Unrealized Gains (Losses) from Investments:        

Net realized losses from investment transactions

    (21,455 )

Change in unrealized appreciation from investments

    421,345  
       
Net realized/unrealized gains from investments     399,890  
       
Change in Net Assets Resulting from Operations   $ 414,006  
       

26   See Notes to Financial Statements




Financial Statements
  Boston Trust SMID Cap Fund
     

STATEMENT OF CHANGES IN NET ASSETS                
    For the year ended   For the period ended
    March 31,   March 31,
    2013   2012(a)
         
                 
Investment Activities:                
Operations:                

Net investment income

  $ 14,116     $ 286  

Net realized gains (losses) from investment transactions

    (21,455 )     30,511  

Change in unrealized appreciation from investments

    421,345       299,253  
             
Change in Net Assets Resulting from Operations     414,006       330,050  
             
Dividends:                

Net investment income

    (18,180 )     (898 )

Net realized losses from investment transactions

    (30,511 )      
             
Change in Net Assets Resulting from Shareholder Dividends     (48,691 )     (898 )
             
Capital Share Transactions:                

Proceeds from shares issued

    1,270,515       2,949,757  

Proceeds from shares issued in subscription in-kind(b)

          325,000  

Dividends reinvested

    43,101       775  

Cost of shares redeemed

    (239,762 )      

Cost of shares redeemed in redemption in-kind(b)

    (324,838 )      
             
Change in Net Assets Resulting from Capital Share Transactions     749,016       3,275,532  
             
Change in Net Assets     1,114,331       3,604,684  
Net Assets:                

Beginning of period

    3,604,684        
             

End of period

  $ 4,719,015     $ 3,604,684  
             
Share Transactions:                

Issued

    117,966       292,427  

Issued in subscriptions in-kind(b)

          32,500  

Reinvested

    3,972       79  

Redeemed

    (22,846 )      

Redeemed in redemption in-kind(b)

    (32,516 )      
             
Change in Shares     66,576       325,006  
             
Accumulated net investment income (loss)   $ 847     $ 2,071  
             

 
Amounts designated as “—” are $0 or have been rounded to $0.
(a)   Commenced operations on November 30, 2011.
(b)   See Note 3 in Notes to Financial Statements.

See Notes to Financial Statements   27




Financial Statements
  Boston Trust SMID Cap Fund
     

FINANCIAL HIGHLIGHTS                
Selected data for a share outstanding throughout the period indicated.
                 
    For the year   For the period
    ended   ended
    March 31,   March 31,
    2013   2012(a)
         
                 
Net Asset Value, Beginning of Period   $ 11.09     $ 10.00  
             
Investment Activities:                

Net investment income

    0.04        

Net realized and unrealized gains from investment transactions

    1.05       1.09  
             
Total from investment activities     1.09       1.09  
             
Dividends:                

Net investment income

    (0.05 )      

Net realized gains from investments

    (0.08 )      
             
Total dividends     (0.13 )      
             
Net Asset Value, End of Period   $ 12.05     $ 11.09  
             
Total Return     10.00%       10.96% (b)
             
Ratios/Supplemental Data:                
Net Assets at end of period (000’s)   $ 4,719     $ 3,605  
Ratio of net expenses to average net assets     1.00%       1.00% (c)
Ratio of net investment income to average net assets     0.37%       0.03% (c)
Ratio of expenses (before fee reductions) to average net assets(d)     2.02%       2.18% (c)
Portfolio turnover rate     33.83%       12.14% (b)

 
Amounts designated as “—” are $0 or have been rounded $0.
(a)   Commenced operations on November 30, 2011.
(b)   Not annualized for periods less than one year.
(c)   Annualized for periods less than one year.
(d)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated

28   See Notes to Financial Statements




Schedule of Portfolio Investments
  Boston Trust Small Cap Fund
    March 31, 2013
     

COMMON STOCKS (99.5%)                
Security Description     Shares   Fair Value ($)
             
Consumer Discretionary (12.9%)                
Columbia Sportswear Co.     91,000       5,267,080  
Dorman Products, Inc.     133,000       4,948,930  
DSW, Inc., Class A     75,900       4,842,420  
Hibbett Sports, Inc.(a)     98,000       5,514,460  
iRobot Corp.(a)     203,000       5,208,980  
Life Time Fitness, Inc.(a)     89,000       3,807,420  
Select Comfort Corp.(a)     271,000       5,357,670  
SodaStream International Ltd.(a)     146,000       7,247,440  
The Men’s Wearhouse, Inc.     167,000       5,581,140  
Vitamin Shoppe, Inc.(a)     118,000       5,764,300  
Weight Watchers International, Inc.     86,000       3,621,460  
Wolverine World Wide, Inc.     176,000       7,809,120  
               
              64,970,420  
               
Consumer Staples (3.0%)                
Darling International, Inc.(a)     203,000       3,645,880  
Hain Celestial Group, Inc.(a)     35,000       2,137,800  
The Fresh Market, Inc.(a)     76,000       3,250,520  
United Natural Foods, Inc.(a)     119,000       5,854,800  
               
              14,889,000  
               
Energy (6.7%)                
CARBO Ceramics, Inc.     98,000       8,924,860  
Geospace Technologies Corp.(a)     75,000       8,094,000  
Lufkin Industries, Inc.     155,000       10,290,450  
Natural Gas Services Group, Inc.(a)     102,525       1,974,631  
RPC, Inc.     281,000       4,262,770  
               
              33,546,711  
               
Financials (21.3%)                
Bank of Hawaii Corp.     202,000       10,263,620  
BioMed Realty Trust, Inc.     121,000       2,613,600  
City National Corp.     70,000       4,123,700  
Cohen & Steers, Inc.     182,000       6,564,740  
Coresite Realty Corp.     177,000       6,191,460  
Corporate Office Properties Trust     92,000       2,454,560  
Dime Community Bancshares, Inc.     176,050       2,528,078  
DuPont Fabros Technology, Inc.     307,000       7,450,890  
East West Bancorp, Inc.     197,000       5,056,990  
Financial Engines, Inc.     191,000       6,918,020  
First Financial Bankshares, Inc.     87,000       4,228,200  
Independent Bank Corp.     117,000       3,813,030  
MarketAxess Holdings, Inc.     219,000       8,168,700  
Signature Bank(a)     65,000       5,119,400  
SVB Financial Group(a)     155,000       10,995,700  
Texas Capital Bancshares, Inc.(a)     137,000       5,541,650  
UMB Financial Corp.     151,000       7,409,570  
Umpqua Holdings Corp.     560,000       7,425,600  
               
              106,867,508  
               
Health Care (13.4%)                
Bruker Corp.(a)     428,000       8,174,800  
Cantel Medical Corp.     152,000       4,569,120  
Computer Programs & Systems, Inc.     80,000       4,328,800  
Haemonetics Corp.(a)     62,000       2,582,920  
ICU Medical, Inc.(a)     106,000       6,248,700  
Landauer, Inc.     37,000       2,086,060  
Meridian Bioscience, Inc.     220,000       5,020,400  
Myriad Genetics, Inc.(a)     199,000       5,054,600  
Neogen Corp.(a)     50,000       2,478,500  
Quality Systems, Inc.     250,000       4,570,000  
Techne Corp.     73,000       4,953,050  
Thoratec Corp.(a)     175,000       6,562,500  
West Pharmaceutical Services, Inc.     162,000       10,520,280  
               
              67,149,730  
               
Industrials (16.1%)                
American Science & Engineering, Inc.     61,000       3,720,390  
Apogee Enterprises, Inc.     206,000       5,963,700  
Chart Industries, Inc.(a)     57,000       4,560,570  
CLARCOR, Inc.     175,000       9,166,500  
ESCO Technologies, Inc.     120,000       4,903,200  
Franklin Electric Co., Inc.     186,000       6,244,020  
Gentherm, Inc.(a)     210,000       3,439,800  
Herman Miller, Inc.     86,000       2,379,620  
Hub Group, Inc., Class A(a)     166,000       6,384,360  
II-VI, Inc.(a)     195,000       3,322,800  
Lindsay Manufacturing Co.     80,000       7,054,400  
Middleby Corp.(a)     56,000       8,520,400  
Simpson Manufacturing Co., Inc.     111,000       3,397,710  
Team, Inc.(a)     136,000       5,585,520  
Watts Water Technologies, Inc., Class A     133,000       6,382,670  
               
              81,025,660  
               
Information Technology (17.9%)                
Blackbaud, Inc.     150,000       4,444,500  
Bottomline Technologies, Inc.(a)     164,000       4,675,640  
Coherent, Inc.     88,000       4,993,120  
InterDigital, Inc.     104,000       4,974,320  
IPG Photonics Corp.     75,175       4,992,372  
Liquidity Services, Inc.(a)     120,000       3,577,200  
Mellanox Technologies Ltd.(a)     95,000       5,273,450  
MicroStrategy, Inc., Class A(a)     36,000       3,638,880  
NIC, Inc.     235,000       4,502,600  
Plantronics, Inc.     241,000       10,649,790  
Polycom, Inc.(a)     560,000       6,204,800  
Power Integrations, Inc.     195,000       8,464,950  
Riverbed Technology, Inc.(a)     241,000       3,593,310  
Sapient Corp.(a)     575,000       7,009,250  
Syntel, Inc.     57,000       3,848,640  
WEX, Inc.(a)     119,000       9,341,500  
               
              90,184,322  
               
Materials (5.0%)                
Calgon Carbon Corp.(a)     270,000       4,887,000  
Commercial Metals Co.     340,000       5,389,000  
Kraton Performance Polymers, Inc.(a)     86,000       2,012,400  
Minerals Technologies, Inc.     139,000       5,769,890  
Quaker Chemical Corp.     117,000       6,905,340  
               
              24,963,630  
               
Utilities (3.2%)                
American States Water Co.     71,000       4,087,470  
New Jersey Resources Corp.     166,000       7,445,100  
South Jersey Industries, Inc.     85,000       4,725,150  
               
              16,257,720  
               
TOTAL COMMON STOCKS (Cost $417,314,121)             499,854,701  
               
INVESTMENT COMPANIES (0.6%)                
State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(b)     3,210,238       3,210,238  
               
TOTAL INVESTMENT COMPANIES (Cost $3,210,238)             3,210,238  
               
Total Investments (Cost $420,524,359)(c) — 100.1%             503,064,939  
Liabilities in excess of other assets (0.1)%             (275,784 )
               
NET ASSETS — 100.0%           $ 502,789,155  
               

 
(a)   Non-income producing security.
(b)   Rate disclosed is the seven day yield as of March 31, 2013.
(c)   See Federal Tax Information listed in the Notes to the Financial Statements.

See Notes to Financial Statements   29




Financial Statements
  Boston Trust Small Cap Fund
     

STATEMENT OF ASSETS AND LIABILITIES        
March 31, 2013        
 
Assets:        
Investments, at fair value (cost $420,524,359)   $ 503,064,939  
Cash     43,220  
Dividends receivable     496,198  
Receivable for capital shares issued     39,639  
Prepaid expenses and other assets     22,236  
       

Total Assets

    503,666,232  
       
Liabilities:        
Payable for investments purchased     396,165  
Payable for capital shares redeemed     41,664  
Accrued expenses and other liabilities:        

Investment adviser

    312,313  

Chief compliance officer

    2,777  

Administration and accounting

    16,445  

Custodian

    9,027  

Transfer agent

    10,116  

Trustee

    1,091  

Shareholder servicing

    14,589  

Other

    72,890  
       

Total Liabilities

    877,077  
       
Net Assets   $ 502,789,155  
       
Composition of Net Assets:        
Capital   $ 414,332,112  
Accumulated net investment income (loss)     196,993  
Accumulated net realized gains from investment transactions     5,719,470  
Net unrealized appreciation from investments     82,540,580  
       
Net Assets   $ 502,789,155  
       
Shares outstanding (par value $0.01, unlimited number of shares authorized)     35,281,301  
       
Net Asset Value, Offering Price and Redemption Price per share   $ 14.25  
       

STATEMENT OF OPERATIONS        
For the year ended March 31, 2013        
 
Investment Income:        
Dividends   $ 4,929,838  
       

Total Investment Income

    4,929,838  
       
Expenses:        

Investment adviser

    2,679,568  

Administration and accounting

    428,065  

Shareholder servicing

    143,826  

Trustee

    14,412  

Custodian

    54,121  

Transfer agency

    44,894  

Chief compliance officer

    13,219  

Recoupment of prior expenses reimbursed by the investment adviser

    21,275  

Other

    189,936  
       

Total expenses before fee reductions

    3,589,316  

Fees voluntarily reduced by Transfer agent

    (5,437 )
       
Net Expenses     3,583,879  
       
Net Investment Income     1,345,959  
       
Net Realized/Unrealized Gains from Investments:        

Net realized gains from investment transactions

    17,943,293  

Change in unrealized appreciation from investments

    27,309,103  
       
Net realized/unrealized gains from investments     45,252,396  
       
Change in Net Assets Resulting from Operations   $ 46,598,355  
       

30   See Notes to Financial Statements




Financial Statements
  Boston Trust Small Cap Fund
     

STATEMENTS OF CHANGES IN NET ASSETS                
    For the year ended   For the year ended
    March 31,   March 31,
    2013   2012
         
                 
Investment Activities:                
Operations:                

Net investment income

  $ 1,345,959     $ 133,968  

Net realized gains from investment transactions

    17,943,293       2,564,171  

Change in unrealized appreciation from investments

    27,309,103       6,975,434  
             
Change in Net Assets Resulting from Operations     46,598,355       9,673,573  
             
Dividends:                

Net investment income

    (1,470,783 )     (258,044 )

Net realized gains from investment transactions

    (11,612,948 )     (19,639,829 )
             
Change in Net Assets Resulting from Shareholder Dividends     (13,083,731 )     (19,897,873 )
             
Capital Share Transactions:                

Proceeds from shares issued

    163,526,538       96,089,797  

Dividends reinvested

    12,261,159       18,302,949  

Cost of shares redeemed

    (34,019,044 )     (44,396,879 )

Cost of shares redeemed in redemption in-kind(a)

    (503,078 )      
             
Change in Net Assets Resulting from Capital Share Transactions     141,265,575       69,995,867  
             
Change in Net Assets     174,780,199       59,771,567  
Net Assets:                

Beginning of period

    328,008,956       268,237,389  
             

End of period

  $ 502,789,155     $ 328,008,956  
             
Share Transactions:                

Issued

    12,160,205       7,662,068  

Reinvested

    950,581       1,557,698  

Redeemed

    (2,568,914 )     (3,601,785 )

Redeemed in redemption in-kind(a)

    (40,571 )      
             
Change in Shares     10,501,301       5,617,981  
             
Accumulated net investment income (loss)   $ 196,993     $  
             

 
Amounts designated as “—” are $0 or have been rounded $0.
(a)   See Note 3 in Notes to Financial Statements.

See Notes to Financial Statements   31



   

Boston Trust Small Cap Fund
     

 FINANCIAL HIGHLIGHTS
Selected data for a share outstanding throughout the periods indicated.

    For the year     For the year     For the year     For the year     For the year  
    ended     ended     ended     ended     ended  
    March 31,     March 31,     March 31,     March 31,     March 31,  
    2013     2012     2011     2010     2009  
                               
Net Asset Value, Beginning of Period   $ 13.24     $ 14.00     $ 11.52     $ 7.21     $ 10.92  
                               
Investment Activities:                                        

Net investment income

    0.05       0.01       0.02       0.02       0.02 (a)

Net realized and unrealized gains (losses) from investment transactions

    1.43       0.20       2.91       4.31       (3.64)  
                               
Total from investment activities     1.48       0.21       2.93       4.33       (3.62)  
                               
Dividends:                                        

Net investment income

    (0.05)       (0.01)       (0.03)       (0.02)       (0.02)  

Net realized gains from investments

    (0.42)       (0.96)       (0.42)             (0.07)  
                               
Total dividends     (0.47)       (0.97)       (0.45)       (0.02)       (0.09)  
                               
Net Asset Value, End of Period   $ 14.25     $ 13.24     $ 14.00     $ 11.52     $ 7.21  
                               
Total Return     11.61%       2.35%       25.78%       60.01%       (33.24)%  
                               
Ratios/Supplemental Data:                                        
Net Assets at end of period (000’s)   $ 502,789     $ 328,009     $ 268,237     $ 133,511     $ 25,504  
Ratio of net expenses to average net assets     1.00%       1.00%       1.00%       1.00%       1.10%  
Ratio of net investment income to average net assets     0.38%       0.05%       0.15%       0.26%       0.21%  

Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment advisor) to average net assets(b)

    0.99%       1.09%       1.12%       1.14%       1.18%  
Portfolio turnover rate     33.34%       30.99%       35.54%       26.68%       21.28%  

 
Amounts designated as “—” are $0 or have been rounded to $0.
(a)   Calculated using the average shares method.
(b)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated.

32  

See Notes to Financial Statements




This page intentionally left blank.


 

  33



Environmental, Social and
Governance Research and
Action Update
(Unaudited)

Walden is pleased to begin 2013 with a report of substantial progress in fostering improved corporate environmental, social and governance (ESG) performance, a tribute to the positive impact of shareholder engagement.

Political Spending & Lobbying
As a leading investor advocate for full disclosure of corporate funds used in the political sphere, Walden is encouraged that the Securities and Exchange Commission (SEC) is considering mandating disclosure of political contributions by publicly traded companies. While the U.S. Chamber of Commerce and other organizations gear up to block such a rule, we have seen a number of portfolio companies step up. We withdrew a resolution at PepsiCo, led by the New York State Common Retirement Fund, when it agreed to disclose direct lobbying and contributions made to trade associations, as well as funds paid to grassroots lobbying and tax exempt groups that write and endorse model legislation. Similarly, Walden’s resolution at 3M was withdrawn with a commitment to detailed disclosure of lobbying activities and expenditures to trade associations. Another resolution at JPMorgan Chase, led by Domini Social Investments and co-filed by Walden, was withdrawn after successful negotiations led to the disclosure of new policies that ensure corporate funds cannot be used for electoral purposes.

Environmental Impacts
After productive discussions with Stryker, we withdrew our shareholder proposal requesting a comprehensive greenhouse gas (GHG) emissions management plan. The company committed to fully assess its facilities, establish GHG goals and targets, and complete the annual questionnaire of the Carbon Disclosure Project, the main repository of corporate responses to climate change. Walden also co-filed a resolution at PNC Financial, led by Boston Common Asset Management, requesting an assessment of GHG emissions in its lending portfolio and exposure to climate change risk in its lending, investing and financing activities. Prompted by PNC’s funding of mountaintop removal coal mining, the SEC denied the bank’s attempt to omit the resolution from its proxy ballot. Additionally, Walden was among the dozen investors who joined Ceres in a letter to the National Federation of Municipal Analysts seeking improved disclosure from water utilities on water supply risk analysis and climate change impacts.

Equality
The debate on the Defense of Marriage Act (DOMA) continues to intensify as the U.S. Supreme Court deliberates its fate. DOMA prevents the federal government from recognizing marriages between same-sex couples considered legally married in their home state. The business community has joined the wave of support for what many believe will be DOMA’s invalidation in June. Walden wrote to twelve portfolio companies commending their decision to join hundreds of others that signed a friend of the court brief to the Supreme Court that essentially called the law bad for business. The companies are: Apple, Cisco Systems, Diageo, EMC, Google, Intel, Johnson & Johnson, Microsoft, Nike, Oracle, Qualcomm, and State Street. Additionally, Walden recently encouraged Denbury Resources to make its inclusive nondiscrimination policy more accessible via the Equal Employment section of its corporate website.

ESG Disclosure
Walden continues to emphasize shareholder initiatives calling for transparency around ESG practices, goals and results. Comprehensive reporting equips investors with information to assess more fully ESG risks and opportunities, and importantly, heightens corporate accountability, which can be an important precursor to more sustainable business conduct. We withdrew a resolution at Wabtec upon its commitment to publish a sustainability report by year-end that will reference the best practice GRI (Global Reporting Initiative) guidelines. Along with Calvert Investments, we have provided detailed feedback on McCormick’s outline for its first sustainability report. Our resolution at Emerson Electric attained shareholder support of 38 percent (up from 35 percent last year), sending a strong message to management that reporting on ESG impacts and results matters to investors.

We close this quarter’s update with words we appreciated from PepsiCo’s CEO, Indra Nooyi, who some Wall Street analysts criticize for her championing of Performance with Purpose, the company’s sustainability strategy. Along with Ceres and Calvert Investments, we let Ms. Nooyi and the Board know that we believe this focus positions the company for long-term business success. Ms. Nooyi reached out personally to thank us for our continued engagement over the years, noting: “Your feedback informs our thinking as we shape the company’s approaches to address the issues that are so important to all of us.”

34



Environmental, Social and Governance Research and Action Update (Unaudited) (continued)

Women on Boards: Too Long in Coming
Facts and forces are coalescing to bring attention to the lack of gender diversity in U.S. corporate boardrooms.

First the facts. Women remain woefully underrepresented among corporate directors despite modest advances in recent years. According to Ernst & Young1, women hold just 14 percent of S&P 1500 company board seats. The larger companies in the S&P 500 fare slightly better with a total of 17 percent. Fully one-quarter of S&P 1500 companies have no female representation at all. And, according to the nonprofit Catalyst, women of color hold just 3 percent of director positions. These numbers are particularly disappointing since women make up nearly half of the U.S. workforce (47 percent) and they are attaining educational credentials at record levels (e.g., U.S. Census Bureau data shows women now account for about six of ten advanced degree holders among the 26-29 year age group).

More facts. Evidence is mounting of a positive relationship between company performance and the presence of women on boards. For example, recent research by Credit Suisse2 (not peer reviewed) found that boards with gender diversity had higher return on equity, lower leverage and better than average growth. Moreover, superior stock price performance was observed for companies with one or more women on boards. The authors posited several reasons for their findings: positive signaling of good governance, stronger efforts board-wide, better mix of leadership skills, access to a wider pool of talent, better representation of consumers, gender differences in risk-aversion, and improved corporate governance.

Forces putting the spotlight on board diversity include women’s organizations and networks, business leaders, media, and importantly, major institutional investors who believe gender diversity is an essential aspect of good corporate governance. With a representative of CalSTRS (California State Teachers Retirement System), Walden’s Tim Smith co-chairs the Investor Committee of the Thirty Percent Coalition—a network of corporate governance experts, corporations, senior business executives, state-wide elected officials, national women’s organizations, and institutional investors—which aims to encourage gender diversity in boardrooms through outreach to companies and other initiatives. Signatories to recent letters to companies lacking women directors have included the Comptrollers of New York State and New York City; the Treasurers of the States of Connecticut, Maryland, Massachusetts, Pennsylvania, Washington State, and California; representatives of CalSTRS, CalPERS and AFL-CIO; and various foundations, religious investors, mutual funds, and investment managers.

Walden is also ramping up engagement on board diversity at selected portfolio companies (American Science & Engineering, CARBO Ceramics, City National, IPG Photonics, NetApp, ResMed, Riverbed Technology, and Sapient), seeking stronger nominating policies and implementation plans to increase the representation of women and people of color. Specifically, Walden recommends companies have a public statement expressing the value of board diversity, nominating charter language that explicitly identifies gender and race as factors considered, and a commitment to a diverse candidate pool. We also often seek to have a conversation with the chairperson of a board’s nominating committee.

Walden is pleased with the early results of this outreach. Riverbed informed us of its new appointment of two directors that added both racial and gender diversity to its Board. Sapient told us it will consider our recommendations during the annual review of corporate governance documents in the coming months. CARBO Ceramics agreed to bring our message to its nominating committee for discussion. NetApp, where we filed a resolution, is exploring steps that may result in the withdrawal of the proposal.

We were particularly impressed with a technology company response to the Thirty Percent Coalition that described gender diversity as a “critical need at the most fundamental level.” The Chair of the Nominating and Governance Committee further stated: “[we] have opened our recruiting process so that we are constantly looking for qualified women candidates, even in the absence of an open seat. So when we do find a woman candidate, we will expand the size of the board to make room for her.”

While progress is always slower to come than we all want, there is reason for optimism.


1

Getting on Board: Women join boards at higher rates, though progress comes slowly; Ernst & Young, December 2012.

   
2

Gender diversity and corporate performance; Research Institute, Thought leadership from Credit Suisse Research, August 2012.

35



Manager Commentary (Unaudited)
 
  Walden Asset Management Fund  
  Walden Equity Fund  
  March 31, 2013  
     
     
  William H. Apfel, CFA  
     
  Portfolio Manager  
  Boston Trust Investment  
  Management, Inc.  
     
  Asset Management Fund Objective  
  The investment objective of the Walden Asset Management Fund is to seek long-term capital growth and income through an actively managed portfolio of stocks, bonds and money market instruments.  
     
  Equity Fund Objective  
  The investment objective of the Walden Equity Fund is to seek long-term growth of capital through an actively managed portfolio of stocks.  
     
  Investment Concerns  
  Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities. The net asset value per share of these Funds will fluctuate as the value of the securities in the portfolio changes.  
     
  Bonds offer a relatively stable level of income, although bond prices will fluctuate, providing the potential for principal gain or loss. Intermediate term, higher quality bonds generally offer less risk than longer-term bonds and a lower rate of return.  
     
  Cash equivalents offer low risk and low return potential.  
     
     
 
Management Discussion of Fund Performance
 
Portfolio Review

The Walden Asset Management Fund (formerly the Walden Balanced Fund) returned 6.83% for the 12-month period, compared to 9.35% for its Morningstar peer group average. The Walden Equity Fund returned 8.27% for the 12-month period, compared to 13.96% for the S&P 500 Index. The shortfall in the Funds’ returns relative to these respective benchmarks was primarily due to the results for our equity selections, described in more detail below. As has often been the case in past periods of sharply rising markets, our “high quality” discipline, which seeks to identify companies with long histories of financial success, limited results as equity markets approached new highs. While trailing the Morningstar peer group, the Walden Asset Management Fund benefited from the equity market’s strong advance. Most importantly, the Fund’s equity allocation began the period near 75% to total assets, or at the upper end of the traditional 45% to 75% range. We did not reduce the equity allocation as stock prices increased, taking full advantage of the upward price trend.

 

As always, equity segment results for the Walden Asset Management Fund, and the entirety of the Walden Equity Fund, were affected by the composition of market returns. In particular, sectors less dependent upon economic growth fared better, as the healthcare and consumer products sectors posted especially strong returns. In contrast, commodity price-dependent materials companies lagged as did the technology sector. Meanwhile, low-quality stocks, as defined by Standard & Poor’s, continued their recent strong returns as investors sought weaker companies whose fortunes might be lifted by a rising market. The latter two trends limited both Funds relative results.

 

Our selections in the finance sector performed well relative to the sector index. Holdings in this sector include two high-quality property-casualty insurance companies. These benefitted from mounting indications that insurance pricing is now rising after years of weakness. While banks continued to lead the market higher, the more domestically oriented regional lenders were particularly good performers. In most instances, we prefer the beneficiaries of a healing domestic economy to the more global and diversified money center institutions. Toward the end of the fiscal year, the latter group suffered as the collapse of Cypriot banks once again called attention to the risks inherent in complex financial institutions.*

 

Fund industrial sector holdings lagged the sector index. Our industrial sector selections have fared well during the four-year market rise, as we emphasized capital goods producers that serve expanding global markets. Despite the slow growing economy, many of these companies have succeeded in strengthening their profitability through improved efficiencies in manufacturing and distribution. In contrast, the best performers in this sector during the past 12-month period were highly cyclical airlines and stocks leveraged to a rebound in construction. While we anticipate that construction activity will gain momentum, we find the valuation of many companies in this industry entails a high degree of speculation.*

 

Finally, the fixed income segment of the Walden Asset Management Fund performed in line with market benchmarks over the past year. In the current environment, we view the role of fixed income in a diversified portfolio as a matter of risk control and diversification. Our expected return forecasts for this segment in the most likely scenarios average near zero.

 

Portfolio Strategy

Four years after stock prices dropped by more than half in the wake of the financial crisis, market indices have fully recovered. Further market advances will depend upon continued profit growth. With profit margins near historical peaks, only those reasonably valued companies that continue to generate rising sales, increased efficiencies, and steady cash flows, may reward investors.

 

We believe our current equity investment strategy is well suited to this environment. While Fund sector weights are similar to those of the S&P 500 Index, and Price-to-Earnings Ratio1 valuations are close to index levels, individual holdings are focused on companies with substantial free cash flows relative to earnings and businesses we consider well placed to generate steady sales and earnings growth. As always, portfolio companies have long histories of attractive profitability, strong balance sheets, and business models we judge to be sustainable far into the future.

 

With all the risks that equities entail, we view them as easily a better option than fixed income alternatives. At today’s valuations, we believe only equities offer the likelihood of attractive long-term returns. Fund equity allocation therefore remains high relative to historical averages. Fixed income holdings are of the highest quality. Average fixed income segment maturities are shorter than appropriate benchmark comparisons, reflecting our expectation that over time interest rates are more likely to rise than fall.

   
1

The Price-to-Earnings Ratio (“P/E Ratio”) is a valuation ratio of a company’s current share price to its per-share earnings. A high P/E means high projected earnings in the future.

* Portfolio composition is subject to change.

36



Investment Performance (Unaudited) Walden Asset Management Fund
Walden Equity Fund

March 31, 2013

    Annualized
     
    1 Year Ended   5 Years Ended   10 Years Ended
    3/31/13   3/31/13   3/31/13
Walden Asset Management Fund1     6.83 %     4.36 %     6.07 %
Walden Equity Fund1     8.27 %     5.54 %     8.04 %
S&P 500 Index     13.96 %     5.81 %     8.53 %
 
Barclays Capital U.S. Government/Credit Bond Index     4.56 %     5.50 %     5.06 %
 
Citigroup 90-Day U.S. Treasury Bill Index     0.08 %     0.31 %     1.66 %
 
Morningstar U.S. Open-End Moderate Allocation Funds Average     9.35 %     4.53 %     6.82 %
 

Hypothetical Growth of a $10,000 Investment

The above charts represent a 10-year hypothetical $10,000 investment in the Walden Asset Management Fund and Walden Equity Fund, and represents the reinvestment of dividends and capital gains in the Funds. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

The Walden Asset Management Fund is measured against a combination of equity and fixed income indices. The Walden Equity Fund is measured against the Standard & Poor’s 500 Index (“S&P 500”) which is widely regarded as a gauge of the U.S. equities market. This index includes 500 leading companies in leading industries of the U.S. economy. Although the S&P 500 focuses on the large cap segment of the market, with approximately 75% coverage of U.S. equities, it is also widely viewed as a proxy for the total market. The Barclays Capital U.S. Government/Credit Bond Index is a component of the Barclays U.S. Aggregate Index. The Barclays Capital U.S. Government/Credit Bond Index includes Treasuries (i.e., public obligations of the U.S. Treasury that have remaining maturities of more than one year), Government-Related issues (i.e., agency, sovereign, supranational, and local authority debt), and USD Corporates. The Citigroup 90-Day U.S. Treasury Bill Index reflects monthly return equivalents of yield averages that are not marked to the market. The Index is an average of the last three-month treasury bill issues. The three-month treasury bills are the short-term debt obligations of the U.S. Government. The Morningstar U.S. Open-End Moderate Allocation Funds Average represents performance of portfolios that seek to provide both capital appreciation and income by investing in three major areas: stocks, bonds, and cash. These portfolios tend to hold larger positions in stocks than conservative-allocation portfolios. These portfolios typically have 50% to 70% of assets in equities and the remainder in fixed income and cash. The indices are unmanaged and their performance does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Funds’ performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

Walden Asset Management Fund
 Fund Net Asset Value: $13.53 
 Gross Expense Ratio1: 1.13% 

Walden Equity Fund
 Fund Net Asset Value: $15.41 
 Gross Expense Ratio1: 1.16% 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

1 

The Gross Expense Ratio is from each Fund’s most recent prospectus, dated August 1, 2012. The Gross Expense Ratio excludes the impact of contractual fee waivers. After giving effect to such fee waivers, the Asset Management Fund’s Net Expense Ratio would be 1.00%, including the indirect expenses of investing in acquired funds. Please see each Fund’s most recent prospectus for details. Additional information pertaining to each Fund’s expense ratio as of March 31, 2013 can be found in the financial highlights. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through August 1, 2013 and may be terminated thereafter.

37



Manager Commentary (Unaudited)
 
  Walden Midcap Fund  
  March 31, 2013  
     
     
  Stephen J. Amyouny, CFA  
     
  Portfolio Manager  
  Boston Trust Investment  
  Management, Inc.  
     
  Fund Objective  
  The Fund seeks long-term capital growth through an actively managed portfolio of stocks of middle capitalization (“midcap”) companies.  
     
  Investment Concerns  
  Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.  
     
  Mid-capitalization funds typically carry additional risks since smaller companies generally have a higher risk of failure.  
     
     
 
Management Discussion of Fund Performance
 
Portfolio Review

The Walden Midcap Fund posted a total return of 9.12% for the 12-month period ended March 31, 2013—a disappointing result in comparison to the benchmark Russell Midcap® Index, which returned 17.30%. Two primary factors contributed to the Fund’s weak performance relative to the benchmark: 1) the strong performance of lower quality stocks versus high-quality stocks, and 2) security selection. Over the last 12 months, investors reacted positively to the aggressive monetary policies of the Fed and other central banks across the globe. As a result, investors increased their exposures to riskier assets, including stocks in lower quality companies, which stand to benefit the most from a reacceleration in global economic activity. This trend presented a headwind to our investment approach, which focuses on higher-quality companies with more stable businesses, greater financial strength, and high levels of profitability. The Fund also experienced disappointing results relative to the benchmark index in two specific sectors: information technology and consumer discretionary. Within information technology, the Fund’s exposure to companies in the enterprise corporate IT markets detracted from results. This technology segment has recently experienced a softening in demand, which adversely affected the performance of several of the Fund’s holdings; however, we continue to believe that it is an attractive segment within the technology sector with solid growth prospects. In the consumer discretionary sector, many highly cyclical stocks with exposure to residential housing performed exceptionally well. This group included homebuilders, producers of household durables, and home retailers as well as companies in the materials sector that supply building and construction materials and paints.*

 

One sector of the market that performed very well and bucked the afore-mentioned trend of lower-quality companies was consumer staples. The Fund’s holdings in this sector performed exceptionally well, thanks in part to investors’ gravitation toward companies with relatively stable businesses and high dividend yields that offer an alternative to low yielding fixed income instruments.*

 

Portfolio Strategy

In recent years, corporations have generally grown earnings per share1 (EPS) from a combination of revenue growth, margin expansion, and share repurchases. We believe that revenue growth in aggregate among our portfolio companies is likely to approximate global gross domestic product2 growth with perhaps a 1% to 2% additional benefit from expected acquisition activity. Based on strong free cash flow generation and very healthy balance sheets, share repurchases are also likely to contribute to future EPS growth. The wildcard in this formula remains the ability of our companies to continue to expand margins. Over the last few years, companies have benefited from operating leverage, rising productivity, low wage cost inflation, improving supply chain logistics, global sourcing, and lower interest expenses. We anticipate that future margin expansion should be modest, in comparison to current levels, and thus will contribute less to EPS growth over the next few years; although, based on present valuations that are quite reasonable, we believe that EPS growth will be sufficient to drive stock prices higher.

 

As always, the Fund will continue to hold a diversified portfolio of high-quality companies with strong balance sheets, sustainable business models, and attractive growth prospects that sell at reasonable valuations. The last point – reasonable valuations – is worth emphasizing. Thanks in large part to the sharp price appreciation of equities over the last few years many stocks now sell at valuations that imply unreasonably high future growth expectations. We continue to monitor the valuations of our Fund holdings and remain disciplined in all facets of our investment approach. In fact, despite the superior financial characteristics of our companies, the Fund holdings presently sells at a Price-to-Earnings Ratio3 on trailing GAAP EPS that is approximately 15% below that of the Russell Midcap Index. We remain confident that our long-term investment approach and discipline will produce attractive future returns.

   
1

The Earnings per Share (“EPS”) Growth indicates the portion of a company’s profit allocated to each outstanding share of common stock. Earnings per share serves as an indicator of a company’s profitability.

   
2

The Gross Domestic Product (“GDP”) is the measure of the market value of the goods and services produced by labor and property in the United States.

   
3

The Price-to-Earnings Ratio (“P/E Ratio”) is a valuation ratio of a company’s current share price to its per-share earnings. A high P/E means high projected earnings in the future.

   
* Portfolio composition is subject to change.

38



Investment Performance (Unaudited) Walden Midcap Fund
March 31, 2013

    Annualized
     
    1 Year Ended       Since Inception
    3/31/13       8/1/11
Walden Midcap Fund1     9.12 %             12.39 %
 
Russell Midcap® Index     17.30 %             15.03 %
 

Hypothetical Growth of a $10,000 Investment

The chart represents the historical performance of a hypothetical $10,000 investment in the Walden Midcap Fund from August 1, 2011 to March 31, 2013, and represents the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

The Walden Midcap Fund is measured against the Russell Midcap® Index, which is an unmanaged index that measures the performance of the mid-cap segment of the U.S. equity universe. The Russell Midcap® Index is a subset of the Russell 1000® Index. It includes approximately 800 of the smallest securities based on a combination of their market capitalization and current index membership. The Russell Midcap® Index represents approximately 31% of the total market capitalization of the Russell 1000 companies. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 Fund Net Asset Value: $12.06 
 Gross Expense Ratio1: 1.28% 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. Returns less than one year are not annualized. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

1 

The Gross Expense Ratio is from the Fund’s most recent prospectus, dated August 1, 2012. The Gross Expense Ratio excludes the impact of any contractual fee waivers. After giving effect to such fee waivers, the Fund’s Net Expense Ratio would be 1.01%, including the indirect expenses of investing in acquired funds. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of March 31, 2013 can be found in the financial highlights. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through August 1, 2013 and may be terminated thereafter.

39



Manager Commentary (Unaudited)
 
  Walden SMID Cap  
  Innovations Fund  
  March 31, 2013  
     
     
  Kenneth P. Scott, CFA  
  Stephen C. Franco, CFA  
  Heidi H. Vanni, CFA  
     
  Portfolio Managers  
  Boston Trust Investment  
  Management, Inc.  
     
  Fund Objective  
  The investment objective of the Walden SMID Cap Innovations Fund is to seek long-term capital growth through an actively managed portfolio of stocks of small- to mid-capitalization companies.  
     
  Investment Concerns  
  Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.  
     
  Small-capitalization funds typically carry additional risks since smaller companies generally have a higher risk of failure, and historically, their stocks have experienced a greater degree of market volatility than stocks on average.  
     
     
 
Management Discussion of Fund Performance
 
Portfolio Review

U.S. equity markets rose sharply for the 12-month period, with the value of the Fund’s benchmark, the Russell 2500® Index increasing 17.73%. The U.S. market welcomed continued improvement in economic fundamentals, and appeared unaffected by the ongoing fiscal challenges of the U.S. and Europe. The Walden SMID Cap Innovations Fund, which focuses on higher quality, more innovative companies, posted strong gains of 21.28% for the period from its inception on June 28, 2012 to the period ended March 31, 2013, although, disappointingly, underperformed the benchmark returns by approximately 4.9 percentage points for the period ending March 31, 2013.

 

Generally, stocks of higher-quality companies underperform when share prices rise sharply and when expectations for volatility are low and falling. This is consistent with the view that stock values, and those of riskier companies in particular, appreciate as investors demonstrate increased appetite for risk.

 

On a key measure of quality–financial leverage–stocks with lower-quality profiles outperformed in the year ended March 31, 2013. We believe this is due not only to the typical performance patterns associated with lower-quality stocks in a strong bull market, but also to historically low interest rates. The most indebted firms currently face fewer burdens than they would in a normal interest rate environment. On other measures of quality, such as profitability, the performance impact is less clear.

 

Portfolio Strategy

The top individual stock contributors to performance this year were mortgage-servicing firm Ocwen Financial (OCN), short haul railroad firm Genesee & Wyoming (GWR), commercial kitchen equipment maker Middleby (MIDD), railroad equipment supplier Wabtec (WAB) and network storage vendor CommVault Systems (CVLT). Laggards this year were premium mattress manufacturers Tempur-Pedic (TPX) and Select Comfort (SCSS), health care software firm Quality Systems (QSII), prepaid debit card firm Green Dot (GDOT) and videoconferencing vendor Polycom (PLCM). Tempur-Pedic and Green Dot were sold due to concerns about the long-term sustainability of their business models.*

 

Walden aims to maintain SMID-cap portfolio sector weights comparable to those of the overall SMID-cap market. Slight differences in sector weights had no significant impact on relative performance. However, at the subsector level there were differences that affected performance. For example, our focus on higher-quality companies results in under weights in certain lower-quality industries, (e.g. airlines, biotechnology, building products, and media) which performed quite well over the previous 12 months.*

 

U.S. economic activity continued to improve in early 2013, with ongoing contributions from consumers, a housing recovery, business investment, and healthy exports, complemented by low inflation and the Federal Reserve maintaining its efforts to hold interest rates at historically low levels. Thus, in spite of several, global economic challenges, the opportunity for continued, positive equity performance, including SMIDcap equity performance, remains in place.

 

That said, with a Price-to-Earnings Ratio1 of 26 times trailing earnings at March 31, 2013, the valuation of the Russell 2500® implies continued strong growth in overall SMID-cap company earnings. Wall Street analysts expect the Russell 2500® companies, in aggregate, to post approximately 20% growth in earnings in 2013. Such earnings growth can be achieved either through strong sales growth, which may be challenging for this large group of companies if the economic recovery remains modest, or through expansion of profit margins, which are already above their historical average. A shortfall in SMID-cap firms’ earnings may prove disappointing at current valuations. However, we continue to believe that investing in reasonably priced shares of a distinct subset of more innovative, higher-quality companies, whose businesses are leveraged to more sustainable elements of growth, will continue to provide substantial value to client portfolios over time.

   
1

The Price-to-Earnings Ratio (“P/E Ratio”) is a valuation ratio of a company’s current share price to its per-share earnings. A high P/E means high projected earnings in the future.

   
* Portfolio composition is subject to change.

40



Investment Performance (Unaudited) Walden SMID Cap
Innovations Fund

March 31, 2013

    6 Months Ended       Since Inception
    3/31/13       6/28/12
Walden SMID Cap Innovations Fund1     11.88 %             21.28 %
 
Russell 2500® Index     16.35 %             26.31 %
 

Hypothetical Growth of a $10,000 Investment

The chart represents the historical performance of a hypothetical $10,000 investment in the Walden SMID Cap Innovations Fund from June 28, 2012 to March 31, 2013, and represents the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

The Walden SMID Cap Innovations Fund is measured against the Russell 2500TM Index, which is an unmanaged index that measures the performance of the small- to mid-cap segment of the U.S. equity universe, commonly referred to as “smid” cap. The Russell 2500 is a subset of the Russell 3000® Index. It includes approximately 2500 of the smallest securities based on a combination of their market cap and current index membership. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 Fund Net Asset Value: $12.09 
 Gross Expense Ratio1: 1.19% 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

1 

The Gross Expense Ratio is from the Fund’s most recent prospectus, dated August 1, 2012. The Gross Expense Ratio excludes the impact of any contractual fee waivers. After giving effect to such fee waivers, the SMID Cap Innovations Fund’s Net Expense Ratio would be 1.01%, including the indirect expenses of investing in acquired funds. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of March 31, 2013 can be found in the financial highlights. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through August 1, 2013 and may be terminated thereafter.

41



Manager Commentary (Unaudited)
 
  Walden Small Cap  
  Innovations Fund  
  March 31, 2013  
     
     
  Kenneth P. Scott, CFA  
     
  Portfolio Manager  
  Boston Trust Investment  
  Management, Inc.  
     
  Fund Objective  
  The investment objective of the Walden Small Cap Innovations Fund is to seek long-term capital growth through an actively managed portfolio of stocks of small capitalization companies.  
     
  Investment Concerns  
  Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.  
     
  Small-capitalization funds typically carry additional risks since smaller companies generally have a higher risk of failure, and historically, their stocks have experienced a greater degree of market volatility than stocks on average.  
     
     
 
Management Discussion of Fund Performance
 
Portfolio Review

U.S. equity markets rose sharply for the 12-month period ended March 31, 2013, with the value of the benchmark Russell 2000® Index increasing 16.30%. The U.S. market welcomed continued improvement in economic fundamentals, and appeared unaffected by the ongoing fiscal challenges of the U.S. and Europe. The Walden Small Cap Innovations Fund, which focuses on higher quality, more innovative companies, posted a strong gain of 12.05% for the 12-month period, nevertheless, disappointingly, underperformed the benchmark return for period. For the 3-year period, and since inception, the Fund underperformed the strong performance of the Russell 2000® by less than 1% annualized, albeit while demonstrating lower volatility.

 

Generally, stocks of higher-quality companies underperform when share prices rise sharply and when expectations for volatility are low and falling. This is consistent with the view that stock values, and those of riskier companies in particular, appreciate as investors demonstrate increased appetite for risk.

 

On a key measure of quality–financial leverage–stocks with lower quality profiles outperformed in the year ended March 31, 2013. We believe this is due not only to the typical performance patterns associated with lower-quality stocks in a strong bull market, but also to historically low interest rates. The most indebted firms currently face fewer burdens than they would in a normal interest rate environment. On other measures of quality, such as profitability, the performance impact is less clear.

 

Performance Attribution Commentary

The top individual stock contributors to performance this year were mortgage servicing company Ocwen Financial (OCN), short haul railroad firm Genesee & Wyoming (GWR), pharmaceutical packaging company West Pharmaceutical (WST), architectural glass manufacturer Apogee Enterprises (APOG), and commercial kitchen equipment maker Middleby (MIDD). Laggards this year were premium mattress manufacturer Select Comfort (SCSS), health care software firm Quality Systems (QSII), prepaid debit card firm Green Dot (GDOT), alternative fuel vehicle equipment maker Fuel Systems Solutions (FSYS), and business-to-business auction firm Liquidity Services (LQDT). We sold Ocwen Financial and Genesee & Wyoming from the Fund due to market capitalization considerations, and sold Green Dot and Fuel Systems due to concerns about the long-term sustainability of their business models.*

 

Walden aims to maintain small-cap portfolio sector weights comparable to those of the overall small-cap market. Slight differences in sector weights had no significant impact on relative performance. However, at the subsector level there were differences that affected performance. For example, our focus on higher-quality companies resulted in under weights in certain lower-quality industries, (e.g. airlines, biotechnology, building products, and construction materials) that fared particularly well during this past year.

 

U.S. economic activity continued to improve in early 2013, with ongoing contributions from consumers, a housing recovery, business investment, and healthy exports, complemented by low inflation and the U.S. Federal Reserve maintaining its efforts to hold interest rates at historically low levels. Thus, in spite of several, global economic challenges, the opportunity for continued, positive equity performance, including small cap equity performance, remains in place.

 

That said, with a Price-to-Earnings Ratio1 of 34 times trailing earnings at March 31, 2013, the valuation of the Russell 2000® implies continued, strong growth in overall small-cap company earnings. Wall Street analysts expect the Russell 2000® companies, in aggregate, to post approximately 20% growth in earnings in 2013. Such earnings growth can be achieved either through strong sales growth, which may be challenging for this large group of companies if the economic recovery remains modest, or through expansion of profit margins, which are already above their historical average. A shortfall in small-cap firms’ earnings may prove disappointing at current valuations. However, we continue to believe that investing in reasonably priced shares of a distinct subset of more innovative, higher-quality companies, whose businesses are leveraged to more sustainable elements of growth, will continue to provide substantial value to Fund holders’ overall portfolios over time.*

   
1

The Price-to-Earnings Ratio (“P/E Ratio”) is a valuation ratio of a company’s current share price to its per-share earnings. A high P/E means high projected earnings in the future.

   
* Portfolio composition is subject to change.

42



Investment Performance (Unaudited) Walden Small Cap
Innovations Fund

March 31, 2013

    Annualized
     
    1 Year Ended       Since Inception
    3/31/13       10/24/08
Walden Small Cap Innovations Fund1     12.05 %             18.60 %
 
Russell 2000® Index     16.30 %             18.87 %
 

Hypothetical Growth of a $10,000 Investment

The chart represents the historical performance of a hypothetical $10,000 investment in the Walden Small Cap Innovations Fund from October 24, 2008 to March 31, 2013, and represents the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

The Walden Small Cap Innovations Fund is measured against the Russell 2000® Index, which is an unmanaged index that measures the performance of the small-cap segment of the U.S. equity universe. The Russell 2000® Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2,000 of the smallest securities based on a combination of their market cap and current index membership. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 Fund Net Asset Value: $18.48 
 Gross Expense Ratio1: 1.16% 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

1 

The Gross Expense Ratio is from the Fund’s most recent prospectus, dated August 1, 2012. The Gross Expense Ratio excludes the impact of any contractual fee waivers. After giving effect to such fee waivers, the Small Cap Innovations Fund’s Net Expense Ratio would be 1.01%, including the indirect expenses of investing in acquired funds. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of March 31, 2013 can be found in the financial highlights. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through August 1, 2013 and may be terminated thereafter.

43




Schedule of Portfolio Investments
 

Walden Asset Management Fund

March 31, 2013
     

 COMMON STOCKS (74.3%)              
Security Description       Shares     Fair Value ($)
               
Consumer Discretionary (8.4%)              
Advance Auto Parts, Inc.     6,000       495,900
Autoliv, Inc.     7,000       483,980
McDonald’s Corp.     8,500       847,365
NIKE, Inc., Class B     18,000       1,062,180
Omnicom Group, Inc.     12,000       706,800
Ross Stores, Inc.     12,000       727,440
The Home Depot, Inc.     2,000       139,560
Time Warner Cable, Inc.     10,000       960,600
               
              5,423,825
               
Consumer Staples (10.2%)              
Colgate-Palmolive Co.     7,850       926,535
Costco Wholesale Corp.     9,200       976,212
McCormick & Co., Inc.     3,000       220,650
Nestle SA, Sponsored ADR     13,000       942,110
PepsiCo, Inc.     12,600       996,786
Procter & Gamble Co.     14,000       1,078,840
Reckitt Benckiser Group PLC, Sponsored ADR     41,000       591,630
SYSCO Corp.     24,000       844,080
               
              6,576,843
               
Energy (7.8%)              
Apache Corp.     9,000       694,440
BG Group PLC, Sponsored ADR     36,000       617,400
ConocoPhillips     18,500       1,111,850
Core Laboratories NV     6,000       827,520
Denbury Resources, Inc.(a)     25,000       466,250
Devon Energy Corp.     14,500       818,090
Phillips 66     7,000       489,790
               
              5,025,340
               
Financials (10.7%)              
American Express Co.     8,000       539,680
BB&T Corp.     15,000       470,850
Chubb Corp.     9,500       831,535
Cincinnati Financial Corp.     21,000       990,990
Comerica, Inc.     17,000       611,150
Commerce Bancshares, Inc.     10,500       428,715
JPMorgan Chase & Co.     15,000       711,900
PNC Financial Services Group, Inc.     10,000       665,000
State Street Corp.     10,000       590,900
T. Rowe Price Group, Inc.     15,000       1,123,050
               
              6,963,770
               
Health Care (9.3%)              
Becton, Dickinson & Co.     9,000       860,490
C.R. Bard, Inc.     7,000       705,460
DENTSPLY International, Inc.     18,000       763,560
Johnson & Johnson, Inc.     9,000       733,770
Medtronic, Inc.     12,000       563,520
Mettler-Toledo International, Inc.(a)     3,100       660,982
Roche Holding AG, Sponsored ADR     10,000       586,000
Stryker Corp.     9,500       619,780
Waters Corp.(a)     6,000       563,460
               
              6,057,022
               
Industrials (11.3%)              
3M Co.     7,500       797,325
Deere & Co.     9,500       816,810
Donaldson Co., Inc.     24,000       868,560
Emerson Electric Co.     18,000       1,005,660
Expeditors International of Washington, Inc.     9,500       339,245
Illinois Tool Works, Inc.     16,000       975,040
Lincoln Electric Holdings, Inc.     11,500       623,070
United Parcel Service, Inc., Class B     9,500       816,050
W.W. Grainger, Inc.     4,650       1,046,157
               
              7,287,917
               
                 
        Shares or        
        Principal        
Security Description       Amount ($)       Fair Value ($)
               
Information Technology (13.3%)              
Accenture PLC, Class A     10,500       797,685
Apple, Inc.     2,300       1,018,049
Automatic Data Processing, Inc.     11,000       715,220
Cisco Systems, Inc.     33,000       690,030
EMC Corp.(a)     26,000       621,140
Google, Inc., Class A(a)     900       714,627
Intel Corp.     20,000       437,000
International Business Machines Corp.     4,500       959,850
Microsoft Corp.     31,000       886,910
NetApp, Inc.(a)     10,000       341,600
Oracle Corp.     25,000       808,500
QUALCOMM, Inc.     9,500       636,025
               
              8,626,636
               
Materials (3.3%)              
AptarGroup, Inc.     12,000       688,200
Praxair, Inc.     6,700       747,318
Sigma-Aldrich Corp.     9,000       699,120
               
              2,134,638
               
TOTAL COMMON STOCKS (Cost $34,379,438)             48,095,991
               
 CORPORATE BONDS (3.7%)              
Consumer Staples (0.3%)              
Campbell Soup Co., 4.50%, 2/15/19     150,000       169,947
               
Financials (2.7%)              
American Express Co., 2.65%, 12/2/22     287,000       281,841
American Express Co., 7.00%, 3/19/18     250,000       312,511
Calvert Social Investment Foundation, Series NOTZ, 0.75%, 8/31/14, MTN(b)     75,000       75,000
Export-Import Bank of Korea, 1.75%, 2/27/18     250,000       249,865
JPMorgan Chase & Co., 3.15%, 7/5/16     250,000       265,277
National Rural Utilities Cooperative Finance Corp., 10.38%, 11/1/18     250,000       365,271
North American Development Bank, 4.38%, 2/1/20     100,000       111,136
Wachovia Corp., 5.75%, 6/15/17     100,000       117,636
               
              1,778,537
               
Industrials (0.1%)              
Hubbell, Inc., 3.63%, 11/15/22     75,000       79,962
               
 
Information Technology (0.4%)              
Oracle Corp., 5.75%, 4/15/18     200,000       241,598
               
 
Telecommunication Services (0.2%)              
AT&T, Inc., 5.50%, 2/1/18     100,000       117,691
               
TOTAL CORPORATE BONDS (Cost $2,127,595)             2,387,735
               
 MUNICIPAL BONDS (1.1%)              
Illinois (0.3%)              
Illinois State, GO, 5.00%, 6/1/27, NATL-RE FGIC, Callable 6/1/13 @ 100     200,000       201,206
               
Ohio (0.2%)              
Ohio State, Series D, GO, 4.50%, 9/15/22, NATL-RE, Callable 3/15/16 @ 100     150,000       164,258
               
Oregon (0.2%)              
Oregon State, Series A, GO, 5.00%, 10/1/14     100,000       105,996
               
Wisconsin (0.4%)              
Wisconsin State, Build America Bonds, GO, 4.60%, 5/1/26, Callable 5/1/21 @ 100     250,000       285,627
               
TOTAL MUNICIPAL BONDS (Cost $703,216)             757,087
               

44   See Notes to Financial Statements




Schedule of Portfolio Investments
 (cont.)
 

Walden Asset Management Fund

March 31, 2013
     

 U.S. GOVERNMENT & U.S. GOVERNMENT AGENCY OBLIGATIONS (16.8%)              
        Shares or        
        Principal        
Security Description       Amount ($)     Fair Value ($)
               
Federal Farm Credit Bank              

5.38%, 11/10/20

    250,000       313,890
                 
Federal Home Loan Bank              

0.88%, 12/12/14

    1,500,000       1,515,811

1.38%, 5/28/14

    500,000       506,895

2.50%, 3/11/22

    200,000       210,092

3.13%, 12/13/13

    1,000,000       1,021,006

3.63%, 10/18/13

    500,000       509,599

5.25%, 12/11/20

    200,000       251,712

5.25%, 8/15/22

    1,000,000       1,272,406

5.50%, 7/15/36

    700,000       940,918
               
              6,228,439
               
Federal National Mortgage Association              

0.88%, 8/28/14

    1,000,000       1,009,191

1.13%, 6/27/14

    500,000       505,872
               
              1,515,063
               
Government National Mortgage Association              

4.00%, 9/15/40

    164,227       180,117

4.00%, 9/15/41

    557,393       608,190

6.50%, 5/15/32

    34,216       39,145
               
              827,452
               
The Financing Corporation              

2.92%, 4/5/13(c)

    100,000       99,993
               
U.S. Treasury Inflation Index Note              

0.63%, 7/15/21

    255,408       292,388
               
U.S. Treasury Inflation Protected Bond              

1.25%, 7/15/20

    1,319,775       1,577,797
               
TOTAL U.S. GOVERNMENT & U.S. GOVERNMENT              
               
AGENCY OBLIGATIONS (Cost $10,215,461)             10,855,022
               
 INVESTMENT COMPANIES (4.0%)              
State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(d)     2,574,260       2,574,260
               
TOTAL INVESTMENT COMPANIES (Cost $2,574,260)             2,574,260
               
Total Investments (Cost $49,999,970)(e) — 99.9%             64,670,095
Other assets in excess of liabilities 0.1%             57,512
               
NET ASSETS — 100.0%           $ 64,727,607
               


(a)   Non-income producing security.
(b)   Illiquid Security.
(c)   Rate represents the effective yield at purchase.
(d)   Rate disclosed is the seven day yield as of March 31, 2013.
(e)   See Federal Tax Information listed in the Notes to the Financial Statements.
ADR   American Depositary Receipt
FGIC   Insured by Financial Guaranty Insurance Company
GO   General Obligation
MTN   Medium Term Note
NATL-RE   Reinsured by National Public Finance Guarantee Corporation
NV   Naamloze Vennootschap
PLC   Public Limited Company

See Notes to Financial Statements   45




Financial Statements
 

Walden Asset Management Fund
     

 STATEMENT OF ASSETS AND LIABILITIES          
March 31, 2013          
           
Assets:          
Investments, at fair value (cost $49,999,970)     $ 64,670,095  
Cash       16,006  
Interest and dividends receivable       167,788  
Prepaid expenses and other assets       6,497  
         

Total Assets

      64,860,386  
         
Liabilities:          
Payable for capital shares redeemed       70,001  
Accrued expenses and other liabilities:          

Investment adviser

      29,892  

Chief compliance officer

      420  

Administration and accounting

      2,549  

Custodian

      1,546  

Transfer agent

      8,973  

Trustee

      165  

Shareholder servicing

      9,938  

Other

      9,295  
         

Total Liabilities

      132,779  
         
Net Assets     $ 64,727,607  
         
Composition of Net Assets:          
Capital     $ 49,955,710  
Accumulated net investment income       145,977  
Accumulated net realized losses from investment transactions       (44,205 )
Net unrealized appreciation from investments       14,670,125  
         
Net Assets     $ 64,727,607  
         

Shares outstanding (par value $0.01, unlimited number of shares authorized)

      4,783,606  
         

Net Asset Value, Offering Price and Redemption Price per share

    $ 13.53  
         

 STATEMENT OF OPERATIONS          
For the year ended March 31, 2013          
           
Investment Income:          
Interest     $ 341,646  
Dividends       969,142  
Less: Foreign tax withholding       (1,131 )
         

Total Investment Income

      1,309,657  
         
Expenses:          

Investment adviser

      435,530  

Administration and accounting

      74,983  

Shareholder servicing

      36,337  

Trustee

      2,514  

Custodian

      10,047  

Transfer agency

      33,226  

Chief compliance officer

      2,250  

Other

      42,629  
         

Total expenses before fee reductions

      637,516  

Fees voluntarily reduced by the transfer agent

      (5,437 )

Fees contractually reduced by investment advisor

      (49,992 )
         
Net Expenses       582,087  
         
Net Investment Income       727,570  
         
Net Realized/Unrealized Gains from Investments:          

Net realized gains from investment transactions

      460,562  

Change in unrealized appreciation from investments

      2,939,385  
         
Net realized/unrealized gains from investments       3,399,947  
         
Change in Net Assets Resulting from Operations     $ 4,127,517  
         

46   See Notes to Financial Statements




Financial Statements
 

Walden Asset Management Fund
     

 STATEMENTS OF CHANGES IN NET ASSETS                    
      For the year ended       For the year ended  
      March 31,       March 31,  
      2013       2012  
                 
                     
Investment Activities:                    
Operations:                    

Net investment income

    $ 727,570       $ 527,632  

Net realized gains from investment transactions

      460,562         649,156  

Change in unrealized appreciation/depreciation from investments

      2,939,385         3,335,936  
                 
Change in Net Assets Resulting from Operations       4,127,517         4,512,724  
                 
Dividends:                    

Net investment income

      (710,488 )       (550,502 )
                 
Change in Net Assets Resulting from Shareholder Dividends       (710,488 )       (550,502 )
                 
Capital Share Transactions:                    

Proceeds from shares issued

      7,258,486         5,722,485  

Proceeds from shares issued in subscription in-kind(a)

              5,098,275  

Dividends reinvested

      524,576         294,548  

Cost of shares redeemed

      (3,552,189 )       (6,041,401 )
                 
Change in Net Assets Resulting from Capital Share Transactions       4,230,873         5,073,907  
                 
Change in Net Assets       7,647,902         9,036,129  
Net Assets:                    

Beginning of period

      57,079,705         48,043,576  
                 

End of period

    $ 64,727,607       $ 57,079,705  
                 
Share Transactions:                    

Issued

      568,831         480,206  

Issued in subscriptions in-kind(a)

              463,901  

Reinvested

      41,417         25,261  

Redeemed

      (279,084 )       (497,437 )
                 
Change in Shares       331,164         471,931  
                 
Accumulated net investment income     $ 145,977       $ 112,702  
                 

 
Amounts designated as “—” are $0 or have been rounded to $0.
(a)   See Note 3 in Notes to Financial Statements.

See Notes to Financial Statements   47




Financial Statements
 

Walden Asset Management Fund
     

 FINANCIAL HIGHLIGHTS
Selected data for a share outstanding throughout the years indicated.

      For the year       For the year       For the year       For the year       For the year  
      ended       ended       ended       ended       ended  
      March 31,       March 31,       March 31,       March 31,       March 31,  
      2013       2012       2011       2010       2009  
                                         
                                                   

Net Asset Value, Beginning of Period

    $ 12.82       $ 12.07       $ 10.98       $ 8.84       $ 11.90  
                                         
Investment Activities:                                                  

Net investment income

      0.15         0.12         0.15         0.16         0.16 (a)

Net realized and unrealized gains (losses) from investment transactions

      0.71         0.75         1.09         2.11         (2.88 )
                                         
Total from investment activities       0.86         0.87         1.24         2.27         (2.72 )
                                         
Dividends:                                                  

Net investment income

      (0.15 )       (0.12 )       (0.15 )       (0.13 )       (0.21 )

Net realized gains from investments

                                      (0.13 )
                                         
Total dividends       (0.15 )       (0.12 )       (0.15 )       (0.13 )       (0.34 )
                                         
Net Asset Value, End of Period     $ 13.53       $ 12.82       $ 12.07       $ 10.98       $ 8.84  
                                         
Total Return       6.83%         7.35%         11.32%         25.78%         (22.91)%  
                                         
Ratios/Supplemental Data:                                                  
Net Assets at end of period (000’s)     $ 64,728       $ 57,080       $ 48,044       $ 41,500       $ 29,005  
Ratio of net expenses to average net assets       1.00%         1.00%         1.00%         1.00%         1.00%  

Ratio of net investment income to average net assets

      1.25%         1.04%         1.30%         1.59%         1.55%  

Ratio of expenses (before fee reductions) to average net assets(b)

      1.10%         1.13%         1.14%         1.17%         1.19%  
Portfolio turnover rate       15.93%         24.56%         31.03%         27.02%         71.27%  


Amounts designated as “—” are $0 or have been rounded to $0.
(a)   Calculated using the average shares method.
(b)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated.

48   See Notes to Financial Statements




Schedule of Portfolio Investments
 

Walden Equity Fund

March 31, 2013
     

 COMMON STOCKS (98.7%)              
Security Description       Shares       Fair Value ($)
               
Consumer Discretionary (10.8%)              
Advance Auto Parts, Inc.     16,500       1,363,725
Autoliv, Inc.     20,500       1,417,370
McDonald’s Corp.     21,500       2,143,335
NIKE, Inc., Class B     46,500       2,743,965
Omnicom Group, Inc.     30,500       1,796,450
Ross Stores, Inc.     29,000       1,757,980
The TJX Cos., Inc.     8,000       374,000
Time Warner Cable, Inc.     26,000       2,497,560
               
              14,094,385
               
Consumer Staples (13.2%)              
Colgate-Palmolive Co.     23,000       2,714,690
Costco Wholesale Corp.     21,000       2,228,310
McCormick & Co., Inc.     10,000       735,500
Nestle SA, Sponsored ADR     35,000       2,536,450
PepsiCo, Inc.     35,000       2,768,850
Procter & Gamble Co.     36,000       2,774,160
Reckitt Benckiser Group PLC, Sponsored ADR     115,000       1,659,450
SYSCO Corp.     50,000       1,758,500
               
              17,175,910
               
Energy (10.2%)              
Apache Corp.     26,000       2,006,160
BG Group PLC, Sponsored ADR     95,000       1,629,250
ConocoPhillips     49,000       2,944,900
Core Laboratories NV     15,000       2,068,800
Denbury Resources, Inc.(a)     58,000       1,081,700
Devon Energy Corp.     37,000       2,087,540
Phillips 66     22,000       1,539,340
               
              13,357,690
               
Financials (14.4%)              
American Express Co.     23,000       1,551,580
BB&T Corp.     38,000       1,192,820
Chubb Corp.     28,000       2,450,840
Cincinnati Financial Corp.     60,000       2,831,400
Comerica, Inc.     48,000       1,725,600
Commerce Bancshares, Inc.     23,000       939,090
JPMorgan Chase & Co.     40,000       1,898,400
PNC Financial Services Group, Inc.     25,000       1,662,500
State Street Corp.     26,000       1,536,340
T. Rowe Price Group, Inc.     40,000       2,994,800
               
              18,783,370
               
Health Care (12.7%)              
Becton, Dickinson & Co.     25,000       2,390,250
C.R. Bard, Inc.     20,000       2,015,600
DENTSPLY International, Inc.     46,000       1,951,320
Johnson & Johnson, Inc.     25,000       2,038,250
Medtronic, Inc.     30,000       1,408,800
Mettler-Toledo International, Inc.(a)     8,500       1,812,370
Roche Holding AG, Sponsored ADR     25,000       1,465,000
Saint Jude Medical, Inc.     10,000       404,400
Stryker Corp.     25,000       1,631,000
Waters Corp.(a)     16,000       1,502,560
               
              16,619,550
               
Industrials (15.2%)              
3M Co.     20,000       2,126,200
Deere & Co.     23,000       1,977,540
Donaldson Co., Inc.     63,000       2,279,970
Emerson Electric Co.     49,000       2,737,630
Expeditors International of Washington, Inc.     23,000       821,330
Hubbell, Inc., Class B     10,000       971,100
Illinois Tool Works, Inc.     42,000       2,559,480
Lincoln Electric Holdings, Inc.     28,000       1,517,040
United Parcel Service, Inc., Class B     25,000       2,147,500
W.W. Grainger, Inc.     12,000       2,699,760
               
              19,837,550
               
Information Technology (17.9%)              
Accenture PLC, Class A     30,000       2,279,100
Apple, Inc.     6,400       2,832,832
Automatic Data Processing, Inc.     32,000       2,080,640
Cisco Systems, Inc.     94,500       1,975,995
EMC Corp.(a)     74,000       1,767,860
Google, Inc., Class A(a)     2,600       2,064,478
Intel Corp.     60,000       1,311,000
International Business Machines Corp.     11,000       2,346,300
Microsoft Corp.     78,000       2,231,580
NetApp, Inc.(a)     24,000       819,840
Oracle Corp.     65,000       2,102,100
QUALCOMM, Inc.     23,000       1,539,850
               
              23,351,575
               
Materials (4.3%)              
AptarGroup, Inc.     30,000       1,720,500
Praxair, Inc.     18,000       2,007,720
Sigma-Aldrich Corp.     25,000       1,942,000
               
              5,670,220
               
TOTAL COMMON STOCKS (Cost $91,693,344)             128,890,250
               
 INVESTMENT COMPANIES (1.2%)              
State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(b)     1,624,857       1,624,857
               
TOTAL INVESTMENT COMPANIES (Cost $1,624,857)             1,624,857
               
Total Investments (Cost $93,318,201)(c) — 99.9%             130,515,107
Other assets in excess of liabilities 0.1%             182,559
               
NET ASSETS — 100.0%           $ 130,697,666
               


(a)   Non-income producing security.
(b)   Rate disclosed is the seven day yield as of March 31, 2013.
(c)   See Federal Tax Information listed in the Notes to the Financial Statements.
ADR   American Depositary Receipt
AG   Aktiengesellschaft (German Stock Company)
PLC   Public Limited Company

See Notes to Financial Statements   49




Financial Statements
 

Walden Equity Fund
     

 STATEMENT OF ASSETS AND LIABILITIES          
March 31, 2013          
           
Assets:          
Investments, at fair value (cost $93,318,201)     $ 130,515,107  
Cash       41,578  
Dividends receivable       197,261  
Receivable for capital shares issued       102,774  
Prepaid expenses and other assets       13,486  
         

Total Assets

      130,870,206  
         
Liabilities:          
Payable for investments purchased       36,309  
Accrued expenses and other liabilities:          

Investment adviser

      48,507  

Chief compliance officer

      802  

Administration and accounting

      4,491  

Custodian

      2,781  

Transfer agent

      9,814  

Trustee

      315  

Shareholder servicing

      48,996  

Other

      20,525  
         

Total Liabilities

      172,540  
         
Net Assets     $ 130,697,666  
         
Composition of Net Assets:          
Capital     $ 94,363,469  

Accumulated net investment income

      298,146  

Accumulated net realized losses from investment transactions

      (1,160,855 )

Net unrealized appreciation from investments

      37,196,906  
         

Net Assets

    $ 130,697,666  
         

Shares outstanding (par value $0.01, unlimited number of shares authorized)

      8,482,726  
         

Net Asset Value, Offering Price and Redemption Price per share

    $ 15.41  
         

 STATEMENT OF OPERATIONS          
For the year ended March 31, 2013          
           
Investment Income:          
Dividends     $ 2,415,317  
Less: Foreign tax withholding       (3,000 )
         

Total Investment Income

      2,412,317  
         
Expenses:          

Investment adviser

      812,878  

Administration and accounting

      132,257  

Shareholder servicing

      161,968  

Trustee

      4,681  

Custodian

      18,124  

Transfer agency

      38,897  

Chief compliance officer

      4,251  

Other

      71,037  
         

Total expenses before fee reductions

      1,244,093  

Fees voluntarily reduced by transfer agent

      (5,437 )

Fees contractually reduced by the investment adviser

      (151,960 )
         
Net Expenses       1,086,696  
         
Net Investment Income       1,325,621  
         
Net Realized/Unrealized Gains from Investments:          

Net realized gains from investment transactions

      1,573,805  

Change in unrealized appreciation from investments

      7,120,222  
         
Net realized/unrealized gains from investments       8,694,027  
         
Change in Net Assets Resulting from Operations     $ 10,019,648  
         

50   See Notes to Financial Statements




Financial Statements
 

Walden Equity Fund
     

 STATEMENTS OF CHANGES IN NET ASSETS                    
      For the year ended       For the year ended  
      March 31,       March 31,  
      2013       2012  
                 
                     
Investment Activities:                    
Operations:                    

Net investment income

    $ 1,325,621       $ 906,589  

Net realized gains from investment transactions

      1,573,805         1,575,647  

Change in unrealized appreciation from investments

      7,120,222         6,155,388  
                 
Change in Net Assets Resulting from Operations       10,019,648         8,637,624  
                 
Dividends:                    

Net investment income

      (1,235,398 )       (866,803 )
                 
Change in Net Assets Resulting from Shareholder Dividends       (1,235,398 )       (866,803 )
                 
Capital Share Transactions:                    

Proceeds from shares issued

      26,075,858         13,201,221  

Dividends reinvested

      1,012,431         703,063  

Cost of shares redeemed

      (9,380,879 )       (9,690,517 )
                 
Change in Net Assets Resulting from Capital Share Transactions       17,707,410         4,213,767  
                 
Change in Net Assets       26,491,660         11,984,588  
Net Assets:                    

Beginning of period

      104,206,006         92,221,418  
                 

End of period

    $ 130,697,666       $ 104,206,006  
                 
Share Transactions:                    

Issued

      1,828,723         1,008,761  

Reinvested

      72,127         55,534  

Redeemed

      (661,573 )       (742,325 )
                 
Change in Shares       1,239,277         321,970  
                 
Accumulated net investment income     $ 298,146       $ 207,923  
                 

See Notes to Financial Statements   51




Financial Statements
 

Walden Equity Fund
     

 FINANCIAL HIGHLIGHTS
Selected data for a share outstanding throughout the years indicated.

      For the year       For the year       For the year       For the year       For the year  
      ended       ended       ended       ended       ended  
      March 31,       March 31,       March 31,       March 31,       March 31,  
      2013       2012       2011       2010       2009  
                                         
                                                   
Net Asset Value, Beginning of Period     $ 14.39       $ 13.32       $ 11.61       $ 8.01       $ 12.54  
                                         
Investment Activities:                                                  

Net investment income

      0.16         0.13         0.11         0.11         0.14 (a)

Net realized and unrealized gains (losses) from investment transactions

      1.01         1.06         1.71         3.63         (4.48 )
                                         
Total from investment activities       1.17         1.19         1.82         3.74         (4.34 )
                                         
Dividends:                                                  

Net investment income

      (0.15 )       (0.12 )       (0.11 )       (0.14 )       (0.10 )

Net realized gains from investments

                                      (0.09 )
                                         
Total dividends       (0.15 )       (0.12 )       (0.11 )       (0.14 )       (0.19 )
                                         
Net Asset Value, End of Period     $ 15.41       $ 14.39       $ 13.32       $ 11.61       $ 8.01  
                                         
Total Return       8.27%         9.06%         15.77%         46.79%         (34.74)%  
                                         
Ratios/Supplemental Data:                                                  

Net Assets at end of period (000’s)

    $ 130,698       $ 104,206       $ 92,221       $ 72,087       $ 43,280  

Ratio of net expenses to average net assets

      1.00%         1.00%         1.00%         1.00%         1.00%  

Ratio of net investment income to average net assets

      1.22%         0.97%         0.93%         1.18%         1.36%  

Ratio of expenses (before fee reductions) to average net assets(b)

      1.14%         1.09%         1.13%         1.16%         1.19%  

Portfolio turnover rate

      10.34%         11.06%         13.07%         25.16%         40.07%  


Amounts designated as “—” are $0 or have been rounded to $0.
(a)   Calculated using the average shares method.
(b)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated.

52   See Notes to Financial Statements




Schedule of Portfolio Investments
 

Walden Midcap Fund

March 31, 2013
     

 COMMON STOCKS (97.3%)              
Security Description       Shares       Fair Value ($)  
               
Consumer Discretionary (14.1%)                
Advance Auto Parts, Inc.     4,300       355,395  
Autoliv, Inc.     6,350       439,039  
Family Dollar Stores, Inc.     6,775       400,064  
Hasbro, Inc.     9,500       417,430  
LKQ Corp.(a)     10,075       219,232  
O’Reilly Automotive, Inc.(a)     4,600       471,730  
Omnicom Group, Inc.     8,000       471,200  
Ross Stores, Inc.     7,650       463,743  
Tractor Supply Co.     1,950       203,053  
                 
              3,440,886  
                 
Consumer Staples (7.1%)                
Campbell Soup Co.     8,600       390,096  
Church & Dwight Co., Inc.     8,425       544,508  
McCormick & Co., Inc.     5,575       410,041  
The Clorox Co.     4,425       391,745  
                 
              1,736,390  
                 
Energy (8.3%)                
Cabot Oil & Gas Corp.     3,875       261,989  
Core Laboratories NV     4,100       565,472  
Denbury Resources, Inc.(a)     21,775       406,104  
Energen Corp.     4,750       247,047  
FMC Technologies, Inc.(a)     6,125       333,139  
Oceaneering International, Inc.     3,025       200,890  
                 
              2,014,641  
                 
Financials (17.3%)                
Bank of Hawaii Corp.     5,925       301,049  
BioMed Realty Trust, Inc.     7,800       168,480  
BOK Financial Corp.     2,750       171,325  
Cincinnati Financial Corp.     9,800       462,462  
Comerica, Inc.     7,250       260,637  
Commerce Bancshares, Inc.     5,879       240,040  
Cullen/Frost Bankers, Inc.     4,350       272,005  
Digital Realty Trust, Inc.     3,325       222,476  
East West Bancorp, Inc.     7,500       192,525  
Eaton Vance Corp.     6,525       272,941  
IntercontinentalExchange, Inc.(a)     1,425       232,375  
Jones Lang LaSalle, Inc.     2,475       246,040  
Northern Trust Corp.     8,475       462,396  
SEI Investments Co.     10,675       307,974  
T. Rowe Price Group, Inc.     5,450       408,041  
                 
              4,220,766  
                 
Health Care (11.2%)                
C.R. Bard, Inc.     4,500       453,510  
DENTSPLY International, Inc.     7,975       338,299  
Laboratory Corp. of America Holdings(a)     2,600       234,520  
MEDNAX, Inc.(a)     1,925       172,538  
Mettler-Toledo International, Inc.(a)     2,200       469,084  
ResMed, Inc.     3,700       171,532  
Techne Corp.     2,525       171,321  
Varian Medical Systems, Inc.(a)     4,800       345,600  
Waters Corp.(a)     3,925       368,597  
                 
              2,725,001  
                 
Industrials (15.8%)                
AMETEK, Inc.     8,025       347,964  
CLARCOR, Inc.     5,100       267,138  
Donaldson Co., Inc.     14,175       512,993  
Dover Corp.     3,000       218,640  
Expeditors International of Washington, Inc.     6,250       223,188  
Graco, Inc.     3,175       184,245  
Hubbell, Inc., Class B     3,700       359,307  
IDEX Corp.     3,975       212,345  
Lincoln Electric Holdings, Inc.     7,200       390,096  
Nordson Corp.     3,400       224,230  
W.W. Grainger, Inc.     2,250       506,205  
Wabtec Corp.     4,075       416,098  
                 
              3,862,449  
                 
Information Technology (14.9%)                
BMC Software, Inc.(a)     10,625       492,256  
Check Point Software Technologies Ltd.(a)     7,875       370,046  
Citrix Systems, Inc.(a)     5,725       413,116  
F5 Networks, Inc.(a)     2,050       182,614  
Factset Research Systems, Inc.     2,400       222,240  
Fiserv, Inc.(a)     2,650       232,749  
NetApp, Inc.(a)     11,600       396,256  
Paychex, Inc.     6,950       243,736  
Riverbed Technology, Inc.(a)     9,450       140,900  
Syntel, Inc.     3,675       248,136  
Teradata Corp.(a)     7,825       457,841  
TIBCO Software, Inc.(a)     11,375       230,003  
                 
              3,629,893  
                 
Materials (4.7%)                
AptarGroup, Inc.     8,350       478,873  
International Flavors & Fragrances, Inc.     2,475       189,758  
Sigma-Aldrich Corp.     6,125       475,790  
                 
              1,144,421  
                 
Utilities (3.9%)                
AGL Resources, Inc.     5,050       211,848  
Northeast Utilities     6,233       270,886  
Questar Corp.     19,225       467,744  
                 
              950,478  
                 
TOTAL COMMON STOCKS (Cost $19,750,475)             23,724,925  
                 
 INVESTMENT COMPANIES (3.2%)              
State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(b)     784,720       784,720  
                 
TOTAL INVESTMENT COMPANIES (Cost $784,720)             784,720  
                 
Total Investments (Cost $20,535,195)(c) — 100.5%             24,509,645  
Liabilities in excess of other assets (0.5)%             (119,491 )
                 
NET ASSETS — 100.0%           $ 24,390,154  
                 


(a)   Non-income producing security.
(b)   Rate disclosed is the seven day yield as of March 31, 2013.
(c)   See Federal Tax Information listed in the Notes to the Financial Statements.

See Notes to Financial Statements   53




Financial Statements
 

Walden Midcap Fund
     

 STATEMENT OF ASSETS AND LIABILITIES          
March 31, 2013          
           
Assets:          
Investments, at fair value (cost $20,535,195)     $ 24,509,645  
Cash       3,699  
Dividends receivable       17,372  
Receivable for capital shares issued       84,420  
Prepaid expenses and other assets       1,560  
         

Total Assets

      24,616,696  
         
Liabilities:          
Payable for investments purchased       203,603  
Accrued expenses and other liabilities:          

Investment adviser

      7,921  

Chief compliance officer

      154  

Administration and accounting

      1,026  

Custodian

      644  

Transfer agent

      8,976  

Trustee

      61  

Other

      4,157  
         

Total Liabilities

      226,542  
         
Net Assets     $ 24,390,154  
         
Composition of Net Assets:          
Capital     $ 20,575,435  
Accumulated net investment income/(loss)       2,898  
Accumulated net realized losses from investment transactions       (162,629 )
Net unrealized appreciation from investments       3,974,450  
         
Net Assets     $ 24,390,154  
         
Shares outstanding (par value $0.01, unlimited number of shares authorized)       2,023,122  
         
Net Asset Value, Offering Price and Redemption Price per share     $ 12.06  
         

 STATEMENT OF OPERATIONS          
For the year ended March 31, 2013          
           
Investment Income:          
Dividends     $ 277,064  
Less: Foreign tax withholding       (522 )
         

Total Investment Income

      276,542  
         
Expenses:          

Investment adviser

      130,323  

Administration and accounting

      23,926  

Shareholder servicing

      220  

Trustee

      734  

Custodian

      3,811  

Transfer agency

      33,354  

Chief compliance officer

      692  

Other

      20,917  
         

Total expenses before fee reductions

      213,977  

Fees voluntarily reduced by Transfer agent

      (5,437 )

Fees contractually reduced by the investment adviser

      (34,176 )
         
Net Expenses       174,364  
         
Net Investment Income       102,178  
         
Net Realized/Unrealized Gains (Losses) from Investments:          

Net realized losses from investment transactions

      (107,396 )

Change in unrealized appreciation from investments

      2,223,917  
         
Net realized/unrealized gains from investments       2,116,521  
         
Change in Net Assets Resulting from Operations     $ 2,218,699  
         

54   See Notes to Financial Statements




Financial Statements
 

Walden Midcap Fund
     

 STATEMENTS OF CHANGES IN NET ASSETS                    
      For the year ended       For the period ended  
      March 31,       March 31,  
      2013       2012(a)  
                 
                     
Investment Activities:                    
Operations:                    

Net investment income

    $ 102,178       $ 22,004  

Net realized losses from investment transactions

      (107,396 )       (55,233 )

Change in unrealized appreciation from investments

      2,223,917         1,750,533  
                 
Change in Net Assets Resulting from Operations       2,218,699         1,717,304  
                 
Dividends:                    

Net investment income

      (105,039 )       (19,338 )
                 
Change in Net Assets Resulting from Shareholder Dividends       (105,039 )       (19,338 )
                 
Capital Share Transactions:                    

Proceeds from shares issued

      8,036,654         12,510,643  

Dividends reinvested

      64,219         9,369  

Cost of shares redeemed

      (37,847 )       (4,510 )
                 
Change in Net Assets Resulting from Capital Share Transactions       8,063,026         12,515,502  
                 
Change in Net Assets       10,176,686         14,213,468  
Net Assets:                    

Beginning of period

      14,213,468          
                 

End of period

    $ 24,390,154       $ 14,213,468  
                 
Share Transactions:                    

Issued

      741,285         1,278,825  

Reinvested

      5,954         963  

Redeemed

      (3,405 )       (500 )
                 
Change in Shares       743,834         1,279,288  
                 
Accumulated net investment income     $ 2,898       $ 5,759  
                 


Amounts designated as “—” are $0 or have been rounded to $0.
(a) Commenced operations on August 1, 2011


See Notes to Financial Statements   55




Financial Statements
 

Walden Midcap Fund
     

 FINANCIAL HIGHLIGHTS
Selected data for a share outstanding throughout the period indicated.

      For the year       For the period  
      ended       ended  
      March 31,       March 31,  
      2013       2012(a)  
                 
                     
Net Asset Value, Beginning of Period     $ 11.11       $ 10.00  
                 
Investment Activities:                    

Net investment income

      0.06         0.02  

Net realized and unrealized gains from investment transactions

      0.95         1.11  
                 
Total from investment activities       1.01         1.13  
                 
Dividends:                    

Net investment income

      (0.06 )       (0.02 )
                 
Total dividends       (0.06 )       (0.02 )
                 
Net Asset Value, End of Period     $ 12.06       $ 11.11  
                 
Total Return       9.12%         11.33% (b)
                 
Ratios/Supplemental Data:                    
Net Assets at end of period (000’s)     $ 24,390       $ 14,213  
Ratio of net expenses to average net assets       1.00%         1.00% (c)
Ratio of net investment income to average net assets       0.58%         0.34% (c)
Ratio of expenses (before fee reductions) to average net assets(d)       1.23%         1.34% (c)
Portfolio turnover rate       12.32%         8.43% (b)


(a)   Commenced operations on August 1, 2011.
(b)   Not annualized for periods less than one year.
(c)   Annualized for periods less than one year.
(d)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated.

56   See Notes to Financial Statements




Schedule of Portfolio Investments
 

Walden SMID Cap Innovations Fund

March 31, 2013
     

 COMMON STOCKS (95.7%)              
Security Description       Shares     Fair Value ($)
               
Consumer Discretionary (13.1%)              
Autoliv, Inc.     3,700       255,818
Columbia Sportswear Co.     2,600       150,488
Dorman Products, Inc.     3,900       145,119
DSW, Inc., Class A     2,300       146,740
Hibbett Sports, Inc.(a)     3,100       174,437
Life Time Fitness, Inc.(a)     3,850       164,703
LKQ Corp.(a)     13,200       287,232
Select Comfort Corp.(a)     10,800       213,516
SodaStream International Ltd.(a)     4,900       243,236
The Men’s Wearhouse, Inc.     4,800       160,416
Tractor Supply Co.     1,900       197,847
Vitamin Shoppe, Inc.(a)     3,500       170,975
Weight Watchers International, Inc.     4,100       172,651
Wolverine World Wide, Inc.     4,500       199,665
               
              2,682,843
               
Consumer Staples (2.7%)              
Darling International, Inc.(a)     7,000       125,720
Hain Celestial Group, Inc.(a)     1,200       73,296
The Fresh Market, Inc.(a)     2,850       121,895
United Natural Foods, Inc.(a)     4,450       218,940
               
              539,851
               
Energy (6.0%)              
CARBO Ceramics, Inc.     2,500       227,675
Core Laboratories NV     725       99,992
Denbury Resources, Inc.(a)     12,400       231,260
Geospace Technologies Corp.(a)     1,400       151,088
Lufkin Industries, Inc.     3,150       209,128
Oceaneering International, Inc.     3,100       205,871
RPC, Inc.     6,550       99,364
               
              1,224,378
               
Financials (22.5%)              
Bank of Hawaii Corp.     6,550       332,805
BioMed Realty Trust, Inc.     5,000       108,000
BOK Financial Corp.     2,200       137,060
Cohen & Steers, Inc.     6,050       218,224
Commerce Bancshares, Inc.     5,400       220,482
Coresite Realty Corp.     3,800       132,924
Cullen/Frost Bankers, Inc.     2,500       156,325
DuPont Fabros Technology, Inc.     9,600       232,992
East West Bancorp, Inc.     13,500       346,545
Eaton Vance Corp.     6,300       263,529
Financial Engines, Inc.     5,500       199,210
Jones Lang LaSalle, Inc.     3,900       387,699
MarketAxess Holdings, Inc.     5,300       197,690
Ocwen Financial Corp.(a)     9,300       352,656
SEI Investments Co.     8,150       235,127
Signature Bank(a)     4,000       315,040
SVB Financial Group(a)     5,300       375,982
Texas Capital Bancshares, Inc.(a)     3,300       133,485
UMB Financial Corp.     2,900       142,303
Umpqua Holdings Corp.     9,000       119,340
               
              4,607,418
               
Health Care (10.6%)              
Bruker Corp.(a)     12,050       230,155
DENTSPLY International, Inc.     2,600       110,292
Haemonetics Corp.(a)     2,450       102,067
ICU Medical, Inc.(a)     3,000       176,850
MEDNAX, Inc.(a)     1,550       138,927
Meridian Bioscience, Inc.     8,000       182,560
Mettler-Toledo International, Inc.(a)     600       127,932
Myriad Genetics, Inc.(a)     6,900       175,260
Neogen Corp.(a)     2,000       99,140
Quality Systems, Inc.     10,150       185,542
ResMed, Inc.     4,000       185,440
Techne Corp.     1,400       94,990
Thoratec Corp.(a)     5,150       193,125
West Pharmaceutical Services, Inc.     2,600       168,844
               
              2,171,124
               
Industrials (15.9%)              
Chart Industries, Inc.(a)     2,200       176,022
CLARCOR, Inc.     4,600       240,948
Donaldson Co., Inc.     9,900       358,281
ESCO Technologies, Inc.     2,250       91,935
Franklin Electric Co., Inc.     4,800       161,136
Genesee & Wyoming, Inc., Class A(a)     2,800       260,708
Hub Group, Inc., Class A(a)     4,400       169,224
Hubbell, Inc., Class B     2,200       213,642
IDEX Corp.     2,400       128,208
Lincoln Electric Holdings, Inc.     3,700       200,466
Lindsay Manufacturing Co.     2,400       211,632
Middleby Corp.(a)     1,700       258,655
Nordson Corp.     3,200       211,040
Wabtec Corp.     3,600       367,596
Watts Water Technologies, Inc., Class A     4,300       206,357
               
              3,255,850
               
Information Technology (13.8%)              
Blackbaud, Inc.     3,500       103,705
Bottomline Technologies, Inc.(a)     3,200       91,232
Coherent, Inc.     2,000       113,480
CommVault Systems, Inc.(a)     1,900       155,762
Factset Research Systems, Inc.     2,000       185,200
InterDigital, Inc.     3,700       176,971
IPG Photonics Corp.     3,650       242,396
Liquidity Services, Inc.(a)     4,300       128,183
Mellanox Technologies Ltd.(a)     2,100       116,571
MicroStrategy, Inc., Class A(a)     1,000       101,080
NIC, Inc.     5,350       102,506
Plantronics, Inc.     4,900       216,531
Polycom, Inc.(a)     14,000       155,120
Power Integrations, Inc.     4,100       177,981
Riverbed Technology, Inc.(a)     7,500       111,825
Sapient Corp.(a)     15,400       187,726
Syntel, Inc.     1,450       97,904
TIBCO Software, Inc.(a)     6,500       131,430
WEX, Inc.(a)     2,950       231,575
               
              2,827,178
               
Materials (6.4%)              
AptarGroup, Inc.     5,400       309,690
Calgon Carbon Corp.(a)     13,300       240,730
Commercial Metals Co.     13,500       213,975
International Flavors & Fragrances, Inc.     1,900       145,673
Kraton Performance Polymers, Inc.(a)     7,050       164,970
Minerals Technologies, Inc.     5,700       236,607
               
              1,311,645
               
Utilities (4.7%)              
AGL Resources, Inc.     4,150       174,093
American States Water Co.     4,350       250,429
New Jersey Resources Corp.     3,700       165,945
Questar Corp.     15,500       377,115
               
              967,582
               
TOTAL COMMON STOCKS (Cost $17,981,879)             19,587,869
               
 INVESTMENT COMPANIES (2.6%)              

State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(b)

    525,308       525,308
               

TOTAL INVESTMENT COMPANIES (Cost $525,308)

            525,308
               

Total Investments (Cost $18,507,187)(c) — 98.3%

            20,113,177

Other assets in excess of liabilities 1.7%

            344,673
               

NET ASSETS — 100.0%

          $ 20,457,850
               


(a)   Non-income producing security.
(b)   Rate disclosed is the seven day yield as of March 31, 2013.
(c)   See Federal Tax Information listed in the Notes to the Financial Statements.

See Notes to Financial Statements   57




Financial Statements
 

Walden SMID Cap Innovations Fund
     

 STATEMENT OF ASSETS AND LIABILITIES          
March 31, 2013          
           
Assets:          
Investments, at fair value (cost $18,507,187)     $ 20,113,177  
Cash       927  
Dividends receivable       10,351  
Receivable for capital shares issued       500,000  
Prepaid expenses and other assets       3,008  
         

Total Assets

      20,627,463  
         
Liabilities:          
Payable for investments purchased       151,308  
Accrued expenses and other liabilities:          

Investment adviser

      3,987  

Chief compliance officer

      95  

Administration and accounting

      885  

Custodian

      390  

Transfer agent

      9,152  

Trustee

      37  

Distribution and service fees

      81  

Other

      3,678  
         

Total Liabilities

      169,613  
         
Net Assets     $ 20,457,850  
         
Composition of Net Assets:          

Capital

    $ 18,858,731  

Accumulated net investment income/(loss)

      1,993  

Accumulated net realized losses from investment transactions

      (8,864 )

Net unrealized appreciation from investments

      1,605,990  
         

Net Assets

    $ 20,457,850  
         

Shares outstanding (par value $0.01, unlimited number of shares authorized)

      1,691,920  
         

Net Asset Value, Offering Price and Redemption Price per share

    $ 12.09  
         

 STATEMENT OF OPERATIONS          
For the period ended March 31, 2013(a)          
           
Investment Income:          
Dividends     $ 85,796  
Less: Foreign tax withholding       (83 )
         

Total Investment Income

      85,713  
         
Expenses:          

Investment adviser

      44,648  

Administration and accounting

      9,410  

Shareholder servicing

      133  

Trustee

      191  

Custodian

      1,633  

Transfer agency

      25,242  

Chief compliance officer

      233  

Other

      14,214  
         

Total expenses before fee reductions

      95,704  

Fees voluntarily reduced by Transfer agent

      (5,437 )

Fees contractually reduced by the investment adviser

      (30,124 )
         
Net Expenses       60,143  
         
Net Investment Income       25,570  
         
Net Realized/Unrealized Gains (Losses) from Investments:          

Net realized losses from investment transactions

      (8,864 )

Change in unrealized appreciation from investments

      1,605,990  
         
Net realized/unrealized gains from investments       1,597,126  
         
Change in Net Assets Resulting from Operations     $ 1,622,696  
         


(a) Commenced operations on June 29, 2012.

58   See Notes to Financial Statements




Financial Statements
 

Walden SMID Cap Innovations Fund
     

 STATEMENTS OF CHANGES IN NET ASSETS          
      For the period ended  
      March 31,  
      2013(a)  
         
           
Investment Activities:          
Operations:          

Net investment income

    $ 25,570  

Net realized losses from investment transactions

      (8,864 )

Change in unrealized appreciation/depreciation from investments

      1,605,990  
         
Change in Net Assets Resulting from Operations       1,622,696  
         
Dividends:          

Net investment income

      (28,882 )
         
Change in Net Assets Resulting from Shareholder Dividends       (28,882 )
         
Capital Share Transactions:          

Proceeds from shares issued

      18,517,915  

Proceeds from shares issued in subscription in-kind(b)

      324,838  

Dividends reinvested

      22,377  

Cost of shares redeemed

      (1,094 )
         
Change in Net Assets Resulting from Capital Share Transactions       18,864,036  
         
Change in Net Assets       20,457,850  
Net Assets:          

Beginning of period

       
         

End of period

    $ 20,457,850  
         
Share Transactions:          

Issued

      1,657,497  

Issued in subscriptions in-kind(b)

      32,484  

Reinvested

      2,039  

Redeemed

      (100 )
         
Change in Shares       1,691,920  
         
Accumulated net investment income (loss)     $ 1,993  
         


Amounts designated as “—” are $0 or have been rounded to $0.
(a) Commenced operations on June 29, 2012.
(b) See Note 3 in Notes to Financial Statements.

See Notes to Financial Statements   59




Financial Statements
 

Walden SMID Cap Innovations Fund
     

 FINANCIAL HIGHLIGHTS
Selected data for a share outstanding throughout the period indicated.

           
      For the period  
      ended  
      March 31,  
      2013(a)  
         
           
Net Asset Value, Beginning of Period     $ 10.00  
         
Investment Activities:          

Net investment income

      0.03  

Net realized and unrealized gains from investment transactions

      2.09  
         
Total from investment activities       2.12  
         
Dividends:          

Net investment income

      (0.03 )
         
Total dividends       (0.03 )
         
Net Asset Value, End of Period     $ 12.09  
         
Total Return       21.28% (b)
         
Ratios/Supplemental Data:          
Net Assets at end of period (000’s)     $ 20,458  
Ratio of net expenses to average net assets       1.00% (c)
Ratio of net investment income to average net assets       0.43% (c)
Ratio of expenses (before fee reductions) to average net assets(d)       1.60% (c)
Portfolio turnover rate       13.31% (b)


(a)   Commenced operations on June 29, 2012.
(b)   Not annualized for periods less than one year.
(c)   Annualized for periods less than one year.
(d)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated.

60   See Notes to Financial Statements




Schedule of Portfolio Investments
 

Walden Small Cap Innovations Fund

March 31, 2013
     

 COMMON STOCKS (98.1%)              
Security Description       Shares     Fair Value ($)  
               
Consumer Discretionary (12.3%)                
Columbia Sportswear Co.     21,050       1,218,374  
Dorman Products, Inc.     24,700       919,087  
DSW, Inc., Class A     14,300       912,340  
Gentex Corp.     300       6,003  
Hibbett Sports, Inc.(a)     18,700       1,052,249  
Life Time Fitness, Inc.(a)     17,200       735,816  
Select Comfort Corp.(a)     50,000       988,500  
SodaStream International Ltd.(a)     27,400       1,360,136  
The Men’s Wearhouse, Inc.     32,000       1,069,440  
Vitamin Shoppe, Inc.(a)     26,500       1,294,525  
Weight Watchers International, Inc.     16,000       673,760  
Wolverine World Wide, Inc.     32,500       1,442,025  
                 
              11,672,255  
                 
Consumer Staples (2.9%)                
Darling International, Inc.(a)     37,775       678,439  
Hain Celestial Group, Inc.(a)     6,600       403,128  
The Fresh Market, Inc.(a)     14,600       624,442  
United Natural Foods, Inc.(a)     22,000       1,082,400  
                 
              2,788,409  
                 
Energy (6.8%)                
CARBO Ceramics, Inc.     18,800       1,712,116  
Geospace Technologies Corp.(a)     13,200       1,424,544  
Lufkin Industries, Inc.     31,200       2,071,368  
Natural Gas Services Group, Inc.(a)     21,900       421,794  
RPC, Inc.     54,475       826,386  
                 
              6,456,208  
                 
Financials (21.0%)                
Bank of Hawaii Corp.     37,900       1,925,699  
BioMed Realty Trust, Inc.     22,400       483,840  
City National Corp.     12,800       754,048  
Cohen & Steers, Inc.     34,050       1,228,183  
Coresite Realty Corp.     33,000       1,154,340  
Corporate Office Properties Trust     17,300       461,564  
Dime Community Bancshares, Inc.     33,050       474,598  
DuPont Fabros Technology, Inc.     57,800       1,402,806  
East West Bancorp, Inc.     37,000       949,790  
Financial Engines, Inc.     36,400       1,318,408  
First Financial Bankshares, Inc.     16,100       782,460  
Independent Bank Corp.     21,800       710,462  
MarketAxess Holdings, Inc.     40,500       1,510,650  
Signature Bank(a)     12,300       968,748  
SVB Financial Group(a)     28,900       2,050,166  
Texas Capital Bancshares, Inc.(a)     25,700       1,039,565  
UMB Financial Corp.     28,400       1,393,588  
Umpqua Holdings Corp.     105,800       1,402,908  
                 
              20,011,823  
                 
Health Care (13.4%)                
Bruker Corp.(a)     80,900       1,545,190  
Cantel Medical Corp.     29,200       877,752  
Computer Programs & Systems, Inc.     15,500       838,705  
Haemonetics Corp.(a)     11,600       483,256  
ICU Medical, Inc.(a)     20,000       1,179,000  
Landauer, Inc.     9,200       518,696  
Meridian Bioscience, Inc.     40,625       927,063  
Myriad Genetics, Inc.(a)     38,000       965,200  
Neogen Corp.(a)     9,500       470,915  
Quality Systems, Inc.     47,200       862,816  
Techne Corp.     13,100       888,835  
Thoratec Corp.(a)     32,900       1,233,750  
West Pharmaceutical Services, Inc.     30,500       1,980,670  
                 
              12,771,848  
                 
Industrials (15.7%)                
American Science & Engineering, Inc.     14,000       853,860  
Apogee Enterprises, Inc.     38,600       1,117,470  
Chart Industries, Inc.(a)     10,500       840,105  
CLARCOR, Inc.     34,000       1,780,920  
ESCO Technologies, Inc.     22,700       927,522  
Franklin Electric Co., Inc.     34,600       1,161,522  
Gentherm, Inc.(a)     40,400       661,752  
Herman Miller, Inc.     15,900       439,953  
Hub Group, Inc., Class A(a)     30,800       1,184,568  
Lindsay Manufacturing Co.     16,700       1,472,606  
Middleby Corp.(a)     10,150       1,544,322  
Simpson Manufacturing Co., Inc.     21,400       655,054  
Team, Inc.(a)     26,350       1,082,195  
Watts Water Technologies, Inc., Class A     25,800       1,238,142  
                 
              14,959,991  
                 
Information Technology (17.8%)                
Blackbaud, Inc.     28,200       835,566  
Bottomline Technologies, Inc.(a)     31,200       889,512  
Coherent, Inc.     16,100       913,514  
InterDigital, Inc.     19,300       923,119  
IPG Photonics Corp.     14,250       946,343  
Liquidity Services, Inc.(a)     22,800       679,668  
Mellanox Technologies Ltd.(a)     17,650       979,751  
MicroStrategy, Inc., Class A(a)     6,600       667,128  
NIC, Inc.     44,400       850,704  
Plantronics, Inc.     45,900       2,028,321  
Polycom, Inc.(a)     105,000       1,163,400  
Power Integrations, Inc.     36,800       1,597,488  
Riverbed Technology, Inc.(a)     43,825       653,431  
Sapient Corp.(a)     109,400       1,333,586  
Syntel, Inc.     10,500       708,960  
WEX, Inc.(a)     23,000       1,805,500  
                 
              16,975,991  
                 
Materials (4.9%)                
Calgon Carbon Corp.(a)     51,200       926,720  
Commercial Metals Co.     63,400       1,004,890  
Kraton Performance Polymers, Inc.(a)     15,600       365,040  
Minerals Technologies, Inc.     25,800       1,070,958  
Quaker Chemical Corp.     22,300       1,316,146  
                 
              4,683,754  
                 
Utilities (3.3%)                
American States Water Co.     13,800       794,466  
New Jersey Resources Corp.     31,600       1,417,260  
South Jersey Industries, Inc.     15,900       883,881  
                 
              3,095,607  
                 
TOTAL COMMON STOCKS (Cost $76,443,182)             93,415,886  
                 
 INVESTMENT COMPANIES (1.9%)              

State Street Institutional U.S. Government Money Market Fund, Investor Shares, 0.01%(b)

    1,829,464       1,829,464  
                 

TOTAL INVESTMENT COMPANIES (Cost $1,829,464)

            1,829,464  
                 

Total Investments (Cost $78,272,646)(c) — 100.0%

            95,245,350  

Liabilities in excess of other assets 0.0%

            (12,610 )
                 
NET ASSETS — 100.0%           $ 95,232,740  
                 


(a)   Non-income producing security.
(b)   Rate disclosed is the seven day yield as of March 31, 2013.
(c)   See Federal Tax Information listed in the Notes to the Financial Statements.

See Notes to Financial Statements   61




Financial Statements
 

Walden Small Cap Innovations Fund
     

 STATEMENT OF ASSETS AND LIABILITIES        
March 31, 2013        
         
Assets:        
Investments, at fair value (cost $78,272,646)     $ 95,245,350
Cash       8,704
Dividends receivable       94,752
Receivable for capital shares issued       32,272
Prepaid expenses and other assets       10,544
       

Total Assets

      95,391,622
       
Liabilities:        
Payable for investments purchased       72,630
Accrued expenses and other liabilities:        

Investment adviser

      38,814

Chief compliance officer

      615

Administration and accounting

      3,377

Custodian

      2,210

Transfer agent

      9,689

Trustee

      242

Distribution and service fees

      16,199

Other

      15,106
       

Total Liabilities

      158,882
       
Net Assets     $ 95,232,740
       
Composition of Net Assets:        
Capital     $ 77,006,370

Accumulated net investment income (loss)

      42,856

Accumulated net realized gains from investment transactions

      1,210,810

Net unrealized appreciation from investments

      16,972,704
       

Net Assets

    $ 95,232,740
       

Shares outstanding (par value $0.01, unlimited number of shares authorized)

      5,154,888
       

Net Asset Value, Offering Price and Redemption Price Per Share*

    $ 18.48
       

 STATEMENT OF OPERATIONS          
For the year ended March 31, 2013          
           
Investment Income:          
Dividends     $ 1,139,362  
         

Total Investment Income

      1,139,362  
         
Expenses:          

Investment adviser

      611,300  

Administration and accounting

      100,434  

Shareholder servicing

      63,690  

Trustee

      3,425  

Custodian

      13,854  

Transfer agency

      37,272  

Chief compliance officer

      3,141  

Other

      54,588  
         

Total expenses before fee reductions

      887,704  

Fees voluntarily reduced by Transfer agent

      (5,437 )

Fees contractually reduced by the investment adviser

      (64,888 )
         
Net Expenses       817,379  
         
Net Investment Income       321,983  
         
Net Realized/Unrealized Gains from Investments:          

Net realized gains from investment transactions

      3,321,577  

Change in unrealized appreciation from investments

      7,311,466  
         
Net realized/unrealized gains from investments       10,633,043  
         
Change in Net Assets Resulting from Operations     $ 10,955,026  
         


*   The Net Asset Value (NAV) per share represents the final traded NAV per share calculated during the reporting period (determined as of March 28, 2013) and does not reflect the rounding effect of certain adjustments recorded for financial reporting purposes. The rounded NAV per share as of March 31, 2013, considering the effect of these financial reporting adjustments, is $18.47.

62   See Notes to Financial Statements




Financial Statements
 

Walden Small Cap Innovations Fund
     

 STATEMENTS OF CHANGES IN NET ASSETS                    
      For the year ended       For the year ended  
      March 31,       March 31,  
      2013       2012  
                 
                     
Investment Activities:                    
Operations:                    

Net investment income

    $ 321,983       $ 31,553  

Net realized gains from investment transactions

      3,321,577         261,025  

Change in unrealized appreciation from investments

      7,311,466         1,299,094  
                 
Change in Net Assets Resulting from Operations       10,955,026         1,591,672  
                 
Dividends:                    

Net investment income

      (331,453 )       (59,243 )

Net realized gains from investment transactions

      (1,863,888 )       (3,327,935 )
                 
Change in Net Assets Resulting from Shareholder Dividends       (2,195,341 )       (3,387,178 )
                 
Capital Share Transactions:                    

Proceeds from shares issued

      20,056,167         25,475,054  

Proceeds from shares issued in subscription in-kind(a)

      503,078         1,691,789  

Dividends reinvested

      1,709,944         2,157,735  

Cost of shares redeemed

      (5,340,602 )       (4,472,977 )
                 
Change in Net Assets Resulting from Capital Share Transactions       16,928,587         24,851,601  
                 
Change in Net Assets       25,688,272         23,056,095  
Net Assets:                    

Beginning of period

      69,544,468         46,488,373  
                 

End of period

    $ 95,232,740       $ 69,544,468  
                 
Share Transactions:                    

Issued

      1,225,851         1,513,736  

Issued in subscriptions in-kind(a)

      31,680         100,047  

Reinvested

      102,176         143,466  

Redeemed

      (315,804 )       (281,200 )
                 
Change in Shares       1,043,903         1,476,049  
                 
Accumulated net investment income/(loss)     $ 42,856       $ (27,691 )
                 


Amounts designated as “—” are $0 or have been rounded to $0.
(a) See Note 3 in the Notes to Financial Statements.

See Notes to Financial Statements   63




Financial Statements
 

Walden Small Cap Innovations Fund
     

 FINANCIAL HIGHLIGHTS
Selected data for a share outstanding throughout the periods indicated.

                                                   
      For the year       For the year       For the year       For the year       For the period  
      ended       ended       ended       ended       ended  
      March 31,       March 31,       March 31,       March 31,       March 31,  
      2013       2012       2011       2010       2009(a)  
                                         
                                                   
Net Asset Value, Beginning of Period     $ 16.92       $ 17.64       $ 14.57       $ 9.19       $ 10.00  
                                         
Investment Activities:                                                  

Net investment income

      0.07         0.01         0.02         0.02         0.03 (b)

Net realized and unrealized gains (losses) from investment transactions

      1.93         0.27         3.59         5.60         (0.83 )
                                         
Total from investment activities       2.00         0.28         3.61         5.62         (0.80 )
                                         
Dividends:                                                  

Net investment income

      (0.07 )       (0.02 )       (0.03 )       (0.02 )       (0.01 )

Net realized gains from investments

      (0.37 )       (0.98 )       (0.51 )       (0.22 )        
                                         
Total dividends       (0.44 )       (1.00 )       (0.54 )       (0.24 )       (0.01 )
                                         
Net Asset Value, End of Period     $ 18.48       $ 16.92       $ 17.64       $ 14.57       $ 9.19  
                                         
Total Return       12.05%         2.28%         25.13%         61.45%         (7.98)% (c)
                                         
Ratios/Supplemental Data:                                                  

Net Assets at end of period (000’s)

    $ 95,233       $ 69,544       $ 46,488       $ 22,057       $ 2,340  

Ratio of net expenses to average net assets

      1.00%         1.00%         1.00%         1.00%         1.16% (d)

Ratio of net investment income to average net assets

      0.40%         0.06%         0.14%         0.26%         0.63% (d)

Ratio of expenses (before fee reductions) to average net assets(e)

      1.09 %       1.15%         1.27%         1.68%         9.61% (d)

Portfolio turnover rate

      31.98 %       24.62%         36.01%         23.07%         4.37% (c)


Amounts designated as “—” are $0 or have been rounded $0.
(a)   Commenced operations on October 24, 2008.
(b)   Calculated using the average shares method.
(c)   Not annualized for periods less than one year.
(d)   Annualized for periods less than one year.
(e)   During the period, certain fees were reduced. If such fee reductions had not occurred, the ratio would have been as indicated.

64   See Notes to Financial Statements




Notes to Financial Statements  
March 31, 2013
     

1.
Organization:
 
The Boston Trust & Walden Funds (the “Trust”) was organized on January 8, 1992 as a Massachusetts business trust and is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust contains the following ten operational funds (individually a “Fund”, collectively the “Funds”):

 
Fund
   
Short Name
   
 
Boston Trust Asset Management Fund (formerly known as Boston Trust Balanced Fund)
   
Asset Management Fund
 
Boston Trust Equity Fund
   
Equity Fund
 
Boston Trust Midcap Fund
   
Midcap Fund
 
Boston Trust SMID Cap Fund
   
SMID Cap Fund
 
Boston Trust Small Cap Fund
   
Small Cap Fund
         
 
Walden Asset Management Fund (formerly known as Walden Balanced Fund)
   
Walden Asset Management Fund
 
Walden Equity Fund
   
Walden Equity Fund
 
Walden Midcap Fund
   
Walden Midcap Fund
 
Walden SMID Cap Innovations Fund
   
Walden SMID Cap Fund
 
Walden Small Cap Innovations Fund
   
Walden Small Cap Fund
   

 
The investment objective of the Asset Management Fund and Walden Asset Management Fund is to seek long-term capital growth and income through an actively managed portfolio of stocks, bonds and money market instruments. The investment objective of the Equity Fund and Walden Equity Fund is to seek long-term capital growth through an actively managed portfolio of stocks. The investment objective of the Midcap Fund and Walden Midcap Fund is to seek long-term capital growth through an actively managed portfolio of stocks of middle capitalization companies. The investment objective of the Small Cap Fund and Walden Small Cap Fund is to seek long-term capital growth through an actively managed portfolio of stocks of small capitalization companies. The investment objective of the SMID Cap Fund and Walden SMID Cap Fund is to seek long-term capital growth through an actively managed portfolio of stocks of small to middle capitalization companies.
   
 
Under the Trust’s organizational documents, its officers and trustees are indemnified against certain liabilities arising out of the performance of their duties to the Trust. In addition, in the normal course of business, the Trust may enter into contracts with its vendors and others that provide for general indemnifications. Each Fund’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Funds. However, based on experience, the Funds expect that risk of loss to be remote.
   
2.
Significant Accounting Policies:
 
The following is a summary of significant accounting policies followed by the Funds in the preparation of their financial statements. The policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”).
   
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results may differ from those estimates.
   
 
Security Valuation:
 
The Funds record their investments at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The valuation techniques used to determine fair value are further described below.
   
 
The value of each equity security, including common stocks, is based either on the last sale price on a national securities exchange, or in the absence of recorded sales, at the closing bid prices on such exchanges, or at the quoted bid price in the over-the-counter market. Equity securities traded on the NASDAQ stock market are valued at the NASDAQ official closing price.
   
 
Bonds and other fixed income securities (other than short-term obligations but including listed issues) are provided by an independent pricing service, the use of which has been approved by the Trust’s Board of Trustees (the “Board”). In making such valuations, the pricing service utilizes both dealer-supplied valuations and electronic data processing techniques that take into account appropriate factors such as institutional-size trading in similar groups of securities, yield, quality, coupon rate, maturity, type of issue, and trading characteristics other than market data and without exclusive reliance upon quoted prices or exchanges or over-the-counter prices, since such valuations are believed to reflect more accurately the fair value of such securities. All debt portfolio securities with a remaining maturity of 60 days or less are valued at amortized cost, which approximates fair value. Under the amortized cost method, discount or premium, if any, is accreted or amortized, respectively, on a constant (straight-line) basis to the maturity of the security.
   
 
The Trust may use a pricing service to value certain portfolio securities where the prices provided are believed to reflect the fair market value of such securities. If market prices are not readily available or, in Boston Trust Investment Management, Inc.’s (the “Adviser”) opinion, market prices do not reflect fair value, or if an event occurs after the close of trading on the exchange or market on which the security is principally traded (but prior to the time the NAV is calculated) that materially affects fair value, the Adviser will value the Funds’ assets at their fair value according to policies approved by the Board.

Investments in investment companies and money market funds are valued at net asset value per share.
   
 
Fair Value Measurements:
 
The valuation techniques employed by the Funds, as described above in Security Valuation, maximize the use of observable inputs and minimize the use of unobservable inputs in determining fair value. The inputs used for valuing the Funds’ investments are summarized in the three broad levels listed below:
   
 
Level 1 — quoted prices in active markets for identical assets
 
Level 2 — other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.)
 
Level 3 — significant unobservable inputs (including the Funds’ own assumptions in determining the fair value of investments)
   
 
The inputs or methodology used to value investments are not necessarily an indication of the risk associated with investing in those investments.


Continued 65




Notes to Financial Statements  
March 31, 2013
     

 
Pursuant to the valuation techniques described above in Security Valuation, equity securities are generally categorized as Level 1 securities in the fair value hierarchy (unless there is a fair valuation event, in which case affected securities are generally categorized as Level 2 securities). Debt securities, including those with a remaining maturity of 60 days or less are generally categorized as Level 2 securities in the fair value hierarchy. Open-end investment companies and money market funds are generally categorized as Level 1 securities in the fair value hierarchy.
   
 
Investments for which there are no such quotations, or for which quotations do not appear reliable, are valued at fair value as determined in good faith by the Pricing Committee under the direction of the Board. These valuations are typically categorized as Level 2 or Level 3 in the fair value hierarchy.
   
 
The following is a summary of the valuation inputs used as of March 31, 2013 in valuing the Funds’ investments based on the three levels defined above:

            Level 2    
      Level 1     Other Significant   Total Investments
 
Fund Name
  Quoted Prices     Observable Inputs   in Securities
   
 
Asset Management Fund
                       
 

Common Stocks1

 
$
214,766,175    
$
   
$
214,766,175  
 

Corporate Bonds1

          11,796,246       11,796,246  
 

Municipal Bonds2

          7,059,817       7,059,817  
 

U.S. Government & U.S. Government Agency Obligations

          39,800,735       39,800,735  
 

Investment Companies

    15,654,911             15,654,911  
                     
 

Total

    230,421,086       58,656,798       289,077,884  
                           
  Equity Fund                        
 

Common Stocks1

    80,214,290             80,214,290  
 

Investment Companies

    1,437,072             1,437,072  
                     
 

Total

    81,651,362             81,651,362  
                           
  Midcap Fund                        
 

Common Stocks1

    34,201,395             34,201,395  
 

Investment Companies

    703,557             703,557  
                     
 

Total

    34,904,952             34,904,952  
                           
  SMID Cap Fund                        
 

Common Stocks1

    4,670,406             4,670,406  
 

Investment Companies

    55,076             55,076  
                     
 

Total

    4,725,482             4,725,482  
                           
  Small Cap Fund                        
 

Common Stocks1

    499,854,701             499,854,701  
 

Investment Companies

    3,210,238             3,210,238  
                     
 

Total

    503,064,939             503,064,939  
   
 
Walden Asset Management Fund
                       
 

Common Stocks1

    48,095,991             48,095,991  
 

Corporate Bonds1

          2,387,735       2,387,735  
 

Municipal Bonds2

          757,087       757,087  
 

U.S. Government & U.S. Government Agency Obligations

          10,855,022       10,855,022  
 

Investment Companies

    2,574,260             2,574,260  
                     
 

Total

    50,670,251       13,999,844       64,670,095  
                           
 
Walden Equity Fund
                       
 

Common Stocks1

    128,890,250             128,890,250  
 

Investment Companies

    1,624,857             1,624,857  
                     
 

Total

    130,515,107             130,515,107  
                           
  Walden Midcap Fund                        
 

Common Stocks1

    23,724,925             23,724,925  
 

Investment Companies

    784,720             784,720  
                     
 

Total

    24,509,645             24,509,645  
                           
 
Walden SMID Cap Fund
                       
 

Common Stocks1

    19,587,869             19,587,869  
 

Investment Companies

    525,308             525,308  
                     
 

Total

    20,113,177             20,113,177  
                           
 
Walden Small Cap Fund
                       
 

Common Stocks1

    93,415,886             93,415,886  
 

Investment Companies

    1,829,464             1,829,464  
                     
 

Total

    95,245,350             95,245,350  
   

 
1
For detailed industry descriptions, see the accompanying Schedules of Portfolio Investments.
 
2
For detailed State classifications, see the accompanying Schedules of Portfolio Investments.

 
The Funds recognize transfers, if any, between fair value hierarchy levels at the reporting period end. There were no transfers between levels as of March 31, 2013 from the valuation input levels used on March 31, 2012. The Funds did not hold any Level 3 securities during the period ended March 31, 2013.

66 Continued




Notes to Financial Statements  
March 31, 2013
     

 
Security Transactions and Related Income:
 
Security transactions are recorded no later than one business day after trade date. For financial reporting purposes, security transactions are recorded on trade date on the last business day of the reporting period. Interest income is recognized on the accrual basis and includes, where applicable, the amortization of premium or discount. Dividend income is recorded on the ex-dividend date. Gains or losses realized on sales of securities are determined by comparing the identified cost of the security lot sold with the net sales proceeds.
   
 
Expenses:
 
Expenses directly attributable to a Fund are charged directly to that Fund. Expenses relating to the Trust are allocated proportionately to each Fund within the Trust according to the relative net assets of each Fund or on another reasonable basis.
   
 
Dividends to Shareholders:
 
Dividends to shareholders are recorded on the ex-dividend date. Dividends to shareholders from net investment income, if any, are declared and paid annually by the Funds. Dividends to shareholders from net realized gains, if any, are declared and distributed at least annually by the Funds.
   
 
The amounts of dividends to shareholders from net investment income and of distributions from net realized gains are determined in accordance with federal income tax regulations, which may differ from GAAP. These “book/tax” differences are either considered temporary or permanent in nature. To the extent these differences are permanent in nature (e.g. return of capital, net operating loss, reclassification of certain market discounts, gain/loss, paydowns, and distributions), such amounts are reclassified within the composition of net assets based on their federal tax-basis treatment; temporary differences (e.g. wash sales and post October losses) do not require reclassification. To the extent dividends to shareholders exceed net investment income and net realized gains for tax purposes, they are reported as distributions of capital.
   
 
Federal Income Taxes:
 
Each Fund intends to continue to qualify as a regulated investment company by complying with the provisions available to certain investment companies, as defined in Subchapter M of the Internal Revenue Code, and to make distributions from net investment income and from net realized capital gains sufficient to relieve it from all, or substantially all, federal income and excise taxes. Therefore, no federal income tax provision is required.
   
 
Management has reviewed tax positions taken in tax years that remain subject to examination by all major tax jurisdictions, including federal (i.e., the last four tax year ends and the interim tax period since then, as applicable). The Funds recognize interest and penalties, if any, related to unrecognized tax benefits, as income tax expense in the Statement of Operations. Management believes that there is no tax liability resulting from unrecognized tax benefits related to uncertain tax positions taken as of and during the year ended March 31, 2013.
   
 
New Accounting Pronouncement:
 
In January 2013, the Financial Accounting Standards Board issued ASU No. 2013-01 “Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities (“ASU 2013-01’) which amended ASC Subtopic 210-20, Balance Sheet Offsetting. ASU 2013-01 clarified the scope of ASU No. 2011-11 “Disclosures about Offsetting Assets and Liabilities (“ASU 2011-11”). ASU 2011-11 requires an entity to disclose information about offsetting and related arrangements to enable users of that entity’s financial statements to understand the effect of those arrangements on its financial position. ASU 2013-01 clarifies the scope of ASU 2011-11 as applying to derivatives accounted for in accordance with Topic 815, Derivatives and Hedging, including bifurcated embedded derivatives, repurchase agreements and reverse repurchase agreements, and securities borrowing and securities lending transactions that are offset either in accordance with other requirements of GAAP or subject to an enforceable master netting arrangement or similar agreement. The guidance in ASU 2013-01 and ASU 2011-11 is effective for interim and annual periods beginning on or after January 1, 2013. Management is evaluating any impact ASU 2013-01 and ASU 2011-11 may have on the Funds’ financial statements.
   
3.
Related Party Transactions and Other Service Arrangements:
 
Investment Adviser:
 
The Funds and the Adviser are parties to an Investment Advisory Agreement under which the Adviser is entitled to receive an annual fee, computed daily and paid monthly, equal to the average daily net assets of each Fund, at the following annual percentage rates before contractual waivers:

 
Fund
   
Fee Rate
 
     
 
Asset Management Fund
    0.75
%
 
 
Equity Fund
    0.75 %  
 
Midcap Fund
    0.75 %  
 
SMID Cap Fund
    0.75 %  
 
Small Cap Fund
    0.75 %  
 
Walden Asset Management Fund
    0.75
%
 
 
Walden Equity Fund
    0.75 %  
 
Walden Midcap Fund
    0.75 %  
 
Walden SMID Cap Fund
    0.75 %  
 
Walden Small Cap Fund
    0.75 %  

 
Additionally, one Trustee of the Trust is Managing Director of the Adviser and an officer of the Trust is an officer of the Adviser. The persons are not paid directly by the Funds.
   
 
Administration and Fund Accounting:
 
Citi Fund Services Ohio, Inc. (“Citi”) serves the Funds as administrator. Citi provides administrative and fund accounting services for a fee that is computed daily and paid monthly, based on the aggregate daily net assets of the Trust.
 
 
Certain officers of the Trust are affiliated with Citi. Such persons were paid no fees directly by the Funds for serving as Officers of the Trust. Citi makes an employee available to service as the Funds’ Chief Compliance Officer (“CCO”) under a Compliance Service Agreement between the Funds and Citi (the “CCO Agreement”). Under the CCO Agreement, Citi also provides infrastructure and support in implementing the written policies and procedures comprising the Funds’ compliance program, including support services to the CCO. For the services provided under the CCO Agreement, the Funds paid Citi $39,123 for the year ended March 31, 2013, plus certain out of pocket expenses. Citi pays the salary and other compensation earned by the CCO as an employee of Citi.
   
 
Distribution:
 
Effective August 1, 2012, BHIL Distributors, Inc., (“BHIL”), a wholly-owned subsidiary of Beacon Hill Fund Services, Inc., serves as the Funds’ distribution agent. The distribution agreement provides for payment of a fixed annual fee of $17,500, fees for review of sales literature and dealer set-up efforts, and reimbursement of out-of-pocket expenses. These amounts are paid monthly to BHIL from the Advisor and not by the Funds. BHIL is not affiliated with Citi or the Adviser. Prior to August 1, 2012, Foreside Distributing Services, L.P., an indirect, wholly-owned subsidiary of Foreside Financial Group, LLC, served as the Funds’ distribution agent.


Continued 67




Notes to Financial Statements  
March 31, 2013
     

 
Shareholder Services:
 
The Funds may enter into shareholder services agreements with investment advisers, banks, trust companies and other types of organizations (“Authorized Service Providers”), which may include affiliates of the Funds, for providing administrative services with respect to shares of the Funds attributable to or held in the name of the Authorized Service Provider for its clients or other parties with whom they have a servicing relationship. Each Fund is authorized to pay non-distribution related shareholder services fees up to 0.25% of the average annual net assets with respect to shares of the Funds serviced by an Authorized Service Provider.
   
 
Custodian and Transfer Agency:
 
Boston Trust & Investment Management Company (“Boston Trust”), the parent company of the Adviser, acts as the Funds’ custodian and transfer agent. Under the custody agreement, Boston Trust receives $1,000 annually per Fund plus an annual asset based fee of 0.016% of the value of securities held. Under the transfer agency agreement, Boston Trust receives a fixed fee of $18,000 annually per fund, accrued daily and paid monthly for its services. Under a sub-transfer agency agreement, Citi receives a fixed annual fee from the Funds that use Citi as sub-transfer agent, accrued daily and paid monthly, plus annual per account fees and certain out of pocket expenses for its services to the Trust.
   
 
Fee Reductions:
 
The Adviser has agreed to reduce its fees payable by the Funds to the extent necessary to limit each Fund’s aggregate annual operating expenses to 1.00% of the average daily net assets. Any such reductions made by the Adviser in its fees or in the payment or reimbursement of expenses that are a Fund’s obligation may be subject to repayment by the Fund within three years provided the Fund receiving the reduction, payment or reimbursement is able to effect such repayment and remain in compliance with applicable expense limitations. The expense limitation agreement shall automatically renew effective August 1 of every year until the Adviser provides written notice of non-renewal to the Trust.
   
 
Pursuant to its agreement, for the periods ended March 31, 2011, 2012 and 2013, the Adviser reimbursed, and has yet to recoup, fees in the following amounts:

 
Fund
  Amount   Expires  
     
 
Equity Fund
 
$
13,866     2014  
                 
 
Midcap Fund
    27,687     2014  
        33,899     2015  
        16,993     2016  
                 
 
SMID Cap Fund
    11,533     2015  
        33,947     2016  
                 
 
Small Cap Fund
    105,195     2014  
        60,584     2015  
                 
 
Walden Asset Management Fund
    32,028     2014  
        33,900     2015  
        49,992     2016  
                 
 
Walden Equity Fund
    51,177     2014  
        26,043     2015  
        151,960     2016  
                 
 
Walden Midcap Fund
    18,288     2015  
        34,176     2016  
                 
 
Walden SMID Cap Fund
    30,124     2016  
                 
 
Walden Small Cap Fund
    61,924     2014  
        45,712     2015  
        64,888     2016  
   

 
During the year ended March 31, 2013, the Adviser recouped amounts from the following Funds:
     
 
Asset Management Fund
   
$
4,171  
 
Equity Fund
      8,013  
 
Small Cap Fund
      21,275  
     

 
As of March 31, 2013, the Adviser may recoup amounts from the Funds as follows:
  Total Potential Recoupment  
     
 
Asset Management Fund
   
$
 
 
Equity Fund
      13,866  
 
Midcap Fund
      78,579  
 
SMID Cap Fund
      45,480  
 
Small Cap Fund
      165,779  
 
Walden Asset Management Fund
   
$
115,920  
 
Walden Equity Fund
      229,180  
 
Walden Midcap Fund
      52,464  
 
Walden SMID Cap Fund
      30,124  
 
Walden Small Cap Fund
      172,524  
     

 
During the year ended March 31, 2013, the transfer agent voluntarily reduced a portion of the transfer agent fees otherwise payable by the Funds, as indicated on each Fund’s Statement of Operations. These voluntary reductions are not subject to recoupment in future years.
 
Other Affiliated Transactions:
During the year ended March 31, 2013, net assets of certain Funds (the “Redeeming Funds”) were exchanged as in-kind transfers for shares of other Funds (the “Subscribing Funds”) within the Trust. Fund shares of the Subscribing Funds, issued in connection with the exchanges, were used to pay for securities, at fair value, transferred from the Redeeming Funds. The total fair value of the in-kind transfers was $324,838 for 32,484 shares of the Walden SMID Cap Fund in exchange for 32,516 shares of the SMID Cap Fund and $503,078 for 31,680 shares of the Walden Small Cap Fund in exchange for 40,571 shares of the Small Cap Fund.
 
During the year ended March 31, 2012, certain net assets of common trust funds, managed by the Advisor, were exchanged as in-kind transfers for shares of certain Funds of the Trust. Fund shares issued in connection with the exchange were used to pay for securities transferred from the common trust funds to certain Funds at fair value. The total fair value of the in-kind transfers was $6,858,946 for 223,273 shares of the Asset Management Fund, $325,000 for 32,500 shares of the SMID Cap Fund, $5,098,275 for 463,901 shares of the Walden Asset Management Fund and $1,691,789 for 100,047 shares of the Walden Small Cap Fund.

68 Continued




Notes to Financial Statements  
March 31, 2013
     

4.
Purchases and Sales of Securities:
 
Cost of purchases and proceeds from sales and maturities of securities, excluding short-term securities and U.S. Government securities, for the Funds for the period ended March 31, 2013, totaled:

 
Fund
    Purchases       Sales and Maturities  
     
 
Asset Management Fund
    $ 19,107,716       $ 12,194,503    
 
Equity Fund
      8,624,684         3,981,923    
 
Midcap Fund
      7,624,849         4,763,074    
 
SMID Cap Fund
      2,002,714         1,286,693    
 
Small Cap Fund
      247,861,643         119,000,680    
     
 
Walden Asset Management Fund
      6,238,544         1,748,984    
 
Walden Equity Fund
      28,155,593         11,172,312    
 
Walden Midcap Fund
      9,828,212         2,106,750    
 
Walden SMID Cap Fund
      19,053,194         1,062,017    
 
Walden Small Cap Fund
      40,393,904         25,556,983    
     

 
Cost of purchases and proceeds from sales and maturities of U.S. Government Securities, excluding short-term securities, for the Funds for the year ended March 31, 2013, totaled:
 
Fund
  Purchases   Sales and Maturities  
     
 
Asset Management Fund
 
$
0  
$
7,765,182
 
 
 
Walden Asset Management Fund
    5,555,978     7,212,610    
     

5.
Federal Income Tax Information:
 
At March 31, 2013, the cost, gross unrealized appreciation and gross unrealized depreciation on securities, for federal income tax purposes, were as follows:
                Gross Tax Unrealized   Gross Tax Unrealized   Net Unrealized Appreciation
      Tax Cost   Appreciation   (Depreciation)   (Depreciation)
   
 
Asset Management Fund
   
$
192,265,346      
$
97,645,755      
$
(833,217 )    
$
96,812,538  
 
Equity Fund
      46,444,492         35,557,646         (350,776
)
      35,206,870  
 
Midcap Fund
      23,742,178         11,407,360         (244,586
)
      11,162,774  
 
SMID Cap Fund
      4,002,845         837,696         (115,059
)
      722,637  
 
Small Cap Fund
      420,420,215         89,147,554         (6,502,830
)
      82,644,724  
   
 
Walden Asset Management Fund
      50,029,682         15,140,937         (500,524
)
      14,640,413  
 
Walden Equity Fund
      93,328,042         38,304,047         (1,116,982
)
      37,187,065  
 
Walden Midcap Fund
      20,535,966         4,183,365         (209,686
)
      3,973,679  
 
Walden SMID Cap Fund
      18,505,369         1,875,094         (267,286
)
      1,607,808  
 
Walden Small Cap Fund
      78,249,094         18,427,611         (1,431,355
)
      16,996,256  
   

 
The tax character of distributions paid during the fiscal year ended March 31, 2013 was as follows:
      Distributions paid from                              
                   
                Net Long Term   Total Taxable   Tax Return of   Total Distributions
      Ordinary Income   Capital Gains   Distributions   Capital   Paid1
   
 
Asset Management Fund
   
$
3,899,407      
$
305,946      
$
4,205,353      
$
     
$
4,205,353  
 
Equity Fund
      861,329                 861,329                 861,329  
 
Midcap Fund
      207,695         662,925         870,620                 870,620  
 
SMID Cap Fund
      45,812         29         45,841         2,850         48,691  
 
Small Cap Fund
      6,375,133         6,708,598         13,083,731                 13,083,731  
   
 
Walden Asset Management Fund
      710,488                 710,488                 710,488  
 
Walden Equity Fund
      1,235,398                 1,235,398                 1,235,398  
 
Walden Midcap Fund
      105,039                 105,039                 105,039  
 
Walden SMID Cap Fund
      23,799                 23,799         5,083         28,882  
 
Walden Small Cap Fund
      915,641         1,279,700         2,195,341                 2,195,341  
   

 
The tax character of distributions paid during the fiscal year ended March 31, 2012 was as follows:
      Distributions paid from                              
                   
                Net Long Term   Total Taxable   Tax Return of   Total Distributions
      Ordinary Income   Capital Gains   Distributions   Capital   Paid1
   
 
Asset Management Fund
   
$
3,373,655      
$
     
$
3,373,655      
$
     
$
3,373,655  
 
Equity Fund
      589,650                 589,650                 589,650  
 
Midcap Fund
      302,768         664,754         967,522                 967,522  
 
SMID Cap Fund
      898                 898                 898  
 
Small Cap Fund
      5,265,166         14,632,707         19,897,873                 19,897,873  
   
 
Walden Asset Management Fund
      550,502                 550,502                 550,502  
 
Walden Equity Fund
      866,803                 866,803                 866,803  
 
Walden Midcap Fund
      19,338                 19,338                 19,338  
 
Walden Small Cap Fund
      995,830         2,391,348         3,387,178                 3,387,178  
   

  1
Total distributions paid may differ from the amount reported in the Statements of Changes in Net Assets because for tax purposes distributions are recognized when actually paid.


Continued 69



Notes to Financial Statements  

March 31, 2013
     

As of March 31, 2013, the components of accumulated earnings on a tax basis were as follows:

      Undistributed   Undistributed           Accumulated   Unrealized   Total
      Ordinary   Long-Term Capital   Accumulated   Capital and Other   Appreciation   Accumulated
      Income   Gains   Earnings   Losses   (Depreciation)2   Earnings (Deficit)
   
  Asset Management Fund   $ 810,566     $ 1,089,703     $ 1,900,269     $     $ 96,812,538     $ 98,712,807  
  Equity Fund     195,579             195,579       (1,569,735 )     35,206,870       33,832,714  
  Midcap Fund     3,675       287,428       291,103       (35,678 )     11,162,774       11,418,199  
  SMID Cap Fund                       (21,614 )     722,637       701,023  
  Small Cap Fund     1,086,062       4,775,622       5,861,684       (49,366 )     82,644,724       88,457,042  
   
  Walden Asset Management Fund     145,977             145,977       (14,493 )     14,640,413       14,771,897  
  Walden Equity Fund     298,146             298,146       (1,151,013 )     37,187,064       36,334,197  
  Walden Midcap Fund     2,898             2,898       (161,858 )     3,973,679       3,814,719  
  Walden SMID Cap Fund                       (8,689 )     1,607,808       1,599,119  
  Walden Small Cap Fund     481,517       764,090       1,245,607       (15,492 )     16,996,256       18,226,371  
   
  2  The differences between book-basis and tax-basis unrealized appreciation (depreciation) is attributable primarily to tax deferral of losses on wash sales.

The Regulated Investment Company Modernization Act of 2010 (the “Act”) was enacted on December 22, 2010. The Act makes changes to several tax rules impacting the Funds. In general, the provisions of the Act will be effective for the Funds’ fiscal year ended March 31, 2013. Although the Act provides several benefits, including the unlimited carryforward of future capital losses, there may be a greater likelihood that all or a portion of each Fund’s pre-enactment capital loss carryforwards, if any, may expire without being utilized due to the fact that post-enactment capital losses get utilized before pre-enactment capital loss carryforwards.

As of March 31, 2013, the following Funds had net capital loss carryforwards, which are available to offset future realized gains. To the extent these carryforwards are used to offset future gains, it is probable that the amounts offset will not be distributed to shareholders.

Pre-enactment capital loss carryforwards subject to expiration:

  Fund Amount   Expires  
     
  Equity Fund $ 1,549,884   2018  
     
  Walden Asset Management Fund   14,493   2018  
  Walden Equity Fund   1,151,013   2018  
     

Post-enactment capital loss carryforwards not subject to expiration:

  Fund   Short Term Amount   Long Term Amount  
     
  SMID Cap Fund   $ 20,244      
     
  Walden Midcap Fund     152,377      
  Walden SMID Cap Fund     4,658      
     

During the year ended March 31, 2013, the following Funds utilized capital loss carryforwards to offset realized capital gains:

  Fund   Amount    
     
  Asset Management Fund   $ 1,026,751    
  Equity Fund     1,107,491    
     
  Walden Asset Management Fund     444,371    
  Walden Equity Fund     1,576,712    
     

Under current tax law, net investment losses and capital losses realized after October 31 of a Fund’s fiscal year may be deferred and treated as occurring on the first business day of the following fiscal year for tax purposes. The following Funds deferred losses as follows:

      Late Year   Post-October  
  Fund   Ordinary Loss   Capital Losses  
     
  Equity Fund   $     $ 19,851    
  Midcap Fund           35,678    
  SMID Cap Fund     1,370          
  Small Cap Fund     49,366          
     
  Walden Midcap Fund           9,481    
  Walden SMID Cap Fund     1,540       2,491    
  Walden Small Cap Fund     15,492          
     

70   Continued



Notes to Financial Statements  

March 31, 2013
     

As of March 31, 2013, the following reclassifications have been made to increase (decrease) such accounts with offsetting adjustments as indicated:

      Accumulated Net   Accumulated Net          
  Fund   Investment Income   Realized Gains   Paid in Capital  
     
  Asset Management Fund   $ 12,991     $ (12,991 )   $    
  Midcap Fund     (1 )     2       (1 )  
  SMID Cap Fund     2,840       1,033       (3,873 )  
  Small Cap Fund     321,817       (321,445 )     (372 )  
     
  Walden Asset Management Fund     16,193       (16,192 )     (1 )  
  Walden Equity Fund           (1 )     1    
  Walden SMID Cap Fund     5,305             (5,305 )  
  Walden Small Cap Fund     80,017       (80,019 )     2    
     

6.   Control Ownership and Principal Holders:
   
The beneficial ownership, either directly or indirectly, of more than 25% of the voting securities of a Fund creates presumptions of control of the Fund, under section 2 (a)(9) of the 1940 Act. As of March 31, 2013, the Funds had individual shareholder accounts and/or omnibus shareholder accounts (comprised of a group of individual shareholders), owning more than 25% of the total shares outstanding of the Fund as detailed below.

  Fund   Control Ownership   % of Ownership
   
  Asset Management Fund   Boston Trust & Investment Management Company     93.3  
  Equity Fund   Boston Trust & Investment Management Company     99.1  
  Midcap Fund   Boston Trust & Investment Management Company     92.3  
  SMID Cap Fund   Boston Trust & Investment Management Company     62.1  
  Walden Asset Management Fund   Boston Trust & Investment Management Company     72.0  
  Walden Equity Fund   Boston Trust & Investment Management Company     28.8  
  Walden Midcap Fund   Boston Trust & Investment Management Company     98.1  
  Walden SMID Cap Fund   Boston Trust & Investment Management Company     56.6  
  Walden Small Cap Fund   Boston Trust & Investment Management Company     33.2  
   

7.   Subsequent Events:
   
Management evaluated subsequent events through the date these financial statements were issued and concluded no subsequent events required recognition or disclosure in these financial statements.

Continued   71



Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Trustees
The Boston Trust & Walden Funds

We have audited the accompanying statements of assets and liabilities, including the schedules of portfolio investments of The Boston Trust & Walden Funds, comprising the Boston Trust Asset Management Fund (formerly, the Boston Trust Balanced Fund), Boston Trust Equity Fund, Boston Trust Midcap Fund, Boston Trust SMID Cap Fund, Boston Trust Small Cap Fund, Walden Asset Management Fund (formerly, the Walden Balanced Fund), Walden Equity Fund, Walden Midcap Fund, Walden SMID Cap Innovations Fund and Walden Small Cap Innovations Fund (the “Funds”), as of March 31, 2013, and the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, and the financial highlights for each of the five periods in the period then ended for the Boston Trust Asset Management Fund, Boston Trust Equity Fund, Boston Trust Midcap Fund, Boston Trust Small Cap Fund, Walden Asset Management Fund, Walden Equity Fund and Walden Small Cap Innovations Fund, the related statements of operations for the year then ended, statement of changes in net assets for each of the two periods in the period then ended, and the financials highlights for each of the two periods in the period then ended for the Boston Trust SMID Cap Fund and Walden Midcap Fund, and the related statements of operations and changes in net assets and the financial highlights for the period June 29, 2012 (commencement of operations) through March 31, 2013, for the Walden SMID Cap Innovations Fund. These financial statements and financial highlights are the responsibility of the Funds’ management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of March 31, 2013, by correspondence with the custodian and brokers. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of each of the Funds constituting The Boston Trust & Walden Funds as of March 31, 2013, and the results of their operations, the changes in their net assets and their financial highlights for the periods indicated above, in conformity with accounting principles generally accepted in the United States of America.

COHEN FUND AUDIT SERVICES, LTD.
Cleveland, Ohio
May 29, 2013

72



Supplementary Information (Unaudited)  

March 31, 2013
     

Federal Income Tax Information:
During the fiscal year ended March 31, 2013, the Funds declared long-term realized gain distributions in the following amounts:

    15% Capital Gains  
       
Asset Management Fund   $ 305,946    
Midcap Fund     662,925    
SMID Cap Fund     29    
Small Cap Fund     6,708,598    
Walden Small Cap Fund     1,279,700    

During the fiscal year ended March 31, 2013, the Funds declared short-term realized gain distributions in the following amounts:

    Short-Term Capital Gains  
       
SMID Cap Fund   $ 30,482    
Small Cap Fund     5,226,344    
Walden Small Cap Fund     664,206    

For the fiscal year ended March 31, 2013, the following percentage of the total ordinary income distributions paid by the Funds qualify for the distributions received deduction available to corporate shareholders.

    Distributions Received Deduction  
       
Asset Management Fund     99.45 %  
Equity Fund     100.00 %  
Midcap Fund     100.00 %  
SMID Cap Fund     47.47 %  
Small Cap Fund     64.62 %  
Walden Asset Management Fund     100.00 %  
Walden Equity Fund     100.00 %  
Walden Midcap Fund     100.00 %  
Walden SMID Cap Fund     100.00 %  
Walden Small Cap Fund     73.29 %  

For the fiscal year ended March 31, 2013, distributions paid by the Funds may be subject to a maximum tax rate of 15%, as provided for by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The Funds intend to designate the maximum amount allowable as taxed at a maximum rate of 15%. Complete information will be reported in conjunction with your 2012 Form 1099-DIV.

    Qualified Dividend Income
     
Asset Management Fund     100.00 %
Equity Fund     100.00 %
Midcap Fund     100.00 %
SMID Cap Fund     46.61 %
Small Cap Fund     63.50 %
Walden Asset Management Fund     100.00 %
Walden Equity Fund     100.00 %
Walden Midcap Fund     100.00 %
Walden SMID Cap Fund     100.00 %
Walden Small Cap Fund     71.92 %

Continued   73



Supplementary Information (Unaudited)  

March 31, 2013
     

Table of Shareholder Expenses:
As a shareholder of the Trust, you incur ongoing costs, including management fees, and other Fund expenses. These examples are intended to help you understand your ongoing costs (in dollars) of investing in the Boston Trust Funds and Walden Funds and to compare these costs with the ongoing costs of investing in other mutual funds.

These examples are based on an investment of $1,000 invested at the beginning of the period and held for the entire period from October 1, 2012, through March 31, 2013.

Actual Expenses
The table below provides information about actual account values and actual expenses. You may use the information below together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the table under the heading entitled “Expenses Paid During Period” to estimate the expenses you paid on your account during this period.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect the costs incurred by the Funds for buying and selling securities. The Funds do not charge transaction fees, such as redemption fees, nor do the Funds charge a sales charge (load). Therefore, the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.

                            Annualized
                    Expenses Paid   Expense Ratio
    Beginning Account Value   Ending Account Value   During Period1   During Period
    10/1/12   3/31/13   10/1/12 - 3/31/13   10/1/12 - 3/31/13
 
Asset Management Fund   $ 1,000.00     $ 1,065.90     $ 4.94       0.96 %
Equity Fund     1,000.00       1,086.40       5.20       1.00 %
Midcap Fund     1,000.00       1,121.00       5.29       1.00 %
SMID Cap Fund     1,000.00       1,125.40       5.30       1.00 %
Small Cap Fund     1,000.00       1,115.20       5.27       1.00 %
 
Walden Asset Management Fund     1,000.00       1,064.10       5.15       1.00 %
Walden Equity Fund     1,000.00       1,089.50       5.21       1.00 %
Walden Midcap Fund     1,000.00       1,120.50       5.29       1.00 %
Walden SMID Cap Fund     1,000.00       1,118.80       5.28       1.00 %
Walden Small Cap Fund     1,000.00       1,117.80       5.28       1.00 %
 
1   Expenses are equal to the average account value times a Fund’s annualized expense ratio, multiplied by the number of days in the most recent fiscal half-year, divided by the number of days in the fiscal year.

Hypothetical Example for Comparison Purposes
The table below provides information about hypothetical account values and hypothetical expenses based on each Boston Trust Fund’s and Walden Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect the costs incurred by the Funds for buying and selling securities. The Funds do not charge transaction fees, such as redemption fees, nor do the Funds charge a sales charge (load). Therefore, the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.

                            Annualized
                    Expenses Paid   Expense Ratio
    Beginning Account Value   Ending Account Value   During Period1   During Period
    10/1/12   3/31/13   10/1/12 - 3/31/13   10/1/12 - 3/31/13
 
Asset Management Fund   $ 1,000.00     $ 1,020.19     $ 4.84       0.96 %
Equity Fund     1,000.00       1,019.95       5.04       1.00 %
Midcap Fund     1,000.00       1,019.95       5.04       1.00 %
SMID Cap Fund     1,000.00       1,019.95       5.04       1.00 %
Small Cap Fund     1,000.00       1,019.95       5.04       1.00 %
 
Walden Asset Management Fund     1,000.00       1,019.95       5.04       1.00 %
Walden Equity Fund     1,000.00       1,019.95       5.04       1.00 %
Walden Midcap Fund     1,000.00       1,019.95       5.04       1.00 %
Walden SMID Cap Fund     1,000.00       1,019.95       5.04       1.00 %
Walden Small Cap Fund     1,000.00       1,019.95       5.04       1.00 %
 
1  
Expenses are equal to the average account value times a Fund’s annualized expense ratio, multiplied by the number of days in the most recent fiscal half-year, divided by the number of days in the fiscal year.

74 Continued  



Supplementary Information (Unaudited)  

March 31, 2013
     

Tabular Summary of Schedules of Portfolio Investments:

The Boston Trust Funds invested, as a percentage of total net assets, in the following industries as of March 31, 2013.

Boston Trust Asset Management Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
Industrials     14.4 %
Financials     14.3 %
U.S. Government & U.S. Government Agency Obligations     13.8 %
Information Technology     13.2 %
Energy     9.3 %
Consumer Staples     9.0 %
Consumer Discretionary     8.2 %
Health Care     6.8 %
Investment Companies     5.4 %
Materials     3.1 %
Municipal Bonds     2.4 %
Telecommunication Services     0.2 %
Liabilities in excess of other assets     -0.1 %
 
Total     100.0 %
 

Boston Trust Equity Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
Industrials     18.6 %
Information Technology     16.8 %
Financials     15.3 %
Consumer Staples     12.0 %
Energy     11.4 %
Consumer Discretionary     11.2 %
Health Care     9.1 %
Materials     4.4 %
Investment Companies     1.8 %
Liabilities in excess of other assets     -0.6 %
 
Total     100.0 %
 

Boston Trust Midcap Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
Financials     17.5 %
Industrials     15.8 %
Information Technology     14.9 %
Consumer Discretionary     14.1 %
Health Care     11.4 %
Energy     8.8 %
Consumer Staples     6.9 %
Materials     4.9 %
Utilities     3.8 %
Investment Companies     2.0 %
Liabilities in excess of other assets     -0.1 %
 
Total     100.0 %
 

Boston Trust SMID Cap Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
Financials     22.9 %
Industrials     16.4 %
Information Technology     14.2 %
Consumer Discretionary     13.8 %
Health Care     11.2 %
Materials     6.6 %
Energy     6.4 %
Utilities     5.0 %
Consumer Staples     2.4 %
Investment Companies     1.2 %
Liabilities in excess of other assets     -0.1 %
 
Total     100.0 %
 

Boston Trust Small Cap Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
Financials     21.3 %
Information Technology     17.9 %
Industrials     16.1 %
Health Care     13.4 %
Consumer Discretionary     12.9 %
Energy     6.7 %
Materials     5.0 %
Utilities     3.2 %
Consumer Staples     3.0 %
Investment Companies     0.6 %
Liabilities in excess of other assets     -0.1 %
 
Total     100.0 %
 

Continued   75



Supplementary Information (Unaudited)  

March 31, 2013
     

The Walden Funds invested, as a percentage of total net assets, in the following industries as of March 31, 2013.

Walden Asset Management Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
U.S. Government & U.S. Government Agency Obligations     16.8 %
Information Technology     13.7 %
Financials     13.4 %
Industrials     11.4 %
Consumer Staples     10.5 %
Health Care     9.3 %
Consumer Discretionary     8.4 %
Energy     7.8 %
Investment Companies     4.0 %
Materials     3.3 %
Municipal Bonds     1.1 %
Telecommunication Services     0.2 %
Other assets in excess of liabilities     0.1 %
 
Total     100.0 %
 

Walden Equity Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
Information Technology     17.9 %
Industrials     15.2 %
Financials     14.4 %
Consumer Staples     13.2 %
Health Care     12.7 %
Consumer Discretionary     10.8 %
Energy     10.2 %
Materials     4.3 %
Investment Companies     1.2 %
Other assets in excess of liabilities     0.1 %
 
Total     100.0 %
 

Walden Midcap Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
Financials     17.3 %
Industrials     15.8 %
Information Technology     14.9 %
Consumer Discretionary     14.1 %
Health Care     11.2 %
Energy     8.3 %
Consumer Staples     7.1 %
Materials     4.7 %
Utilities     3.9 %
Investment Companies     3.2 %
Liabilities in excess of other assets     -0.5 %
 
Total     100.0 %
 

Walden SMID Cap Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
Financials     22.5 %
Industrials     15.9 %
Information Technology     13.8 %
Consumer Discretionary     13.1 %
Health Care     10.6 %
Materials     6.4 %
Energy     6.0 %
Utilities     4.7 %
Consumer Staples     2.7 %
Investment Companies     2.6 %
Other assets in excess of liabilities     1.7 %
 
Total     100.0 %
 

Walden Small Cap Fund        
    Percentage of Total
Security Allocation for the Schedule of Portfolio Investments   Net Assets
 
Financials     21.0 %
Information Technology     17.8 %
Industrials     15.7 %
Health Care     13.4 %
Consumer Discretionary     12.3 %
Energy     6.8 %
Materials     4.9 %
Utilities     3.3 %
Consumer Staples     2.9 %
Investment Companies     1.9 %
Liabilities in excess of other assets     0.0 %
 
Total     100.0 %
 

Other Information:
A description of the policies and procedures that the Funds use to determine how to vote proxies related to portfolio securities is available (i) without charge, upon request, by calling 1-800-282-8782 ext. 7050, and (ii) on the Securities and Exchange Commission’s (the “Commission”) website at http://www.sec.gov.

Information regarding how the Funds voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available (i) without charge, upon request, by calling 1-800-282-8782 ext. 7050, (ii) on the Boston Trust & Investment Management, Inc. website at http://www.btim.com; and (iii) on the Commission’s website at http://www.sec.gov.

The Funds file complete schedules of portfolio holdings for each Fund with the Commission for the first and third quarters of each fiscal year on Form N-Q. The Funds’ Form N-Q is available on the Commission’s website at http://www.sec.gov. The Funds’ Form N-Q may be reviewed and copied at the Commission’s Public Reference Room in Washington, D.C. and information on the operation of the Public Reference Room may be obtained by calling 1-800-SEC-0330.


76 Continued  



Supplementary Information (Unaudited)  

March 31, 2013
     

The annual consideration by the Board of Trustees (the “Board”) of the continuation of the investment advisory agreement between Boston Trust Investment Management, Inc., (the “Adviser”) and Boston Trust Asset Management Fund, Boston Trust Equity Fund, Boston Trust Midcap Fund, Boston Trust SMID Cap Fund, Boston Trust Small Cap Fund, Walden Asset Management Fund, Walden Equity Fund, Walden Midcap Fund, Walden SMID Cap Innovations Fund and Walden Small Cap Innovations Fund (the “Funds”).

Section 15 of the Investment Company Act of 1940 (the “1940 Act”) requires that the Investment Advisory Agreement with the Boston Trust Investment Management, Inc. (the “Adviser”) be renewed annually by the Board, including a majority of the Board of Trustees of The Boston Trust & Walden Funds (the “Trust”) who are not “interested persons” of the Trust or of the Adviser (“Independent Trustees”). It is the duty of the Board to request as much information as is reasonably necessary to evaluate the terms of the Investment Advisory Agreement and determine whether its continuance is fair to the Funds and their shareholders. The Board considered the continuation of the Investment Advisory Agreement at an in-person meeting held on March 1, 2013. The Board requested, and the Adviser provided, information and data relating to: (i) the investment performance of each series of the Trust (the “Funds”) and the Adviser; (ii) the nature, extent and quality of the services provided by the Adviser to the Funds; (iii) the cost of the services to be provided and the profits to be realized by the Adviser and its affiliates from the relationship with the Funds; (iv) the extent to which economies of scale will be realized as the Funds grow; (v) whether the fee levels refleect these economies of scale to the benefit of Funds’ shareholders; (vi) the advisory fees paid by other comparable funds advised by the Adviser or by a different investment adviser; (vii) the Funds’ expense ratios and the expense ratios of similar funds; and (viii) the effect of any fee waivers and expense reimbursements made by the Adviser.

At the meeting on March 1, 2013, the Board engaged in a thorough review process to determine whether to continue the Investment Advisory Agreement. The Board met directly with representatives of the Adviser and reviewed the information and data listed above, as supplemented by Citi Fund Services Ohio, Inc., the Trust’s administrator. As part of its deliberations, the Board also considered and relied upon the information about the Funds and the Adviser that it had received throughout the year as part of its ongoing oversight of the Funds and their operations. The Board reviewed the performance of the Boston Trust Funds and the Walden Funds from inception through December 31, 2012, comparing the performance to various indices and also, in the case of the Boston Trust Asset Management Fund and the Walden Asset Management Fund, to a bond index, equity index and Treasury bills. The Board noted that as of December 31, 2012, all of the Funds except the Boston Trust SMID Cap Fund underperformed their respective indices for the one-year period, but each outperformed its benchmark index for the five-year period and all but the Boston Trust SMID Cap Fund, the Walden Midcap Fund and the Walden SMID Cap Innovations Fund, which are very new Funds with little operating history, outperformed its benchmark index for the since inception period. While the Boston Trust Asset Management Fund and the Walden Asset Management Fund outperformed the S&P 500 Index and the 90 Day US Treasury Bills for the five-year period, it underperformed the Barclays Capital G/C Bond Index for that time period.

The Board then turned to a review of the range of advisory fees paid by the Boston Trust Funds and Walden Funds to BTIM and the total operating expenses of each Fund. The Board noted that, with the exception of the Boston Trust Asset Management Fund, Walden Asset Management Fund, Boston Trust Equity and the Walden Equity Fund, each Boston Trust Fund and Walden Fund had a contractual advisory fee that was at or below the peer group average. The contractual advisory fees for the Boston Trust Asset Management Fund and the Walden Asset Management Fund were equal to the median fees for the peer group and only 0.04% above the average for the peer group and well the below the peer group’s highest fee of 1.00%. The contractual advisory fees for the Boston Equity Fund and the Walden Equity Fund were only 0.04% above the average for the peer group and well the below the peer group’s highest fee of 1.00%.

The Board noted that BTIM has been operating under an Expense Limitation Agreement that requires BTIM to waive fees and/or reimburse expenses to the extent total operation expenses of all any Fund exceeds 1.00%. The actual advisory fees charged by all the Boston Trust and Walden Funds, except Boston Trust Asset Management Fund, Walden Asset Management Fund, Boston Trust Equity and the Walden Equity Fund, are below the peer group average after expense waivers and/or reimbursements. Actual advisory fees for the Walden Equity Fund were 0.02% above the average for the peer group, while the actual advisory fees for the Boston Trust Equity Fund were 0.15% above the peer group and well below the peer group’s highest fee of 1.00%. The actual advisory fees for the Walden Asset Management Fund were 0.04% above the average for the peer group, while the actual advisory fees for the Boston Trust Asset Management Fund were 0.13% above the average for the peer group. The actual advisory fees for both Funds were well below the peer group’s highest fee of 1.00%. The Board noted that BTIM would conduct a breakpoint analysis and consider advisory fee breakpoints in the future.

Turning to total operating expenses, the Board noted that the expense ratios for all the Boston Trust Funds and Walden Funds, other than the Boston Trust Equity and the Walden Equity Fund, are lower than the industry average after expense waivers and/or reimbursements. The expense ratios for the Boston Trust Equity and the Walden Equity Fund are 0.01% above the peer group and equal to the median for the peer group. After considering the comparative data as described above, and the proposed renewal of the Expense Limitation Agreement, the Board concluded that the advisory fees and expense ratios were reasonable.


Continued   77



Supplementary Information (Unaudited)  

March 31, 2013
     

The Board then gave careful consideration to the nature, extent and quality of the services provided by BTIM. The Trustees reviewed the organizational structure of BTIM and Boston Trust, BTIM’s investment philosophy, its portfolio construction process, its fixed income approach and its brokerage policies. The Board reviewed the adviser’s experience and the capabilities of its personnel, as well as the quality of the reports and other materials received from BTIM. Taking into account the personnel involved in servicing the Funds, as well as the materials and services described above, the Board expressed satisfaction with the quality of the services received from BTIM.

Next, in reviewing the costs of the services to be provided and the profits to be realized by BTIM, the Board reviewed the adviser’s audited balance sheets for calendar years 2011 and 2012 and the gross and net profit margins realized on each Fund. The Board noted that the adviser’s relationship with the Funds was profitable even though BTIM was operating under an Expense Limitation Agreement with the Trust. The Board discussed the custody and transfer agency fees earned by Boston Trust for services provided to the Funds, which are reduced by amounts paid for sub-custody services.

In reaching its conclusions with respect to the continuation of the Investment Advisory Agreement, the Board did not identify any single controlling factor. Rather, the Board noted that a combination of factors influenced their decision making process. The Board did, however, identify the commitment of the Adviser to the successful operation of the Funds and the level of Fund expenses as being important elements of their consideration. The Board took notice of the fact that the Adviser has maintained an Expense Limitation Agreement with respect to each of the Funds since the inception of each Fund pursuant to which total operating expenses for each of the Funds is limited, which the Board noted benefits shareholders in each of the Funds. The Board took further notice of the fact that the Adviser has agreed to continue the Expense Limitation Agreement for each of the Funds. Based upon their review and consideration of these factors and other matters deemed relevant by the Board in reaching an informed business judgment, a majority of the Board, including a majority of the Independent Trustees, concluded that the terms of the Investment Advisory Agreement are fair and reasonable and the Board voted to renew the Investment Advisory Agreement for an additional one-year period.


78    



Information about Trustees and Officers (Unaudited)  

March 31, 2013
     

Overall responsibility for management of the Funds rests with the Board of Trustees. The names of the Trustees and Officers of the Funds, their addresses, ages and principal occupations during the past five years are provided in the tables below. The business address of the persons listed below is 3435 Stelzer Road, Columbus, Ohio 43219-3035, unless otherwise listed. Trustees who are deemed “interested persons,” as defined in the Investment Company Act of 1940, are referred to as Interested Trustees. Trustees who are not interested persons are referred to as Independent Trustees. The Funds do not have any Interested Trustees. The Funds’ Statement of Additional Information includes additional information about the Funds’ Trustees and is available, without charge and upon request, by calling 1-800-282-8782 or by visiting www.btim.com.

 
                Number of Funds   Other Directorships
    Positions(s)   Term of Office*       in Fund Complex   Held by Trustee
    Held with   and Length of   Principal Occupation(s)   Overseen by   during the past
Name, Date of Birth   the Funds   Time Served   During Past Five Years   Trustee   five years
 
INTERESTED TRUSTEES            
 
Lucia B. Santini
One Beacon Street,
33rd Floor
Boston, MA 02108
Date of Birth: 10/2/1958
  Trustee and
President
  Since 2011   Managing Director, Boston Trust Investment Management, Inc., February, 2001 to present; Senior Vice President and Senior Portfolio Manager, Boston Trust & Investment Management Company (bank trust company), November 1993 to present.   10   None
 
INDEPENDENT TRUSTEES            
 
Michael M. Van Buskirk
Date of Birth: 2/22/1947
  Trustee and
Chairman of the
Board
  Since 1992   President and Chief Executive Officer, Ohio Bankers League, May 1991 to present.   10   The Coventry Funds Trust; Advisers Investment Trust
 
Diane E. Armstrong
Date of Birth: 7/2/1964
  Trustee   Since 2004   President, Armstrong Financial Services (financial planning firm), November 2012 to present; Managing Director of Financial Planning Services, WealthStone (financial planning firm), July 2008 to present. Principal of King, Dodson Armstrong Financial Advisors, Inc., August 2003 to July 2008. Director of Financial Planning, Hamilton Capital Management, April 2000 to August 2003.   10   The Coventry Funds Trust
 
Dr. James H. Woodward
Date of Birth: 11/24/1939
  Trustee   Since 2006   Chancellor Emeritus, University of North Carolina at Charlotte, August 2005 to present. Chancellor, North Carolina State University, June 2009 to April 2010. Chancellor, University of North Carolina at Charlotte, July 1989 to July 2005.   10   The Coventry Funds Trust
 
OFFICERS WHO ARE NOT TRUSTEES
 
Jennifer Ellis
One Beacon Street,
33rd Floor
Boston, MA 02108
Date of Birth: 7/29/1972
  Treasurer   Since 2011   Chief Financial Officer/Treasurer, Boston Trust & Investment Management Company, May 2011 to present; Finance Director, Bain Capital, June 2008 to May 2010; Vice-President of Finance, Vesbridge Partners, June 2004 to June 2008.        
                     
Curtis Barnes
100 Summer Street
Boston, MA 02110
Date of Birth: 9/24/1953
  Secretary   Since 2007   Senior Vice President-Regulatory Administration Citi Fund Services Ohio, Inc. (fund administrator), May 1995 to present.        
                     
Eric B. Phipps **
Date of Birth: 6/20/1971
  Chief Compliance
Officer
  Since 2006   Vice President, Citi Fund Services Ohio, Inc. (fund administrator), June 2006 to present. Staff Accountant, United States Securities and Exchange Commission, October 2004 to May 2006.        
 
*  
Trustees hold their position with the Funds until their resignation or removal. Officers hold their positions with the Funds until a successor has been duly elected and qualified.
**  
Mr. Phipps serves as Chief Compliance Officer. His compensation is reviewed and approved by the Board of Trustees and paid by Citi pursuant to a Compliance Services Agreement between Citi and the Trust. The fee paid pursuant to the Compliance Services Agreement by the Fund is not indicative of the total compensation received by Mr. Phipps.

79




This page intentionally left blank.

80




This page intentionally left blank.

81




     
     
    Investment Adviser
    Boston Trust Investment Management, Inc.
    One Beacon Street
    Boston, MA 02108
     
     
    Custodian and Transfer Agent
    Boston Trust & Investment Management Company
    One Beacon Street
    Boston, MA 02108
     
     
    Administrator
    Citi Fund Services Ohio, Inc.
    3435 Stelzer Road
    Columbus, OH 43219
     
     
    Distributor
    BHIL Distributors, Inc.
    4041 N. High Street, Suite 402
    Columbus, OH 43214
     
     
    Independent Registered Public Accounting Firm
    Cohen Fund Audit Services, Ltd.
    1350 Euclid Avenue, Suite 800
    Cleveland, OH 44145
     
    Legal Counsel
    Thompson Hine LLP
    41 South High Street, Suite 1700
    Columbus, OH 43215
     
     
     
     
     
     
     
    This report is intended for the shareholders of the Funds and may not be used as sales literature unless preceded or accompanied by a current prospectus.
     
     
    Past performance results shown should not be considered a representation of future performance. Share price and returns will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Statements and other information herein are dated and subject to change.
     
     
     
     
     
     
    05/13
     
     



Item 2. Code of Ethics.

  (a) The registrant has adopted a code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. This code of ethics is included as an Exhibit.
   
  (b) During the period covered by the report, with respect to the registrant’s code of ethics that applies to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions; there have been no amendments to, nor any waivers granted from, a provision that relates to any element of the code of ethics definition enumerated in paragraph (b) of this Item 2.

Item 3. Audit Committee Financial Expert.

3(a)(1) The registrant’s board of directors has determined that the registrant has at least one audit committee financial expert serving on its audit committee.
3(a)(2) The audit committee financial expert is Diane Armstrong, who is “independent” for purposes of this Item 3 of Form N-CSR.

Item 4. Principal Accountant Fees and Services.




                 
        2013   2012
(a)   Audit Fees   $ 87,750   $ 87,750
                 
                 
(b)   Audit-Related Fees   $ 13,500   $ 12,000

The fees for 2011 relate to the consent issuance in three Form 17f-2 filings filed with the Securities and Exchange Commission (“SEC”).
The fees for 2012 relate to the consent issuance in three Form 17f-2 filings filed with the SEC.




        2013   2011
(c)   Tax Fees   $ 22,500   $ 22,500

Tax fees for both years related to the preparation of the Funds’ federal and state income tax returns, federal excise tax return review and review of capital gain and income distribution calculations.

(d)   2013   2011
All Other Fees   $ 0   $ 0

Item 5.  Audit Committee of Listed Registrants.

Not applicable.

Item 6.  Investments.

(a) Included as part of the report to shareholders filed under Item 1.
(b) Not applicable.

Item 7.  Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 8.  Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 9.  Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 10.  Submission of Matters to a Vote of Security Holders.

Not applicable.

Item 11.  Controls and Procedures.

(a)  The registrant’s principal executive officer and principal financial officer have concluded, based on their evaluation of the registrant’s disclosure controls and procedures as conducted within 90 days of the filing date of this report, that these disclosure controls and procedures are adequately designed and are operating effectively to ensure that information required to be disclosed by the registrant on Form N-CSR is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

(b)  There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Act (17 CFR 270.30a-3(d)) that occurred during the second fiscal quarter of the period covered by this report that have materially affected or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 12.  Exhibits.

(a)(1)  The code of ethics that is the subject of the disclosure required by Item 2 is attached hereto.

(a)(2)  Certifications pursuant to Rule 30a-2(a) are attached hereto.

(a)(3)  Not applicable.

(b)  Certifications pursuant to Rule 30a-2(b) are furnished herewith.




SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)           The Boston Trust & Walden Funds
   
By (Signature and Title)*   /s/ Lucia Santini, President
   
Date      May 29, 2013

     Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title)*   /s/ Lucia Santini, President
   
Date      May 29, 2013
   
By (Signature and Title)*   /s/ Jennifer Ellis, Treasurer
   
Date      May 29, 2013